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SUMMARY
Stroke is  a frequent cause of death and d is a b i l i t y  in Western 
society fo r  which therapy has l i t t l e  to o f fe r .  The l im ita t io n s  of 
therapy fo r  completed stroke has placed great emphasis on stroke 
prevention and th is  is  manifested mainly by the e lim ination and 
control o f previously id e n t i f ie d  r is k  fac to rs , of which hypertension 
is  the prime example. The occurrence of a trans ien t ischaemic attack 
(TIA) is  an important r is k  fac to r because, although only a m inority  of 
strokes are preceded by such an attack, the incidence of completed 
stroke fo llow ing a TIA is  high, p a r t ic u la r ly  i f  the attack occurs in 
the carotid  te r r i t o r y .  In a m a jority  o f patients who experience a TIA 
the cause of the attack is  id e n t i f ie d ;  thromboembolic disease is  the 
commonest aetio logy and extracranial a r te r ia l  disease is  the source of 
emboli in most of these patients. In a m inority  of patients the cause 
o f th e ir  symptoms remains undiscovered, often in sp ite  of extensive 
inves tiga tion . The studies in th is  thesis set out to determine i f  TIAs 
of unknown aetiology shared the poor prognosis of thromboembolic 
attacks, and i f  so whether haemorheological abnormalities could 
explain these attacks.
A retrospective follow-up study of patients with caro tid  
d is t r ib u t io n  TIAs, in whom no embolic source had been id e n t i f ie d  by 
routine screening procedures, indicated tha t the stroke r is k  in th is  
group is  almost as high as tha t observed in studies o f the natural 
h is to ry  of TIA. In the l ig h t  of th is  f ind ing  i t  was f e l t  important to 
attempt to discover the cause of the symptoms in th is  group of 
patients with a view to developing a ra tiona l management po licy . TIAs 
are the re su lt  of focal cerebral perfusion fa i lu re  which may
th e o re t ic a l ly  be due to inadequate perfusion pressure, diminished 
vessel radius or increased blood v iscos ity .  Each of the f i r s t  two 
mechanisms has been previously implicated in the pathogenesis of TIA. 
Consequently i t  seemed reasonable to investigate the possible ro le of 
increased blood v isco s ity  in unexplained TIAs.
A prospective study o f whole blood v isco s ity ,  and i t s  
determinants, in carotid  te r r i t o r y  TIA revealed tha t there are no 
differences in whole blood v isco s ity  between patients with unexplained 
attacks and those with presumed thromboembolic disease, id e n t i f ie d  by 
Doppler carotid  scanning. Plasma fibrinogen levels were s ig n i f ic a n t ly  
higher in patients with carotid  disease compared to those without 
detectable carotid  disease. A study to compare haemorheological 
parameters in TIA patients with a normal age and sex-matched control 
group, demonstrated tha t although whole blood v iscos ity  was the same 
in both groups plasma v isco s ity  and plasma fibrinogen were both 
s ig n if ic a n t ly  higher in the TIA group. Further studies revealed tha t 
these changes in plasma v iscos ity  and fibrinogen are s im ila r  in 
magnitude to those found in peripheral a r te r ia l  disease pa tien ts , who 
have well documented blood v iscos ity  abnormalities.
Elevations in plasma fibrinogen levels may occur fo r  many 
reasons. With regard to cerebrovascular disease the most re levant 
chronic influences on the plasma fibrinogen level are the presence of 
hypertension and c iga re tte  smoking, both of which may cause i t  to 
r ise .  The p o s s ib i l i t y  tha t the elevated fibrinogen levels in TIA 
patients, p a r t ic u la r ly  those with carotid  disease, were due to an 
increased prevalence of smoking and hypertension in these groups was 
considered. Sub-group analysis revealed tha t the influence o f
c l in i c a l l y  evident a r te r ia l  disease, manifested e ithe r by symptoms or 
pos it ive  Doppler caro tid  screening, outweighed the e f fe c t  of smoking 
and hypertension.
In conclusion, TIA patients who do not have a detectable embolic 
source are at a r is k  of stroke and cardiovascular morbidity comparable 
to other patients with TIA, and therefore merit continued review 
and/or repeated or more extensive inves tiga tion . V iscosity  
abnormalities do not account fo r  symptoms in these patients . However, 
fibrinogen levels are elevated in a l l  TIA patients , most notably those 
w ith carotid  disease. In view of the association between raised plasma 
fibrinogen and a r te r ia l  disease i t  is  possible tha t patients with 
unexplained symptoms have undetected a r te r ia l  disease which acts as a 
source of emboli.
I t  is  accepted tha t fibrinogen is  a r is k  fac to r fo r  ischaemic 
heart disease and stroke, and these studies now show tha t i t  is  
associated with TIA and the degree of detectable caro tid  disease. The 
re la tionsh ip  between raised fibrinogen and atheroma may be causative, 
consequential or merely co incidenta l. I f  increases in fibr inogen 
fo llow  the development of a r te r ia l  lesions or are produced by common 
s tim u li then fibrinogen leve ls act only as markers of disease. I f  
however, raised fibrinogen levels promote atheroma production or 
predispose to thrombosis in re la t ion  to p re-ex is t ing  atheroma then 
defibrinogenation therapy may be benefic ia l in ind iv idua ls  a t r is k  
from a r te r ia l  disease. Studies on the e ff icacy  of such therapy must 
await the development o f more su itab le  drugs than are ava ilab le  a t 
present.
Chapter 1 
INTRODUCTION: STROKE AND TRANSIENT ISCHAEMIC ATTACK
Stroke is  an important cause of morbid ity and m o rta l i ty  in developed 
countries; in most of the western world i t  is  exceeded as a cause of 
death only by heart disease and malignant disease (1 ,2 ). Both s o c ia l ly  
and economically the burden of stroke morbidity is  high and although 
most of those a f f l ic te d  are e ld e r ly ,  up to one th i rd  may be o f working 
age (3). The Framingham Study demonstrated tha t almost three-quarters 
o f stroke survivors suffered long term d is a b i l i t y  and 16% were 
permanently hospita lized (4). With th is  e f fe c t  on the community i t  is
not surpris ing tha t stroke therapy and prevention are the focus of
much atten tion  and research.
Brain in fa rc t io n  is  i r re ve rs ib le  and therapy fo r  completed stroke
is  l im ited  to minimising the area of in fa rc t io n ,  re h a b i l i ta t io n  o f the
pa tien t and prevention of stroke recurrence. The inadequacy o f therapy 
fo r  completed stroke, and the p o te n t ia l ly  catastrophic e ffec ts  of th is  
event, have meant tha t great e f f o r t  has been directed towards 
id e n t ify in g  and e lim inating r is k  factors  fo r  th is  disease in the hope 
of reducing i t s  incidence. Stroke is  a heterogeneous condition 
comprising thromboembolic brain in fa rc t io n ,  intracerebral haemorrhage 
and subarachnoid haemorrhage, accounting fo r  69-80%, 10-12% and 7-8% 
respective ly, o f a l l  strokes (3 ,5). Risk factors are d i f fe re n t  fo r  
each of these conditions but on the basis of numbers alone i t  is  
obvious tha t those re lated to thromboembolic disease are the most 
re levant. The most important of these is  hypertension and i t  is  also a 
r is k  fac to r fo r  intracerebral haemorrhage. The s ign if icance of
hypertension as a r is k  fac to r is  re lated not only to i t s  strong 
corre la t ion  with cerebral in fa rc t io n  but also to i t s  high prevalence. 
Control of hypertension is  an essential fac to r in stroke prevention 
and successful pu rsu it of th is  goal has been postulated as one reason 
fo r  the diminishing stroke rate (6).
Figures fo r  many European countries, as well as the United States 
o f America, demonstrate tha t the incidence of stroke is  declin ing , and 
in some countries has been declin ing fo r  many years (2 ,7 ,8 ). The 
id e n t i f ic a t io n  and control of hypertension in the community may have 
contributed to the apparent acceleration in th is  decline in recent 
years (6,9) but cannot account fo r  changes which have been taking 
place fo r  decades; f igures from the USA fo r  example ind icate tha t the 
incidence of stroke has been decreasing since 1900 (2 ,7 ,8 ). S im ila r ly ,  
modifications in l i f e s t y le  such as stopping smoking, increasing 
exercise and decreasing d ie tary  fa t  intake, designed to lessen the 
incidence of a r te r ia l  disease generally, can also be responsible only 
fo r  recent changes.
In sp ite  o f the e ffec ts  which hypertension control and other 
changes may have had on stroke incidence i t  remains a major problem. 
One overwhelming d i f f i c u l t y  is  tha t stroke occurs in the m a jo r ity  o f 
cases without warning and under these circumstances only screening the 
general population to detect and elim inate r is k  factors  w i l l  be o f 
benefit .  In a m inority  of ind iv idua ls  however, completed stroke is  
preceded by a trans ien t ischaemic attack (TIA) and the occurrence of 
such an event presents the attending physician with an opportun ity to 
prevent i t s  progression to cerebral in fa rc t io n .  There is  disagreement 
about the proportion of completed strokes which are preceded by one or 
more TIAs; estimates range from 10% to 50% (5,10,11). Likewise, 
studies on the natural h is to ry  of TIA show a wide va r ia t ion  in the
incidence of subsequent stroke (table 1.1). There are several possible 
reasons fo r  these wide va r ia t ions . A l l  studies o f the natural h is to ry  
o f TIA were carried out several years ago and w i l l  not be repeated, 
since no TIA patients are now l e f t  untreated. I t  is  l i k e ly  tha t many 
of the groups studied were heterogeneous fo r  two reasons: f i r s t l y ,  a 
uniform, widely accepted d e f in i t io n  o f TIA was not agreed u n t i l  
re la t iv e ly  recently ; secondly, the absence of adequate assessment of 
in trac ra n ia l disease by computed tomography resulted in the inclusion 
o f patients with non-vascular cerebral diseases.
However i t  is  now generally accepted tha t trans ien t cerebral 
ischaemia carries a g reatly  increased r is k  o f subsequent stroke 
(19,20). I t  has been estimated tha t o f the patients who develop stroke 
in the f i r s t  f iv e  years a f te r  an i n i t i a l  TIA 20-24% w i l l  do so in the 
f i r s t  month and 42-50% in the f i r s t  year (17,21). A fte r th is  period 
the c l in ic a l  r is k  is  5-7% per annum (21,22) which may be up to four or 
f iv e  times the r is k  in a control population (19,20). I t  is  c lear tha t 
th is  group o f patients may benefit from investiga tion  and treatment o f 
whatever underlying disorder predisposes them to stroke.
In the m a jority  o f cases th is  underlying disorder is  a r te r ia l  
disease (See chapter 2 .2). Like a r te r ia l  disease which presents in 
other s ites  i t  is  not a localised disorder, a fa c t  which is  borne out 
by the high m o rta l i ty  from coronary disease suffered by patients who 
present with TIAs. Indeed, although the incidence of stroke is  high in 
these pa tients , the commonest cause o f death is  myocardial in fa rc t io n  
(17,18,23). The concept tha t TIA may be an early  manifestation o f 
otherwise subclin ica l a r te r ia l  disease w i l l  be discussed a t some 
length in th is  thesis.
Author Year No. strokes/patients(%) Follow up
ACHESON (12) 1964 42/82 (51.2%) 39 months (mean)
MARSHALL (13) 1964 4/180 (2%) 3 months - 7 years
PEARCE (14) 1965 2/20 (10%) 10.6 months (mean)
BAKER (15) 1968 17/79 (22.5%) 41 months (mean)
ZEIGLER (16) 1973 22/135(16.3%) 36 months (mean)
CARTLIDGE (17)* 1977 85/199(42.7%) 5£ - 20 years
TOOLE (18) 1978 11/56 (19.6%) 3 - 1 4  years
*Some patients treated
TABLE 1.1
NATURAL HISTORY OF TIA : STROKE RISK
Treatment o f patients with TIA is  controversial and randomised 
t r i a l s  of surgical and medical management are in progress. In 
addition , the assessment o f these patients by non-invasive means is  
the focus of much research. The i n i t i a l  aim of th is  thesis was to 
contribute to the management of th is  problem by studying a small group 
o f TIA patients in whom no obvious cause of th e ir  symptoms could be 
id e n t i f ie d  using current techniques of inves tiga tion ; and in whom, 
consequently, appropriate therapy could not be in s t i tu te d .  I t  was 
thought tha t abnormal blood v iscos ity  might be important in the 
genesis o f th e ir  symptoms. Exploration of th is  hypothesis led to an 
extensive evaluation of haemorheology and i t s  re la t ion  to r is k  factors  
in patients with TIA. Before the possible relevance of haemorheology 
in TIA may be discussed i t  is  necessary to define the pathophysiology 
and diagnosis of TIA in greater de ta il than has been done so fa r ,  and 
these w i l l  be discussed in the next chapter.
Chapter 2.
PATHOPHYSIOLOGY AND DIAGNOSIS OF TIA.
2.1 DEFINITION
Variable d e f in i t io n  o f TIA has been one reason fo r  the d i f fe re n t  
conclusions reached in various studies of the pathogenesis and natural 
h is to ry  o f th is  syndrome (12-18). In recognition o f th is ,  an ad hoc 
Committee fo r  the C lass if ica t io n  of Cerebrovascular Disease, set up by 
the Advisory Council fo r  the National In s t i tu te  o f Neurological and 
Communicative Disorders and Stroke, published d e f in i t io n s  covering TIA 
and a l l ie d  disorders in 1975 (24). These d e f in i t io n s  are now widely 
accepted. TIAs are defined as "episodes of temporary and focal 
cerebral dysfunction of vascular o r ig in ,  rapid in onset, which are 
variable in duration, commonly las t in g  from two to 15 minutes but 
occasionally las t ing  as long as a day". A ll attacks resolve with no 
residual d e f ic i t .  Episodes which la s t  longer than 24 hours but resolve 
completely in one week are prolonged revers ib le  ischaemic neurological 
d e f ic i ts  (PRIND) and d i f f e r  from TIAs only in th e ir  duration. Any 
d e f ic i t  which lasts  fo r  more than a week is  defined as a stroke. I t  
must be appreciated tha t these time l im i ts  are a rb i t ra ry  and do not 
imply any differences in aetio logy or necessarily delineate groups fo r  
subsequent treatment. Consequently, as w i l l  be discussed la te r  
(chapter 2 .2), there is  considerable heterogeneity w ith in  groups with 
regard to pathophysiology.
The d e f in i t io n  o f TIA uses symptomatology as i t s  sole c r i te r io n  
and the diagnosis, therefore, must depend on the h is to ry . The duration 
of most attacks is  less than 15 minutes and most signs w i l l  have 
resolved completely by the time a pa tien t obtains medical a tten tion .
I t  is  important to e l i c i t  precise de ta i ls  of an attack to allow 
d i f fe re n t ia t io n  from other syndromes which may mimic TIA. Migraine, 
fo r  example, may produce hemiplegia but a careful h is to ry  should 
id e n t i fy  patients whose attacks are accompanied by headache or are 
characterised by gradual onset of symptoms, thus excluding them from 
consideration as TIAs. I t  is  more d i f f i c u l t  to exclude other causes of 
focal symptoms by h is to ry  alone and even c l in ic a l  examination may 
contribute l i t t l e .
The vascular supply of the brain is  derived almost e n t i re ly  from 
the c i rc le  of W i l l is  a t the base o f the sku ll and th is  is  supplied in 
turn by the vertebral and carotid  a r te r ie s . TIAs are described e ithe r 
as carotid  or vertebrobasilar in d is t r ib u t io n  depending on which part 
o f the c ircu la t io n  appears to be predominantly affected. This 
anatomical d i f fe re n t ia t io n  is  associated with c l in ic a l  and 
pathophysiological differences between attacks in the two areas.
Diagnosis of vertebrobasilar ischaemia (VBI) is  more d i f f i c u l t  
because the symptoms commonly encountered, such as vert igo  and 
unsteadiness, occur in a wide range of other conditions and are often 
not re lated to cerebrovascular disease. These symptoms may also be 
vague and, in recognition o f th is ,  VBI is  not diagnosed on the basis 
of ve r t igo , d ip lop ia , dysarthria , or dysphagia alone, but only i f  
these symptoms occur in concert with other diagnostic events such as 
homonymous hemianopia or motor or sensory d e f ic i t .  Attacks in the 
carotid  te r r i t o r y  are often more d e f in i te  events and are less l i k e ly  
to be confused with anything except s ig n if ic a n t  cerebral disease.
Perhaps the most important d ifference between carotid  TIA and VBI 
is  tha t the la t te r  is  said to carry a lesser r is k  of subsequent 
stroke (13,15,16,25). This may be a l l ie d  to differences in 
pathophysiology between attacks in the two systems and is  something 
which w i l l  be discussed fu r th e r (chapter 2 .3 ). Because of th is  
perceived d ifference in stroke r is k ,  surgical treatment o f VBI in the 
form of vertebral a rte ry  surgery is  rare, in contrast to carotid  
surgery which is  widely practised.
The investiga tion  of symptomatic patients to exclude non-vascular 
causes of TIA and to id e n t i fy  the l i k e ly  aetio logy of an attack w i l l  
be discussed la te r .  An understanding of the pathophysiology of TIA is  
an important prerequis ite  fo r  the appreciation of the methods used to 
investigate these patients and a discussion of th is  fo llows.
2.2 PATHOPHYSIOLOGY
Several pathophysiological mechanisms have been advanced to 
explain TIAs with varying degrees of acceptance. These include 
a r te r ia l  spasm, haemodynamic abnormalities, embolism and 
haematological abnormalities and each of these w i l l  now be considered 
in turn .
A. Spasm.
What was perhaps the f i r s t  attempt to explain TIAs was published 
as long ago as 1891 when vascular spasm was invoked as an explanation 
fo r  trans ien t cerebral ischaemic symptoms. Peabody reported a case o f 
recurring r ig h t  hemiparesis in a 56 year old man in whom, at post 
mortem, he was unable to detect any signs of cerebral in fa rc t io n  (26).
He a tt r ib u te d  these symptoms to spasm of the middle cerebral a rte ry  
which was of s u f f ic ie n t  duration to cause ischaemia but not s u f f ic ie n t  
to lead to in fa rc t io n .  Evidence to support th is  suggestion is  lacking.
Vasospasm is  a feature of migraine and may be seen on angiograms 
carried out during an attack o f hemiplegia a t t r ib u ta b le  to th is  
disease (27). Apparent areas of spasm have been observed in vessels in
models of hypertensive encephalopathy, but th is  is  most l i k e ly  to be a
local reactive phenomenon in response to leakage of plasma from 
damaged vessels. Harrison mentions several cases of TIA in whom the 
blood pressure was found to be grossly elevated during a TIA and 
suggests tha t reactive vasoconstriction as a response to increased 
perfusion pressure may be relevant (28). No evidence ex is ts  to suggest
tha t th is  re f le x  spasm leads to focal ischaemia and th is
pathophysiological mechanism remains unproven.
B. Haemodynamics.
Decreased cerebral perfusion almost inva r iab ly  leads to global 
rather than focal symptoms. This was demonstrated by Kendell and 
Marshall in 1963 when they studied 37 patients with TIA (29). Attempts 
to reproduce th e ir  focal symptoms by manipulation on a t i l t  table 
fo llow ing the administration of ganglion blocking drugs fa i le d  in a l l  
but one case. Examination of patients during TIAs has also shown tha t 
few are hypotensive at the time of the attack (30).
I f  haemodynamic events were important in the pathogenesis o f TIA 
then some association between manoeuvres l i k e ly  to produce hypotension 
and the onset of symptoms should be apparent. While there have been 
iso lated cases reported where l inks  between onset of TIA and 
p re c ip ita t in g  factors have been apparent, these are most unusual (31).
Cardiac arrhythmias may produce systemic hypotension and might 
be expected to produce symptoms due to cerebral hypoperfusion. Again 
these symptoms tend to be global rather than foca l.  In 290 patients 
requiring pacemaker insertion  fo r  cardiac arrhythmias Reed et al found 
only four who described focal cerebral symptoms, while global cerebral 
symptoms were common, occurring in 235 patients (32). In another 
report of cardiac arrhythmia associated with cerebral ischaemia, none 
o f the patients studied experienced focal symptoms (33). A contro lled 
study of possible cardiac causes of TIA found tha t the incidence of 
arrhythmias in the control population was as high as in the group of 
patients with TIA (34).
In unusual circumstances reduced cerebral perfusion pressure may 
lead to focal signs and th is  was the case in the pa tien t described by 
Eastcott in the f i r s t  European report of a successful caro tid  
reconstruction (35). This pa tien t experienced recurrent hemiplegic 
attacks and amaurosis fugax coincident with episodes of cardiac 
arrhythmia. Angiography demonstrated a r ig h t  caro tid  stenosis 
ip s i la te ra l  to the affected hemisphere. Surgical correction of the 
stenosis by excision and end to end anastomosis caused reso lu tion of 
the cerebral symptoms, although the arrhythmias persisted 
postoperatively. Ruff observed several patients who became hypotensive 
in the course of arteriography and only those with a haemodynamically 
s ig n if ic a n t  carotid  stenosis developed focal neurological d e f ic i t s  
(36).
In summary, therefore, i t  appears tha t hypotension, however 
caused, w i l l  only provoke focal cerebral symptoms in unusual 
circumstances eg, when a t ig h t  a r te r ia l  stenosis renders a region 
se le c t ive ly  vulnerable to a drop in perfusion pressure. This mechanism 
probably accounts fo r  only a small proportion of a l l  TIAs.
C. Embolism
Denny-Brown in 1960 re lated TIA to stenosis or occlusion of at 
least one major cerebral a rte ry  and proposed tha t i t  could be 
p rec ip ita ted by a decrease in blood pressure, anaemia or increased 
blood v iscos ity .  He also postulated tha t recovery from the attacks 
depended upon co lla te ra l c ircu la t io n  and tha t cerebral emboli may be 
important in th e ir  pathogenesis (37).
Shortly before th is  in 1959 Fisher had published an account of 
observations of the re t in a l vessels in a pa tien t during the course of 
an attack of amaurosis fugax (38). White material was observed in the 
vessels obstructing b ifu rca tions  then gradually fragmenting and moving 
more d is ta l ly .  Obstruction of the re t in a l vessels corresponded to the 
pattern of visual f ie ld  loss and, as the embolus fragmented, v is ion  
gradually returned. These observations were confirmed two years la te r  
by Ross Russell (39). This was the f i r s t  d ire c t  evidence tha t symptoms 
of trans ien t vascular obstruction in the re t ina  were due to emboli and 
not to vascular spasm. I t  was considered tha t such events were 
un like ly  to be confined to the v is ib le  vessels of the re t ina  and 
s im ila r  embolic occlusion of the cerebral vessels could be in fe rred  to 
explain other TIAs. At the time of th e ir  i n i t i a l  observations Fisher 
and Ross Russell were unaware of the nature of the substance which 
constituted the embolic m ateria l. Later, McBrien and his co-workers 
demonstrated from pathological studies tha t these emboli in the 
re t in a l a r te r ies  were made up o f p la te le t  aggregates (40).
Most of the evidence in favour of embolism as a cause o f TIA is  
in d ire c t .  For example, the occurrence of atheroma at the caro tid  
b ifu rca tion  is  much more frequent in TIA patients than in con tro ls . 
Harrison and Marshall compared angiograms from patients with completed
stroke, TIA, and cerebral tumour, and noted tha t atheroma s u f f ic ie n t  
to cause stenosis at the o r ig in  of the in terna l carotid  was present in 
40% of patients with hemispheric TIA, but in only 3% of patients with 
cerebral tumour (41). The degree o f stenosis at the carotid  
b ifu rca tion  is  ra re ly  s u f f ic ie n t  to cause reduction in flow. I t  has 
been demonstrated in a carotid  model tha t only when the cross 
sectional area of a stenosis is  less than two square m il l im e tres , is  
reduction in flow inev itab le , and a stenosis which leaves a luminal 
cross sectional area greater than 5mm2, never produces decreased flow , 
provided pressure is  maintained (42). In a medium-sized in terna l 
carotid  of 10mm diameter, a cross sectional area of 5mm2 is  achieved 
with a stenosis greater than 80% and a 2mm2 area with a stenosis 
greater than 90%. When atheroma produces stenosis less severe than 
th is ,  the association between i t  and TIA presumably depends on i t s  
a b i l i t y  to produce emboli.
A number of studies have shown tha t caro tid  endarterectomy 
performed soon a fte r  a TIA is  more l i k e ly  to demonstrate thrombus in 
association with atheroma than i f  i t  is  performed a fte r  a greater time 
in te rv a l.  In an i n i t i a l  study of 12 patients , Gunning reported tha t 
thrombus was present i f  endarterectomy was carried out w ith in  s ix  or 
seven weeks a f te r  a TIA, but not i f  the in te rva l was longer (43). 
Harrison and Marshall's series of 52 patients demonstrated thrombus in 
66% of cases operated on w ith in  four weeks o f a TIA but in only 21% of 
those treated la te r  then th is  (44). Thrombus formation in association 
with atheroma is  an episodic event which appears to be temporally 
re lated to the occurrence of TIA.
The chance of f ind ing  thrombus in re la t io n  to a carotid  
atheromatous plaque also varies with the degree of stenosis produced, 
ie ,  with the size of the plaque (44). In t ig h t ly  stenosed les ions, 60%
w i l l  have thrombus attached, while stenoses o f between 25% and 70% 
w i l l  be associated with thrombus in only 50% of cases. Lesser degrees 
of stenosis are associated with thrombus in only 10% of cases. Large 
atheromatous plaques are more complex structures than smaller lesions 
and often contain areas o f haemorrhage and u lcera tion , which accounts 
fo r  th is  association with thrombus formation (45). The more benign 
prognosis of minor stenosis in terms of stroke r is k  also f i t s  well 
with these observations (46). Small plaques carry a poorer prognosis 
i f  they are ulcerated (47) and carotid  endarterectomy performed in 
patients with ulcerated, non stenotic  plaques, produces r e l i e f  of 
symptoms in the m a jo r ity  o f cases (48).
Further evidence re la t in g  microembolic events to TIAs is  
available from early  angiographic study of such patients . In 25% of 
patients who have angiography carried out w ith in  48 hours of a TIA or 
minor stroke, occlusion o f small in tracerebral a r te r ies  may be 
demonstrated. These obstructions are not demonstrable on subsequent 
arteriograms in the same patients (49,50).
More support fo r  the embolic theory o f TIA pathogenesis is  
provided by the demonstration of an increased incidence of TIA in 
patients with va lvu la r heart disease. Rheumatic heart disease is  not 
uncommonly associated with embolism to the brain, re t ina , and other 
organs and these emboli may give r ise  to c l in i c a l l y  evident episodes 
of ischaemia. In a series of 325 patients with rheumatic heart 
disease, Hutchinson id e n t i f ie d  44 (14%) who had experienced c lass ic  
cerebral embolic episodes (51). Half of these patients had hemispheric 
symptoms and one quarter experienced amaurosis fugax; the remainder 
suffered vertebrobasilar attacks. Amaurosis fugax is  commonly 
associated with rheumatic heart disease, occurring in up to one-th ird  
of pa tients , and is  unrelated to the presence of arrhythmias (52). The
absence o f association with arrhythmia has led to the conclusion tha t 
emboli o r ig ina te  from the abnormal valve le a f le ts  and not from the 
chambers of the heart. Emboli a r is ing  from the a t r ia  or ven tr ic les  
secondary to f i b r i l l a t i o n  or myocardial in fa rc t io n ,  are often 
implicated in the pathogenesis of stroke. These emboli are larger and 
more stable than those o r ig ina t in g  from the valve le a f le ts  or from 
ulcerated atheromatous plaques. A possible explanation of these 
observations is  tha t small f r ia b le  emboli cause TIAs and larger stable 
emboli cause completed strokes.
The l in k  between rheumatic heart disease and TIA has long been 
established but in recent years a tten tion  has been focused on less 
well recognised disease o f the heart valves as a source o f  emboli.
Myxomatous degeneration of the m itra l valve (prolapsing m itra l valve,
floppy m itra l valve) was recognised as a d is t in c t  e n t i ty  in the la te  
1950s and early  1960s. In 1975 i t  was established tha t i t  was a common 
abnormality with an incidence of 5-10% in the general population 
(53,54). Barnett f i r s t  drew a ttention  to th is  condition as a cause o f 
TIA in 1974 with a report on four pa tients , and followed th is  w ith 
other, larger series of cases (55-57). Subsequently he found tha t 
m itra l valve prolapse occurred in 40% of patients under 45 years of
age with TIA or stroke, but in only 6.8% of an age and sex matched
control group (58); he concluded tha t i t  was a s ig n if ic a n t  source of 
emboli in young patients in whom the incidence of atheroma was low.
M itra l annulus c a lc i f ic a t io n  is  another long recognised condition 
which has only re la t iv e ly  recently been shown to be re levant in the 
pathogenesis of TIA. De Bono found tha t e ight patients in a series o f 
151 with cerebral or re t in a l ischaemia had th is  va lvu la r defect, but 
found no case among 188 matched controls (59). In four o f these cases, 
emboli were v isua lised in the re t ina  and these had appearances
consistent with c a lc i f ie d  debris. These c l in ic a l  studies o f va lvu lar 
disease have been supported in th e ir  conclusions by evidence from 
pathological studies which have shown tha t thrombus does form on 
abnormal valve cusps and may subsequently embolise (60,61).
The evidence in favour of embolism as a cause of TIA in the 
m a jority  of cases is  strong and potentia l sources of emboli may be 
found in 75% of patients with trans ien t re t in a l or cerebral ischaemia 
(34). There are, nevertheless, a number of s itua tions  which are not 
e n t i re ly  s a t is fa c to r i ly  explained by the embolism theory. Many 
patients experience m u lt ip le  TIAs which may be stereotyped, and some 
authors object to the embolic theory as an explanation of these 
attacks on the grounds tha t i t  is  d i f f i c u l t  to imagine recurrent 
emboli consis tently  f ind ing  th e ir  way in to  the same vessel. In answer 
to th is ,  Harrison points out tha t careful h is to ry  taking w i l l  
demonstrate tha t attacks, which at f i r s t  appear id e n t ic a l,  have subtle 
differences which may indicate emboli occluding adjacent but separate 
cerebral a r te r ia l  branches (62). Others point to the work by Honour in 
which repeated emboli from cerebral vessels in rabbits could be shown 
to enter the same d is ta l vessel (63).
One frequently  observed c l in ic a l  event which casts doubt on the 
theory tha t embolism can explain a l l  TIAs, is  the occurrence of 
symptoms in the d is t r ib u t io n  of an occluded vessel. In many patients 
with recurring TIAs in the carotid  d is t r ib u t io n  the attacks cease, 
without stroke, when the vessel occludes. Some patients , however, w i l l  
continue to experience trans ien t ischaemic symptoms in the 
d is t r ib u t io n  of such an occluded vessel. I f  these re su lt  from emboli, 
then these emboli must f in d  th e ir  way to the appropriate c irc u la t io n  
v ia  extra-cran ia l to in tra -c ra n ia l c o l la te ra ls ,  or across the c i r c le  
of W i l l is .  A study of these patients has revealed tha t a m a jo r ity  have
s ig n if ic a n t  disease in the vessels supplying the co lla te ra l channels 
which f i l l  the c irc u la t io n  d is ta l to the occlusion, ie , in the 
proximal common caro tid  or the external caro tid . I t  has also been 
postulated tha t emboli could arise from the proximal "stump" o f the 
occluded in terna l caro tid  and s im i la r ly  make th e i r  way v ia c o l la te ra ls  
(64). Yet another explanation is  tha t the d is ta l " t a i l "  o f thrombus in 
an occluded in terna l carotid  may release emboli in to  the c i r c le  of 
W i l l is .  These explanations are not e n t i re ly  sa tis fa c to ry  and the cause 
of symptoms in these patients remains unproved.
D. Haematological abnormalities
Neurological manifestations of haematological disease have been 
recognised since early  th is  century, and in 1960 M il l ikan  et al 
described carotid  and vertebrobasilar insu ff ic iency  as a consequence 
of polycythaemia in 22 patients seen at the Mayo c l in ic  (65). The 
symptoms described in these patients were c le a r ly  spe c if ic  
neurological events and d is t in c t  from such vague symptoms as 
dizziness, blurred v is ion , and headache, often reported by patients 
with polycythaemia. Polycythaemic patients have been extensively 
investigated by Thomas and his co-workers who have shown th a t cerebral 
blood flow (CBF) varies inversely with haematocrit (66,67). In 
patients with polycythaemia, low CBF may promote stas is in small 
vessels and give r ise  to trans ien t obstruction. A high haematocrit 
also promotes thrombus formation due to in te ractions between red c e l ls  
and p la te le ts  which are enhanced in polycythaemia by the high p la te le t  
count.
Anaemia as a cause of TIA has also been reported in the 
l i te ra tu re  but has received less a ttention  (68). I f  diminished oxygen 
supply to the brain is  postulated as a mechanism, then some
explanation of the focal nature o f the symptoms is  required. In the 
series of f iv e  patients reported by Seikert (68), at least two had 
s ig n if ic a n t  atheroma and i t  seems l i k e ly  tha t a region o f reduced 
perfusion is  essential i f  anaemia is  to produce focal rather than 
global symptoms. Anaemia is  thus akin to hypotension as a cause of 
TIA; a predisposing pattern of atherosclerosis is  required to produce 
focal symptoms.
Other unusual haematological abnormalities have been reported as 
rare causes of TIA. Severe leucocytosis in leukaemic patients has been 
id e n t i f ie d  as a cause of vertebrobasilar ischaemia, presumably as a 
re su lt  of the obstruction of small vessels by large numbers of white 
ce l ls  (69).
The p o s s ib i l i t y  tha t less read ily  detectable haematological 
abnormalities, ie ,  those producing v isco s ity  changes, may have a ro le 
in the genesis of TIAs is  a major top ic  of discussion in th is  thesis
and w i l l  be considered in de ta il la te r .
Summary
I t  is  now generally accepted tha t the commmonest and most 
important cause of TIA is  embolism from the proximal vasculature. The
carotid  b ifu rca tion  is  the commonest s i te  o f atheroma in the cerebral
c ircu la t io n  (70) and is  implicated as the source of emboli in most 
patients (34). Some patients undoubtedly embolise from other vessels 
and from diseased heart valves and th is  p o s s ib i l i t y  must be borne in 
mind during the investiga tion  of trans ien t ischaemic symptoms. In a 
small m inority  of patients haematological abnormalities may account 
fo r  th e ir  symptoms and the diagnosis is  established by a simple blood 
count.
2.3 DIAGNOSIS
C lin ica l History
The importance of the h is to ry  in the diagnosis of trans ien t 
ischaemic attacks cannot be overemphasised. The short duration of most 
attacks and the absence o f c l in ic a l  signs fo llow ing resolution means 
tha t the physician is  un like ly  to witness anything of relevance and 
must re ly  on the testimony of the pa tien t and any other witnesses to 
the event. Perhaps su rp r is ing ly  th is  does not mean tha t i t  is  a 
d i f f i c u l t  diagnosis to make but care must be taken to avoid confusion 
with a number of other neurological disturbances.
Attacks are normally divided in to  those a ffec t ing  the posterio r 
c ircu la t io n  (ve rteb robas ila r) , and those a ffec ting  the caro tid  
d is t r ib u t io n  (hemispheric). The pattern of symptoms produced in each 
area is  usually cha rac te r is t ic .  The importance of th is  separation of 
attacks in to  vertebrobasilar and carotid  is  th reefo ld . F i r s t ly ,  
vertebrobasilar ischaemia (VBI) is  believed to carry a less serious 
prognosis in terms of the l ike lihood  of subsequent stroke (13,15,16). 
Secondly, the aetio logy of attacks in d i f fe re n t  areas may vary 
s ig n i f ic a n t ly .  For example, haemodynamic disturbance due to kinking of 
vessels in the neck is  thought to be important in many instances o f 
VBI but i t  is  a rare cause of carotid  TIA (71-73). F in a lly ,  in view of 
the f i r s t  two reasons, and the re la t iv e ly  inaccessible nature o f the 
vertebral a r te r ie s , surgical in tervention is  reserved la rg e ly  fo r  the 
carotid  vessels.
Carotid TIAs are characterised by rapid onset of symptoms, 
usually maximal in less than two minutes, which commonly a f fe c t  the 
motor or sensory d is t r ib u t io n  on one side. Symptoms may be purely
motor or sensory or a combination of both. Absent or decreased motor 
function may be manifest as clumsiness, weakness, or incoordination. 
Sensory impairment alone may be less s t r ik in g  since function is  
normal; numbness or paraesthesia a ffec t ing  the arm and/or ip s i la te ra l  
leg may be the sole abnormality. Dysphasia may be a feature of caro tid  
attacks involv ing the l e f t  hemisphere but th is  symptom occurring alone 
is  not diagnostic of a TIA. Homonymous hemianopia may occur but is  an 
unusual symptom in carotid  d is t r ib u t io n  TIA. Transient un ila te ra l 
blindness (amaurosis fugax) is  an important and common presentation of 
carotid  attacks. The blindness may be complete or p a rt ia l  a ffec t ing  
only the upper or lower visual f ie ld s ,  and the pa tien t frequently  
describes the onset as being l ik e  a shutter or b lind  being lowered or 
raised. Resolution occurs in f iv e  to ten minutes and the en tire  
episode is  painless (24).
The c l in ic a l  features of vertebrobasilar attacks are often less 
precise than carotid  TIAs and VBI is  consequently more read ily  
confused with other disorders, but the h is to ry  w i l l  s t i l l  be adequate 
fo r  diagnostic purposes in nearly a l l  cases. Like carotid  attacks, 
symptoms are rapid in onset and ty p ic a l ly  la s t  less than 30 minutes. 
Motor and sensory symptoms need not be l im ited  to one side and 
un ila te ra l symptoms may a f fe c t  d i f fe re n t  sides in d i f fe re n t  attacks. 
Drop attacks may occur and visual symptoms include complete or p a r t ia l  
blindness and d ip lop ia . Vertigo, dysarthria  and dysphagia may 
accompany attacks but none of these symptoms occurring alone should be 
considered diagnostic of ischaemia (24). The duration of TIAs in both 
c ircu la t ions  is  s im ila r ;  symptoms resolve in the m a jority  o f cases 
w ith in  h a lf  an hour but may la s t  up to 24 hours.
Examination
C lin ica l examination of patients with a h is to ry  of trans ien t 
cerebral ischaemia is  concerned mainly with detection of causes o f the 
ischaemia and exclusion of other disorders which may mimic TIA; 
examination has almost no part to play in the diagnosis of the 
ischaemic event i t s e l f ,  except in the un like ly  event of the attack 
being witnessed. Since the pathogenesis of TIA is  in t im a te ly  re lated 
to cardiovascular disease, examination of the cardiovascular system as 
a whole may y ie ld  information on the aetio logy of TIA. Examination of 
peripheral pulses may show d e f ic i ts  ind ica tive  o f widespread vascular 
disease but spe c if ic  examination of the carotids is  of l i t t l e  benefit .  
Palpation of pulses in the neck ra re ly  y ie lds  useful information; 
severe stenosis or occlusion of the in terna l carotid  a r te ry  may ex is t 
in the presence of a palpably normal carotid  pulse. Auscultation of 
the cervical region fo r  b ru its  is  notoriously inaccurate in the 
detection of carotid  disease (74). Audible b ru its  can o r ig ina te  not 
only from the in terna l caro tid , where th e ir  presence may ind ica te 
c l in i c a l l y  relevant disease, but also from the external caro tid  and 
the heart. Conversely, severe in terna l carotid  stenosis may be present 
w ithout a detectable b ru i t  and an occluded vessel never produces a 
b ru i t .
The heart is  frequently a source of pathology which may be 
relevant in TIA, and p a r t icu la r  a tten tion  should be paid to the ra te , 
rhythm, and character of the pulse, the detection of abnormal 
precordial signs and sounds, and the blood pressure in both arms. The 
presence of arrhythmias, or murmurs ind ica tive  of va lvu la r disease can 
s ig n ify  possible embolic sources. The recognition (and treatment) of 
hypertension is  also important in any pa tien t with symptoms of
cerebrovascular disease in view of the well defined r is k  association. 
Examination of the op tic  fundus may reveal b r igh t intravascular 
plaques, f i r s t  described by Hollenhorst (75), which are believed to be 
cholesterol c rys ta ls  which have arisen from ulcerated atheromatous 
plaques. Rarely, during attacks of amaurosis fugax, pale p la te le t  
emboli may be seen traversing the re t in a l vessels, and c a lc i f ie d  
emboli from heart valves have been id e n t i f ie d  in the re t ina l 
c ircu la t io n  (59).
2.4 INVESTIGATION
Laboratory investiga tion  of TIA patients should include a f u l l  
blood count, serum biochemistry, blood glucose and plasma l ip id s .  An 
electrocardiograph (ECG) w i l l  ass is t in detection of relevant cardiac 
disease and ind icate which patients should have more deta iled cardiac 
assessment using echocardiography or 24 hour ambulatory ECG 
monitoring. I t  is  now accepted tha t these la t te r  tests have l i t t l e  
place in the evaluation of TIA patients as a group but rather have an 
important ro le to f u l f i l  in the fu r the r investiga tion  of ind iv idua ls  
selected on the basis of abnormal physical examination or ECG 
abnormalities (76-79). In view o f the higher proportion of younger 
patients shown to have cardiac abnormalities some authors have 
suggested tha t these investigations should also be carried out 
rou tine ly  in patients under the age o f 45 who present w ith TIA or 
stroke (80,81).
Atheroma of the extracranial carotid  a rte ry  is  found in 31-78% of 
patients with carotid  d is t r ib u t io n  TIAs (34,50,82-85); evaluation o f 
the carotid  vessels is  therefore an important part of the assessment
of these patients . Trad itiona l in t ra -a r te r ia l  angiography is  the most 
d ire c t  and s t i l l  the most accurate method of displaying the carotid  
c ircu la t io n  but i t  is  invasive with a d e f in i te  morbidity. In an 
attempt to diminish the demand fo r  and therefore the morbid ity from 
arteriography, many non-invasive tests which detect disordered carotid  
c ircu la t io n  have been devised in the past ten years. Non-invasive 
assessment of the carotid  vasculature may be d ire c t  or in d ire c t .
D irect tests  re ly  on information gained d ire c t ly  from the carotid  
vessels a t, or close to , the common carotid  b ifu rca t io n ; in d ire c t  
tests assess changes in the more d is ta l carotid  c irc u la t io n .  A b r ie f  
review of the most re levant tests  with a discussion of th e ir  
underlying p r inc ip les  and current usefulness fo llows.
Ind irec t tests
Ophthalmodynamometry
This technique was developed early  th is  century and involves 
increasing in traocu la r pressure to the point where blanching of the 
ophthalmic a r te ry , observed through an ophthalmoscope, ind icates tha t 
in traocu lar and ophthalmic a r te r ia l  pressures are equal. I t  was 
developed i n i t i a l l y  to measure pressure in the re t in a l a r te ry  which is  
a d ire c t  branch of the in terna l caro tid ; changes in i t s  pressure often 
m irror changes in carotid  artery  pressure. Stenosis or occlusion of 
the in terna l carotid  on one side may produce a lowering o f the 
ip s i la te ra l  re t in a l a rte ry  pressure. A d ifference between sides o f 15% 
or more strongly suggests in terna l caro tid  disease (86). There are 
l im ita t io n s  to the usefulness of th is  examination as a screening te s t  
fo r  carotid  disease. F i r s t ly ,  i t  w i l l  only detect high grade stenosis 
or occlusion; lesser degrees of stenosis or ulcerated plaques which 
may be of diagnostic relevance w i l l  be overlooked. Secondly, even in
patients with occlusion or high grade stenosis, co l la te ra l c ircu la t io n  
may develop s u f f ic ie n t ly  to equalise pressure in the re t in a l a r te r ies  
and no abnormality w i l l  be apparent. S im ila r ly  b i la te ra l  carotid  
disease may produce equal lowering of pressure on both sides and 
y ie ld  an apparently normal re s u lt .  For these reasons th is  
investigation has been la rge ly  superseded in the detection of carotid  
artery  disease.
A ir  oculoplethysmography (PPG)
A ir  OPG is  a more ob jective method of measuring ophthalmic a rte ry  
pressure. Small suction cups are applied to the sclera and an 
increasing vacuum applied. This causes a r ise  in in traocu la r pressure 
which is  proportional to the vacuum. The suction cups are also 
connected to a pulse detector which records ophthalmic a rte ry  
pulsation. Pulsation ceases when in traocu lar pressure exceeds 
ophthalmic a rte ry  pressure. Difference between the sides suggests 
carotid  disease. The drawbacks o f th is  investiga tion  are s im ila r  to 
those of ophthalmodynamometry. In an e f fo r t  to overcome these, various 
manoeuvres, including carotid  compression and ca lcu la tion of the ra t io  
of ophthalmic a rte ry  to brachial a r te ry  pressure have been recommended 
to improve the diagnostic accuracy of th is  procedure (87). Despite 
th is  the diagnostic usefulness o f th is  te s t  remains l im ited  to the 
detection o f occlusion or near occlusion and even so i t  may not be 
able to d is tingu ish  between these two states.
Fluid oculoplethysmography
Pulsation of the eyeball during systole provides the basis fo r  
the more sophisticated technique of f l u id  oculoplethysmography. 
Systo lic  expansion is  detected by f lu id  f i l l e d  sc lera l cups; the 
waveform, timing and amplitude of the pulse may be studied. U n ila te ra l 
carotid  disease is  detected by comparing the r ig h t  and l e f t  eyes and
b i la te ra l  stenoses by comparing the ocular pulse with the ear pulse 
v ia photoplethysmographic sensors on the ear lobe. Using th is  
technique alone stenosis of greater than 40% in the in terna l caro tid  
may be detected with an accuracy of 87% (88). This technique shares a 
disadvantage common to a l l  in d ire c t  tests which is  tha t even when 
abnormalities are detected, no information on th e ir  location is  
ava ilab le. This may be improved by combining th is  investiga tion  with 
phonoangiography, discussed below.
Supraorbital Doppler
The supraorbita l a rte ry  is  a branch of the ophthalmic a rte ry  
which takes part in the superf ic ia l temporal anastomosis w ith the 
superf ic ia l temporal a rte ry . Normal flow in the supraorbital a r te ry  is  
directed out of the o rb i t ,  but in cases of in terna l carotid  stenosis 
th is  flow may be reversed. Under these circumstances compression o f 
the ip s i la te ra l  supe rf ic ia l temporal a r te ry , instead of re su lt ing  in 
increased flow as would normally be the case, leads to diminished, 
abolished or reversed flow in the supraorbita l a r te ry . These changes 
in flow may be detected by a d irec tiona l Doppler flow probe placed 
over the supraorbital a r te ry . This technique is  l im ited  to the 
detection of stenoses of 75% or more and even in these circumstances 
gives r ise  to many fa lse  pos it ive  and fa lse  negative resu lts  (89).
Supraorbital photoplethysmography is  an a l l ie d  technique which 
u t i l is e s  photoplethysmographs rather than Doppler probes to measure 
pulsation in the relevant vessels. I t  appears to be no be tte r than the 
Doppler method in terms o f diagnostic accuracy (90).
Direct tests
Carotid phonoangiography
The l im ited  value of auscultation o f the neck in the detection of 
carotid  b ru its  has already been mentioned. Phonoangiography is  an 
extension of simple auscultation which attempts to overcome these 
l im ita t io n s  by using a microphone to record b ru its  in the neck thus 
permitting analysis of th e ir  q u a l i ty ,  timing and duration (91). A 
b ru i t  which las ts  fo r  75% of systole is  associated with stenosis of 
50% or more and one which continues in to  d iasto le indicates a stenosis 
of 80-90%. The value o f th is  investiga tion  is  l im ited  by interference 
from b ru its  from the external carotid  and by the fa c t  tha t a t ig h t  
stenosis (greater than 90%) may produce no b ru i t .  I t  is  also 
impossible to d is t ingu ish  between occlusion and a normal vessel. These 
l im ita t io n s  are overcome by combining th is  investiga tion  with f lu id  
oculoplethysmography.
Doppler Techniques
A b r ie f  review o f the use o f Doppler detectors in the 
investiga tion  of carotid  disease is  given here. A more extensive 
discussion of the p r in c ip le s , execution and usefulness of Doppler 
imaging and spectrum analysis is  given in chapter f iv e .
1. Imaging.
Pulsed ultrasound may be used to produce an image of blood 
vessels on an oscilloscope screen. The apparatus required to do th is  
consists of a Doppler probe which both generates and receives 
ultrasound signals, and a position-sensing arm connected v ia  a 
position resolving computer to an oscilloscope. A column o f blood 
moving in the scanned vessel produces a Doppler s h i f t  in the re f lec ted  
signal and th is  is  indicated as a white spot on the oscilloscope
screen. Passing the probe to and fro  over the vessel allows a p icture 
to be b u i l t  up on the screen which re f le c ts  the shape of the column of 
blood. Using pulsed Doppler imaging alone detects carotid  stenosis of 
>25% with an overall accuracy of 72% (92); occlusion is  detected with 
an accuracy of almost 100% (92).
2. Resistance index.
Pulsed ultrasound can also be used to measure the ve lo c ity  of 
blood in vessels being scanned and th is  ca p a b il i ty  is  u t i l is e d  in 
ca lcu la tion of the so-called Pourcelot index, which is  a measure of 
carotid  stenosis. Normally there is  high ve lo c ity  flow in the in terna l 
carotid  in d iasto le  because of the re la t iv e ly  low vascular resistance 
of the cerebral c irc u la t io n .  In the external ca ro tid , as in other 
peripheral a r te r ie s ,  flow is  low in d iasto le  due to high peripheral 
resistance. Normally the pattern of flow in the common carotid  
re f le c ts  flow in the in terna l carotid  but in the presence o f in terna l 
carotid  stenosis resistance increases and d ia s to l ic  flow diminishes. 
The flow pattern in the common carotid  then resembles tha t in the 
external caro tid . The Pourcelot index is  a measure of the resistance 
to d ia s to l ic  flow in the common carotid  and is  calculated thus:
R = (Vp-Vd)/Vp
where Vp is  peak ve lo c ity  and Vd is  d ia s to l ic  ve lo c ity .  A f igu re  >0.9 
is  strongly ind ica tive  o f a haemodynamically s ig n if ic a n t  stenosis and 
one between 0.75 and 0.9 suggests stenosis. This te s t  has a very low 
s e n s i t iv i ty  and i t  is  therefore useless fo r  screening in sp ite  o f i t s  
high s p e c i f ic i t y  (90).
3. Spectrum analysis.
The re f lec ted  Doppler signal from blood flowing in a major a rte ry  
has a cha rac te r is t ic  spectrum which may be displayed graph ica lly  as a 
frequency/time p lo t .  A stenosis produces two pr inc ipa l changes in the 
pattern of laminar flow of f lu id  in a tube: an increase in ve lo c ity  
through the stenosed segment and tu rbu lent flow d is ta l to i t .  Both of 
these changes occur in blood flow through an a r te r ia l  stenosis and 
both may be detected by analysis o f changes in the Doppler s h i f t  
signal spectrum. Flow through a stenosis shows an increased peak 
frequency compared to flow in a normal vessel because peak frequency 
varies d ire c t ly  with ve lo c ity .  Examination of the signal obtained 
d is ta l to the stenosis reveals spectrum broadening, an increase in the 
range of ve lo c it ie s  in the vessel lumen ind ica tive  of tu rbu len t flow. 
Consideration of both of these changes by an experienced technician 
increases the accuracy of Doppler diagnosis of s ig n if ic a n t  (>25%) 
carotid  a rte ry  stenosis to 95% (92). (For fu r the r discussion and 
i l lu a t r a t io n  of these techniques see chapter 5.)
Combined tes ts .
The accuracy of non invasive assessment may be improved by 
combining complementary investigations and th is  is  the practice 
recommended by a number o f authors. Kartchner and McRae recommend the 
combination of f lu id  oculoplethysmography and carotid  phonoangiography 
(93). Their resu lts  demonstrate tha t stenosis of >40% can be detected 
with 90% accuracy and other reports of th is  combination confirm th is  
assertion (94).
Pulsed Doppler imaging may be eas ily  combined with waveform 
analysis and th is  is  the routine screening te s t  in the vascular 
laboratory in Gartnavel General Hospital, where the patients in th is
thesis were studied. An extensive study of these techniques and 
comparisons with other approaches were carried out by another author 
and form the basis of a thesis (92). These resu lts  show tha t in terna l 
carotid  stenosis o f >25% is  detected with an accuracy of 95%, a 
f ind ing  supported by others (95,96). This approach w i l l  be described 
in greater de ta il in the methods section of th is  thesis.
Recently Duplex scanning has become widely available and is  
increasing in popu la rity  as a method fo r  assessment of carotid  
disease. This investiga tion  combines B-mode ultrasound imaging of the 
vessels with pulsed Doppler spectral analysis and permits more 
accurate grading of caro tid  disease. Minor i r re g u la r i t ie s  o f the 
vessel wall can be detected and repeated scans may be used to monitor 
changes at the carotid  b ifu rca t io n . I t  has beeen shown tha t 
h is to log ica l cha rac te r is t ics  of carotid  plaque may be accurately 
determined using th is  method, and th is  ca p ab il i ty  is  being used to 
d iv ide patients in to  groups at high and low r is k  o f subsequent stroke 
(97). A non-homogeneous appearance of a plaque at ultrasound 
examination is  associated with intraplaque haemorrhage, which in turn 
is  more l i k e ly  to be associated with symptomatic disease (45,98). 
Findings such as these are now being used as a basis fo r  pa tien t 
selection fo r  surgery. I t  seems l i k e ly  tha t as the a v a i la b i l i t y  of 
th is  investiga tion  widens and experience in i t s  use increases, i t  w i l l  
replace ex is t ing  methods of non-invasive assessment of caro tid  
disease.
Chapter 3.
HAEMORHEOLOGY
3.1 INTRODUCTION
Rheology is  the study of the flow and deformation of l iq u id s  and 
so lids , and haemorheology is  the application of th is  study to the 
constituents o f blood. In te res t in haemorheology is  not new and a t the 
beginning of th is  century a great deal of a tten tion  was focused on 
abnormalities of blood v iscos ity .  There was considerable va r ia t ion  in 
the measurement o f v iscos ity  at th is  stage with the re su lt  tha t 
comparisons could not be made between labora tories. These 
d i f f i c u l t i e s  were compounded by the discovery in 1915 tha t blood was 
a non-Newtonian l iq u id ,  ie , i t s  v isco s ity  was not constant at a given 
temperature. I t  became apparent tha t to y ie ld  meaningful resu lts  blood 
v iscos ity  had to be measured at constant definable shear rates, and 
the a b i l i t y  to do th is  did not become available u n t i l  the development 
o f ro ta tiona l viscometers in the 1960s. Since then these machines have 
come in to  l im ited  c l in ic a l  use and in te re s t in haemorheology has been 
rekindled. This in te re s t has been fu r the r encouraged by the 
l im ita t io n s  of vascular surgery in improving blood flow in 
cardiovascular disease. Before an appreciation of the place of 
haemorheology in modern c l in ic a l  practice may be had, an understanding 
of some basic concepts of blood flow and v isco s ity  is  essentia l.
Viscosity  may be considered as the resistance to flow due to 
in terna l f r i c t io n  between adjacent layers of a f lu id .  In laminar flow, 
adjacent layers move pa ra l le l to one another but at d i f fe re n t  
v e lo c it ie s ,  and th is  movement o f one f lu id  layer on another is  called 
shearing. The ve lo c ity  gradient between layers of f lu id  is  the shear 
ra te , given by:
dv
dx
This is  represented diagramatica lly in f igu re  3.1. Shear rate is  
measured in inverse seconds ( s " l ) .
Shear stress is  the force required to produce shearing and 
consequent flow; measured as force per u n it  area and expressed in 
Pascals (Pa).
V iscosity  is  defined as the ra t io  of the shear stress to the 
shear rate i t  produces. Thus:
V iscosity  = Shear stress = Pa -  Pa.s (Pascal seconds)
Shear rate s~*
In Newtonian f lu id s ,  v iscos ity  is  constant at a given 
temperature, ie , the ra t io  of shear stress to shear rate is  constant, 
and any change in shear stress w i l l  produce a proportionate change in 
shear ra te. The behaviour of blood does not fo l low  th is  pa ttern; 
increases in shear stress produce disproportionate increases in shear 
ra te, ie , the v iscos ity  decreases with increasing shear ra te . This 
property of blood is  known as th ixo tropy and is  due mainly to 
erythrocyte aggregation and f l e x i b i l i t y .  There is  a l im i t  to th is  
v a r ia b i l i t y  of v iscos ity  and at shear rates over 100 s“ l  (present 
in most of the normal c ircu la t io n )  blood behaves in a Newtonian 
fashion. Non-Newtonian behaviour is  manifest also by the existence of 
y ie ld  stress. Yield stress is  the minimum force necessary to in i t i a t e
FIGURE 3.1 
DIAGRAMMATIC REPRESENTATION OF SHEARING 
(a fte r Dormandy (99)) .
f low; i f  shear stress decreases below y ie ld  stress, flow ceases. These 
features of the non-Newtonian properties of blood are i l lu s t ra te d  
diagrammatically in f igu re  3.2.
3.2 BLOOD FLOW IN LARGE VESSELS
I t  has been customary to consider haemorheology under the 
headings of flow in large (conductance) vessels ( ie ,  greater than 100 
pm in diameter), and flow in the m icroc ircu la t ion . Blood flow through 
a narrow tube was described by the French physician JLM Po iseu ille  in 
1846 by the formula:
q = 5Pnr^
8Ln
where Q = blood flow, P = the pressure drop across the tube, r = the 
tube radius, L = the tube length and n = v iscos ity .
This formula was i n i t i a l l y  used to describe the flow of a 
Newtonian f lu id  and i t  is  therefore inaccurate when describing blood 
flow. However, because blood behaves in a Newtonian fashion a t high 
shear rates (>100s"l) i t  allows us to discuss the major factors  
which determine flow in large vessels. The most important 
physiological influences on blood flow are exerted by perfusion 
pressure and vessel radius. In cerebral perfusion, blood flow is  held 
constant over a wide range o f perfusion pressure by va r ia tions  in 
vascular tone. However, in pathological states when th is  
autoregulatory a b i l i t y  is  impaired or when vasodila ta tion is  maximal, 
fo r  example in the presence of ischaemia, v isco s ity  assumes much 
greater importance as a determinant of flow.
Shear 
stress
Yield 
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FIGURE 3.2
RELATIONSHIP BETWEEN SHEAR STRESS AND SHEAR RATE: 
DIFFERENCES BETWEEN BLOOD AND NEWTONIAN FLUID 
(a fte r Dormandy (99)) .
Haematocrit is  the major con tr ibu tor to blood v iscos ity  at a l l  
shear rates (100,101) and, p a r t ic u la r ly  above i t s  physiological range, 
re la t iv e ly  small increases in haematocrit w i l l  produce large increases 
in v iscos ity  (Figures 3.3 and 3 .4 ). This influence o f haematocrit on 
whole blood v isco s ity  becomes more pronounced at low shear rates and 
i t  is  an important fac to r in flow in smaller vessels. Increasing the 
haematocrit has a twofold e f fe c t  on v isco s ity ;  f i r s t l y  through an 
increase in the concentration of red ce lls  and secondly by increasing 
red ce ll aggregation (rouleaux formation). Aggregation is  revers ib le  
and is  re lated to shear rate as well as to haematocrit. In streamlined 
flow in conductance vessels, shear rates are maximal close to the 
vessel wall and decrease towards the centre of the lumen. Red ce ll 
aggregates tend to occur in the centre of th is  flow where shear rates 
are lower. The formation o f these aggregates is  fa c i l i t a te d  by the 
creation of in te rc e l lu la r  bridges by protein molecules. Fibrinogen is  
known to be involved in formation of these linkages and any increase 
in i t s  concentration leads to an increase in red ce ll aggregabi1i t y  
and consequently v isco s ity .  The non-Newtonian behaviour o f blood is  
largely explained by these c e l l /p ro te in  in te ractions (102).
Erythrocyte deformabi1i t y  is  another important fac to r in whole 
blood v iscos ity .  In laminar flow in large vessels, erythrocytes deform 
and are oriented lo n g itu d in a l ly  (103). Any interference w ith th is  
deformation w i l l  tend to increase resistance to flow. However i t  is  in 
the m icroc ircu la t ion  tha t erythrocyte deformabi1i t y  and f l e x i b i l i t y  
assume th e ir  greatest importance and th is  w i l l  be discussed la te r .
Particu la te  constituents of blood other than red c e l ls  also 
contribute to v iscos ity .  White ce l ls  are large and r ig id  in comparison 
with red ce lls  but are normally present in such small numbers tha t 
th e ir  contr ibu tion to overall v iscos ity  is  re la t iv e ly  small. In
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exceptional circumstances such as leukaemia, where large numbers of 
white ce l ls  are present in the peripheral blood, th e ir  presence may 
s ig n if ic a n t ly  contribute to v isco s ity ,  mainly by plugging small 
vessels. P la te le ts  on the other hand, are normally present in large 
numbers and contribute to v isco s ity  by aggregating. In contrast to red 
ce ll rouleaux these aggregates form ir re v e rs ib ly  and may influence 
v iscos ity  in two ways. F i r s t ly ,  they may in i t i a t e  in travascular 
coagulation and subsequent thrombus formation and secondly, aggregates 
may phys ica lly  obstruct a r te r io le s  and c a p i l la r ie s .  The formation of 
p la te le t  aggregates is  influenced by a va r ie ty  of features of normal 
laminar flow in large vessels. Red ce ll aggregates occupying axia l 
positions in the blood flow tend to displace p la te le ts  la te r a l ly  to 
the high shear areas close to the vessel w a ll.  This exposes p la te le ts  
to high shear stress and may lead to p la te le t  d isruption and 
activa t ion  by release of adenosine diphosphate. The tendency of 
p la te le ts  to migrate towards the vessel wall is  increased in the 
presence of enhanced erythrocyte aggregation and th is  in turn is  
increased, as we have seen, by a raised haematocrit.
The f in a l  major con tr ibu tor to whole blood v isco s ity  is  plasma. 
Plasma v iscos ity  is  determined almost e n t i re ly  by the protein 
concentration. The re la t iv e  contributions to v isco s ity  of the 
d i f fe re n t  proteins depends on th e ir  concentration, molecular s ize , and 
molecular shape. Albumin and globulin  are the most abundant proteins 
in plasma and are responsible fo r  about 75% of plasma v isco s ity .  
Fibrinogen makes up less than 5% of plasma protein content but is  
responsible fo r  more than 20% of the measured v isco s ity .  This is  
because of i t s  very high molecular weight (340,000, about f iv e  times 
tha t of albumin) and i t s  elongated shape. The length to diameter ra t io  
of the fibrinogen molecule is  18.4 compared to 3.95 fo r  albumin and
th is  physical property is  responsible in part fo r  the disproportionate 
con tr ibu tion to plasma v iscos ity  (104). As mentioned above, red ce ll 
aggregation is  influenced by plasma protein concentration and 
fibrinogen has been shown to form bridges between red c e l ls .  The 
influence of fibrinogen on blood v isco s ity  is  therefore two-fo ld and 
th is  may explain why the fibrinogen concentration has such an 
apparently disproportionate influence on blood v iscos ity ,  and why 
factors which influence fibrinogen concentration are so important in a 
c l in ic a l  se tt ing .
3.3 BLOOD FLOW IN THE MICROCIRCULATION
In vessels less than 100pm in diameter blood flow is  influenced 
by several e ffec ts  which are not apparent in conductance vessels. The 
most important difference is  an apparent reduction in haematocrit, and 
therefore v isco s ity ,  fo r  which two separate mechanisms are 
responsible. The f i r s t ,  i n i t i a l l y  described in 1931, is  the 
Fahraeus-Lindqvist phenomenon which is  a reduction in the apparent 
v isco s ity  o f blood flowing through tubes of progressively smaller 
diameters (105). I t  is  due to the dynamic reduction in haematocrit 
caused by an increase in ve lo c ity  of red c e l ls  re la t iv e  to plasma 
which causes red ce lls  to move fu r the r apart. This re la t iv e  change in 
ve lo c ity  stems from axial migration of erythrocytes which consequently 
travel fas te r than peripheral plasma (103). The Fahraeus e f fe c t  
influences v iscos ity  u n t i l  a vessel diameter o f 5-7pm is  reached when 
a sudden increase in v iscos ity  becomes apparent. This so-called 
inversion phenomenon, f i r s t  observed by Dintenfass (106), occurs a t a 
vessel size s im ila r to the diameter of the erythrocyte and presumably
re f le c ts  the overrid ing importance of erythrocyte f l e x i b i l i t y  as a 
determinant of v isco s ity  in vessels of th is  size. The second method by 
which haematocrit is  reduced is  known as the screening e f fe c t .  This is  
a mechanical reduction in haematocrit a r is ing  from the geometry of the 
c a p i l la ry  o r i f ic e  which causes plasma to be se le c t ive ly  channelled 
in to  i t .  This e f fe c t  seems to be less s ig n if ic a n t  than the Fahraeus 
e f fe c t  in reducing c a p i l la ry  haematocrit (107).
In addition to these e ffec ts , peculiar to vessels o f small 
diameter, v iscos ity  in the m icroc ircu la t ion  is  affected by a l l  o f the 
factors which influence v iscos ity  elsewhere in the c irc u la t io n ;  
haematocrit, red ce ll f l e x i b i l i t y ,  red ce ll aggregation and plasma 
v iscos ity  are the most s ig n if ic a n t .  The influence of haematocrit on 
blood flow in the m icroc ircu la t ion  may be less than i t  is  in 
conductance vessels because of the lower haematocrit in c a p i l la ry  
beds. I t  is  s t i l l  re levant however, not least because a l l  o f the 
e ffec ts  described in the previous paragraph are to some extent 
haematocrit dependent. (107)
Erythrocyte aggregation and f l e x i b i l i t y  may have profound e ffec ts  
on the m icroc ircu la t ion , p a r t ic u la r ly  in low flow states. The diameter 
of the vessels is  such tha t they may be occluded by erythrocyte 
aggregates which can occur at low shear rates. The diameter o f 
c a p i l la r ie s  is  often less than tha t of erythrocytes and c a p i l la ry  
c ircu la t io n  depends on the f l e x i b i l i t y  and low interna l v is c o s ity  o f 
these c e l ls .  Increases in red ce ll r i g id i t y  produced by ageing, 
haemoglobinopathies or other disorders may have a deleterious e f fe c t  
on the m icroc ircu la t ion .
3 .4  SUMMARY
Blood v isco s ity  is  the th i rd  determinant of flow a f te r  perfusion 
pressure and vessel radius. I t  is  affected p r in c ip a l ly  by shear ra te , 
haematocrit, erythrocyte f l e x i b i l i t y  and aggregation, and plasma 
v iscos ity .  The re la t iv e  importance of each of these factors varies 
according to the region o f the c ircu la t io n  under consideration.
Haemorheology is  a complex subject which has only begun to be 
explored but the broad p r inc ip les  outlined in th is  chapter are a 
s u f f ic ie n t  basis fo r  an understanding of the studies which fo l lo w  in 
th is  thesis. Some aspects require more detailed discussion and th is  
w i l l  be done a t the relevant points in the te x t .
Chapter 4 .
CEREBROVASCULAR DISEASE AND HAEMORHEOLOGY
4.1 INTRODUCTION
Extensive investiga tion  of patients with TIA w i l l  reveal the 
cause in the m ajority  of cases. A few w i l l  have haematological 
disorders and other unusual explanations but the m a jority  w i l l  be 
shown to have disease of the in terna l carotid  a rte ry  or another source 
o f emboli such as va lvu la r heart disease. In a s ig n if ic a n t  m inority  
however, no apparent cause fo r  the symptoms w i l l  be discovered. In De 
Bono's series, a f te r  investiga tion  with ECG monitoring, cardiac 
ultrasound and carotid  angiography, 25% of the patients came in to  th is  
category (34). I t  was in an e f fo r t  to account fo r  the symptoms in th is  
group tha t v isco s ity  studies were in s t i tu te d  in our patients .
Flow of a l iq u id  through a tube is  c la s s ic a l ly  described 
according to the Po iseu ille  equation as being proportional to the 
pressure gradient and the fourth power of the radius and inversely 
proportional to the tube length and the v isco s ity  of the l iq u id .  I f  
cerebrovascular disease is  considered in terms of the flow of blood 
through the cerebral vasculature then i t  is  apparent tha t
abnormalities of pressure gradient and vessel radius have been 
implicated in i t s  pathogenesis but tha t the v isco s ity  component of 
th is  equation has been la rge ly  ignored. I t  is  widely accepted fo r  
example tha t hypotension and hypertension have important cerebral 
manifestations, and the ro le  of vessel diameter (with p a r t ic u la r  
reference to the carotids) in the pathogenesis of TIA has already been 
mentioned (chapter 2.2). ( I t  is  important to remember however, tha t 
a r te r ia l  stenosis most often contributes to symptomatic cerebral 
disease by acting as a source of emboli, or the s i te  of subsequent 
thrombotic occlusion, and not by l im i t in g  f low .)  The ease with which 
each of these variables is  assessed may explain th is  state o f a f fa i r s .  
Measurement o f systemic blood pressure is  easy, and accurate 
assessment of the carotid  vasculature is  now possible by v ir tu e  of 
many invasive and non-invasive techniques. Reproducible blood 
v iscos ity  measurements on the other hand, have only re la t iv e ly  
recently become available in a c l in ic a l  s itua t ion  and accurate 
assessment s t i l l  requires expensive instruments which are not widely 
ava ilab le . Another possible reason fo r  the neglect of v isco s ity  
estimations is  the fa c t  tha t manipulation of v iscos ity  in most cases 
is  of no proven therapeutic benefit.
There are several reasons fo r  believing tha t the study of blood 
v isco s ity  (haemorheology) may be important in cerebrovascular disease:
1. A re la tionsh ip  between haemorheological factors  and a r te r ia l  
disease in other s ites  is  well established.
2. Haemorheological abnormalities have been id e n t i f ie d  in stroke 
patients.
3. Morbidity and m o rta l i ty  in stroke may be re lated to 
haemorheological fac tors .
4. There is  a re la tionsh ip  between cerebral blood flow and blood 
v iscos ity .
5. Risk factors fo r  stroke have haemorheological e ffec ts .
6. Experimental work and c l in ic a l  studies suggest tha t reduction 
of v iscos ity  may be benefic ia l in thrombotic stroke.
I f  abnormal blood v iscos ity  is  involved in the pathogenesis of 
cerebrovascular disease there may be important therapeutic 
im plications. Reduction o f v iscos ity  may reduce the incidence of 
stroke in high r is k  groups, minimise the e f fe c t  o f stroke, or prevent 
recurrent stroke. The evidence supporting a l in k  between 
cerebrovascular disease and haemorheology w i l l  now be reviewed under 
the headings outlined above.
4.2 RHEOLOGY OF ARTERIAL DISEASE
Haemorheological changes have been found both in patients with 
coronary a rte ry  disease and peripheral vascular disease. Several 
studies have demonstrated increased blood v isco s ity  fo llow ing acute 
myocardial in fa rc t io n  (108,109). S im ilar abnormalities e x is t  in 
patients with ischaemic heart disease but w ithout evidence of a recent 
myocardial in fa rc t io n  (110,111). Furthermore, blood v isco s ity  has been 
re lated to the extent of coronary artery  disease demonstrated at 
arteriography (110). The reason fo r  increased blood v isco s ity  in these 
patients is  not c lear. Increased haematocrit has been demonstrated by 
some studies (110,111), but not by others (112,113). Plasma v isco s ity  
on the other hand, is  said to be increased according to most reports, 
and th is  is  l i k e ly  to be due to increased fibr inogen leve ls which have 
often been demonstrated in these groups o f patients (110-112).
In patients with peripheral a r te r ia l  disease whole blood 
v isco s ity  is  raised due to increases in haematocrit, fibrinogen or red 
ce ll  r i g id i t y  or a combination of a l l  three (114). A re la tionsh ip  has 
also been established between haemorheological abnormalities in 
patients with in te rm it te n t claudication and the need fo r  subsequent 
amputation (115). I f  vascular reconstruction is  performed on patients 
with lower limb ischaemia then g ra f t  surviva l is  related to 
preoperative blood v isco s ity  (116). In a recent placebo-controlled 
double-blind study, haemodi1ution s u f f ic ie n t  to produce a reduction in 
v isco s ity  was shown to be benefic ia l in extending the walking distance 
of patients with in te rm it te n t c laudication (117).
4.3 RHEOLOGY AND STROKE
Several authors have found increased blood v isco s ity  a f te r  
stroke. This is  mainly due to increases in haemoglobin, haematocrit 
and fibrinogen (118-120). Red ce ll de form ability  may be reduced, 
con tr ibu ting to increases in v iscos ity  but th is  f ind ing  has not been 
confirmed (121). As in patients with myocardial in fa rc t io n  i t  is  
uncertain i f  these v iscos ity  changes precede the ischaemic event or 
re su lt  from i t .  There is  a gradual reduction in v isco s ity  among 
survivors as the time elapsed since the event increases but i t  always 
remains elevated compared to controls (Lowe, personal communication).
An association between elevated haematocrit and cerebral symptoms 
has been recognised fo r  a long time in patients with polycythaemia. 
These symptoms are varied and most, l ik e  headache and ve r t ig o , are 
vague and non-specific . There is  also however, an increased incidence 
of cerebral vascular occlusive events in these patients. As observed
in chapter 2.2 polycythaemia is  associated with an increased incidence 
of TIA. This was f i r s t  reported in 1960 when M il l ikan  described 22 
patients who had both polycythaemia and trans ien t ischaemic attacks 
and he concluded tha t a thrombotic tendency could be important in the 
genesis o f TIA (65). In 1983 Pearce et al described three patients who 
presented with TIAs and who were found to have lacunar in fa rc ts  
detected by CT scanning (122). A l l  three patients had haematocrits 
greater than 53%. In a review in 1962 S ilve rs te in  et al observed an 
incidence of stroke o f between 5 and 19% in polycythaemic patients 
(123); the vast m a jority  of these events are due to thrombosis rather 
than haemorrhage and are a consequence of s tasis and thrombocytosis.
This increased l i a b i l i t y  to cerebral in fa rc t io n  varies d i re c t ly  
with the level of haematocrit (124) which suggests tha t increases in 
v iscos ity  consequent on raised haematocrit may be important in 
cerebral in fa rc t io n .  An association between level of haematocrit and 
subsequent complications c le a r ly  has important im plications fo r  
therapy; lowering the haematocrit should reduce the incidence of 
cerebral events in th is  group of patients.
Epidemiological evidence fo r  a broader l in k  between stroke r is k  
and haematocrit has been provided by the Framingham study (125). Men 
with haemoglobin values of at least 15g/dl and women with at least 
14g/dl had twice as many strokes as ind iv idua ls  with lower values.
When the e ffec ts  of smoking and hypertension, both factors  associated 
with stroke and elevated haematocrit, were taken in to  account, the 
e f fe c t  of haemoglobin level was less. I t  is  possible tha t the 
influence of hypertension and smoking on stroke r is k  is  p a r t ly  
mediated through v isco s ity  changes. The ro le  of haematocrit in the 
pathogenesis of cerebral in fa rc t io n  was fu r th e r studied by Toghi and 
his colleagues in 432 post mortem examinations (126). They
demonstrated tha t the r is k  of cerebral in fa rc t io n  was increased in 
patients with a high haematocrit and th is  r is k  increased sharply when 
haematocrit values exceeded 45%. Perhaps not su rp r is ing ly  they also 
observed tha t th is  increased r is k  is  more obvious in patients with 
severe cerebral atherosclerosis than in those with mild a r te r ia l  
disease.
4.4 MORBIDITY AND MORTALITY
M o rta l i ty  a f te r  acute stroke has been re lated to abnormal blood 
v isco s ity .  Both raised haematocrit and fibrinogen are associated with 
increased hospital m o rta l i ty  (120,127). Recovery from stroke is  
thought to depend in part on rapid development of co l la te ra l flow and 
th is  may be impaired i f  blood v iscos ity  is  increased. Following 
carotid  occlusion in ge rb i ls ,  the size of cerebral in fa rc t  produced 
increases with the haematocrit (128). S im ila r ly ,  in patients with 
carotid  occlusion, Harrison found tha t the size of in fa rc t  measured by 
CT scan was re lated to the haematocrit (129). I t  is  accepted tha t at 
the margins of a cerebral in fa rc t ,  autoregulation is  impaired and 
dynamic control of vasodila ta tion and vasoconstriction is  lo s t  (130). 
Under these circumstances blood flow is  determined by perfusion 
pressure and v iscos ity .  I f  a major vascular occlusion is  the 
underlying pathology, perfusion pressure w i l l  be reduced and v isco s ity  
may be the most important determinant of flow. Under these 
circumstances increased v iscos ity  w i l l  reduce perfusion and may lead 
to an extension of the volume of in fa rc t io n .
4.5 CEREBRAL BLOOD FLOW
One explanation of the re la tionsh ip  between high haematocrit and 
cerebrovascular disease may l i e  with the decreased cerebral blood flow 
(CBF) which occurs in patients with raised packed ce ll volumes. 
Sluggish flow leading to stasis and thrombosis is  an appealing 
concept. The cause of the decreased CBF in patients with a high 
haematocrit is  the subject of some controversy. Venesection produces 
an increase in CBF and early  studies concluded tha t th is  was at least 
p a r t ly  due to the decrease in whole blood v iscos ity  which follows 
venesection (66,67). However, a r te r ia l  oxygen content is  also reduced 
by venesection and cerebral autoregulation w i l l  cause CBF to increase 
to maintain cerebral oxygen transport. I t  was i n i t i a l l y  thought tha t 
th is  change in oxygen carriage was not s u f f ic ie n t  to explain f u l l y  the 
observed changes in CBF and v isco s ity  a lte ra t io ns  were also re levant.
Later c l in ic a l  studies cast doubt on th is  conclusion. In a study 
in 59 paraproteinaemic patients , Brown found a s ig n if ic a n t  co rre la t ion  
between CBF and a r te r ia l  oxygen content but no corre la t ion  between CBF 
and v isco s ity  (131). The same author, in another study, observed 
a r te r ia l  oxygen content and whole blood v iscos ity  in re la t io n  to CBF 
in 54 subjects with a wide range of haematocrits (132). Again a r te r ia l  
oxygen content appeared to be the main determinant of CBF. Blood 
v iscos ity  had no s ig n if ic a n t  influence on CBF once a r te r ia l  oxygen 
content had been taken in to  account. In contrast, recent animal 
studies to assess the re la t iv e  contributions of v is co s ity  and a r te r ia l  
oxygen content to the control of CBF have not substantiated these 
c l in ic a l  observations. Hudak and Muizelaar, in lambs and ge rb ils  
respective ly, have independently shown tha t both a r te r ia l  oxygen 
content and blood v iscos ity  contribute to the control o f CBF
(133,134). On balance i t  seems tha t both v isco s ity  and a r te r ia l  oxygen 
content regulate CBF to some extent but tha t in man the la t te r  is  by 
fa r  the more important.
In any event, observations on the control of CBF in subjects with 
normal vasculature may not be e n t i re ly  relevant in an e lde r ly  
population with a high incidence of cerebrovascular disease. There are 
l im i ts  to cerebral autoregulation and, when these are exceeded, blood 
flow passively fo llows changes in perfusion pressure and blood 
v isco s ity .  The importance o f v iscos ity  in determining flow may then be 
increased. Grotta in 1982 studied 53 patients and contro ls, and 
demonstrated corre la t ion  between blood v isco s ity  and CBF (101). Both 
haematocrit and fibrinogen leve ls correlated inversely with CBF when 
examined in d iv id u a l ly ,  but the association with CBF was strongest when 
they were considered together.
4.6 RISK FACTORS
The re la tionsh ip  between high haematocrit, whether pathological 
or "high normal", and stroke r is k  has been discussed (chapter 3 .3 ). 
Other factors  which influence blood v isco s ity  have also been shown to 
be r is k  factors fo r  stroke. Wilhelmsen et a l , in a prospective study 
of 792 men, found tha t raised fibrinogen and blood pressure were 
p o s it iv e ly  correlated with subsequent stroke (135). Although the 
association between fibrinogen and stroke was weaker when blood 
pressure, serum cholesterol and smoking were taken in to  account, i t  
remained s ig n if ic a n t .  Since hypertension and smoking are both
associated with a raised plasma fibrinogen (136,137), i t  is  possible 
once again tha t the association between these r is k  factors  and stroke 
is  mediated v ia v isco s ity  changes.
4.7 HAEMORHEOLOGICAL THERAPY IN STROKE
The observation tha t increased blood v isco s ity  produced by an 
elevated haematocrit increases the volume of in fa rc ts  fo llow ing 
vascular occlusion suggests tha t v iscos ity  changes in the opposite 
d irec t ion  may be benefic ia l (128,129). In patients with an adequate 
co l la te ra l c ircu la t io n  an increase in cerebral blood flow fo llow ing a 
reduction in haematocrit might be expected to improve perfusion at the 
margins o f an in fa rc t  s u f f ic ie n t ly  to l im i t  the size of tha t in fa rc t .  
In an uncontrolled study o f hypervolaemic haemodilution in nine stroke 
patients, Wood and Fleischer (138) observed neurological improvement 
in e ight. In th is  study mean haematocrit was reduced from 41% to 32%, 
mean a r te r ia l  pressure from 101 to 94mmHg and central venous pressure 
raised from 4 to 12cmH20. Despite the reduction in haematocrit i t  
was calculated from previous experimental work tha t oxygen de live ry  
(blood oxygen content x flow) was increased, p a r t ic u la r ly  in ischaemic 
tissue , and th is  constitu tes the theore tica l basis fo r  the e ff ica cy  of 
haemodilution. Further work by the same group, th is  time combining 
venesection with intravenous infusion to produce isovolaemic 
haemodilution, demonstrated encouraging quan t ita t ive  EEG changes in 11 
stroke patients (139).
Recovery from stroke is  immensely variable and c le a r ly  assessment 
o f any therapy properly requires a randomised study. Strand et al 
carried out such a study on 102 stroke patients of whom 52 received
isovolaemic haemodilution therapy in the form of venesection of 
250-650ml and synchronous infusion of Dextran 40, while the remaining 
50 acted as controls (140). Assessment of both groups at three months 
fo llow ing the ischaemic event revealed identica l m o rta l i ty  rates.
Among the survivors however, 13% of the treatment group were s t i l l  in 
hospital as opposed to 39% of the controls and the figures fo r  those 
unable to walk were 8% and 31% respective ly. In view of these 
encouraging resu lts  fu r the r randomised studies are under way.
4.8 CONCLUSION
I t  appears from evidence c ited here tha t there is  a substantia l 
l in k  between blood v iscos ity  and i t s  determinants, and cerebrovascular 
disease. In some circumstances, primary p ro l i fe ra t iv e  polycythaemia 
fo r  example, abnormal v iscos ity  is  d i re c t ly  implicated in 
cerebrovascular events, while in others, eg, elevated plasma 
fibr inogen, v iscos ity  changes and stroke may be linked simply through 
common ae tio log ica l fac to rs . Further study o f the ro le o f blood 
v isco s ity  in cerebrovascular disease is  warranted, f i r s t l y  because i t  
may increase our understanding of the condition and i t s  
pathophysiology, and secondly because manipulation of v is c o s ity  may be 
be ne f ic ia l,  not only in established stroke (see above), but in stroke 
prevention.
Chapter 5.
METHODS AND PATIENTS 
5.1 INTRODUCTION
Several techniques are common to some of the studies described in 
th is  thesis and i t  is  appropriate at th is  stage to describe these in 
d e ta i l .  In recognition of the fa c t  tha t some of the investigations are 
not widely available and are fa m il ia r  only to l im ited  numbers of 
sp e c ia l is ts ,  a discussion of the fundamental p r inc ip les  involved and 
th e ir  place in general medical practice is  included. The recruitment 
of patients and control subjects fo r  the various studies w i l l  also be 
discussed. The chapter w i l l  conclude with a description o f the 
s ta t is t ic a l  methods employed in analysis of the various data obtained 
in the studies.
5.2 PLASMA VISCOSITY
A. P r in c ip le s .
Plasma may be considered simply as a plasma protein so lu tion  fo r  
purposes of v iscos ity  measurement. Other constituents of plasma such 
as urea and glucose, contribute very l i t t l e  to v iscos ity  and even 
extreme changes in the levels of these solutes produce no measurable 
changes in v isco s ity  (89). Although plasma v iscos ity  corre lates with 
to ta l protein concentration, th is  corre la t ion  is  poor due to the 
variable e ffec ts  of d i f fe re n t  proteins on v iscos ity .  The con tr ibu tion
of any p a r t ic u la r  protein to to ta l v isco s ity  depends not only on i t s  
concentration but i t s  molecular size and configuration. Fibrinogen, 
despite i t s  re la t iv e ly  low concentration, has a d isproportionate ly 
large e f fe c t  on v isco s ity  because of i t s  molecular shape. The long 
narrow fibrinogen molecule disrupts laminar flow much more e f fe c t iv e ly  
than the more compact albumin.
Unlike whole blood, plasma is  a Newtonian f lu id  and i t s  behaviour 
w i l l  conform to the re la tionsh ip  described by the Po iseu ille  equation:
0 = 5Pnr4 
8Ln
The v isco s ity  of plasma is  independent of shear ra te.
Plasma v isco s ity  can be e f fe c t iv e ly  determined in c a p i l la ry  
viscometers in which the rate of flow along a tube of known radius and 
length under a constant head of pressure can be measured, and 
v iscos ity  calculated from th is .  Because v isco s ity  varies with 
temperature i t  must be measured a t a f ixed  known temperature to allow 
meaningful comparison o f resu lts  (see below).
Plasma v isco s ity  remains remarkably constant in the absence of 
extreme physiological in s u l t .  Overhydration, dehydration, and 
strenuous exercise may produce measurable changes and should be 
avoided p r io r  to specimen co lle c t io n . There is  evidence fo r  circadian 
influence on plasma protein concentration and the timing o f sampling 
should be decided bearing th is  in mind.
B. Plasma Viscometers
Several methods are available fo r  sa t is fa c to ry  measurement o f 
plasma v iscos ity :  c a p i l la ry  viscometers, ro ta t iona l viscometers, and 
f a l l in g  ball viscometers have a l l  been recommended. The c a p i l la ry  
viscometer developed by Harkness has been availab le commercially fo r
some years, is  widely used and is  now the recommended method 
(141,142). I t  is  an accurate machine, is  re la t iv e ly  simple to use and 
large numbers of samples may be processed rap id ly . I t  has been used 
fo r  several years in the Department of Medicine laboratory in the 
Royal In f irm ary, Glasgow where the measurements fo r  th is  thesis were 
carried out.
The Coulter Harkness viscometer (Coulter Electronics L td .,  
Harpenden, Hertfordshire , England) consists o f the fo llow ing 
components:
1. Cap illa ry  section: precision bore glass tubing of 0.38mm in 
diameter.
2. Mercury reservo ir : to provide a constant head of pressure.
This section incorporates electrodes to operate the e lec tron ic  
timer.
3. Connecting tubes and reservo ir primed with 3.6% sa line , the 
density of which is  close to the mean density of plasma.
4. E le c tr ic  pump.
5. E lectronic timer.
6. Water bath.
The viscometer is  pictured in f igu re  5.1 and represented 
diagrammatically in f igu re  5.2. The plasma sample is  added to the cup 
and is  then drawn along the c a p i l la ry  under a constant head of 
pressure provided by the mercury column. The e lec tron ic  timer is  
switched on and then o f f  as the mercury meniscus passes the two 
electrodes in the horizontal limb of the mercury f i l l e d  section o f the 
tubing. The timer measures in steps of 0.02 seconds and the recorded 
time is  displayed u n t i l  the timer is  manually reset. Waste samples are 
drawn o f f  by the pump attached to the reservo ir on the l e f t  o f the
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COULTER-HARKNESS CAPILLARY VISCOMETER.
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FIGURE 5.2
DIAGRAMMATIC REPRESENTATION OF COULTER-HARKNESS VISCOMETER 
(compare with figure 5 .1 ).
instrument. The en tire  measuring section o f the instrument is  immersed 
in the water bath at a constant temperature ( i n i t i a l l y  25°C and la te r  
37°C, in th is  series of studies)
C. Measurement
The e lec tron ic  timer measures the time taken fo r  0.2ml o f mercury 
to pass between the electrodes; an iden tica l volume of the te s t  f l u id  
is  drawn along the c a p i l la ry  in the same in te rv a l .  The v isco s ity  of
the te s t  f l u id  can then be calculated as fo llows:
V iscos ity  of = V iscosity  of standard x time flow of te s t  
te s t  f l u id  Time flow o f standard
In th is  case the standard f lu id  is  3.6% sa line , which has a 
density s im ila r  to plasma. By adjusting the head of pressure the time 
flow in seconds o f the standard so lu tion may be a ltered to become
equal to ten times the v isco s ity  in mPa.s. The ca lcu la tion then
becomes:
V iscosity  of te s t  f lu id  = 0.1 x time of flow of te s t  f lu id .
Each sample is  measured twice (only 0.5 ml. is  required each 
time) and the mean taken as the re su lt .
The reference values fo r  plasma v isco s ity  a t 37°C are 1.16-1.37 
mPa.s in adults, u n t i l  la te  middle age when increasing plasma 
fibrinogen causes a gradual r ise  (142).
D. Collection and preparation of plasma sample
Venous blood was collected v ia  an antecubital vein without stasis 
(to  avoid increase in plasma protein concentration) and transferred to 
a standard f u l l  blood count container. No anticoagulant is  free from 
e ffe c t  on plasma v isco s ity  but potassium edetate at concentrations 
provided in these bo tt les  by addition of exactly 5ml of blood has 
least e f fe c t  (142).
Separation of plasma (by cen tr ifugation  at 3,000 g fo r  10 
minutes) was carried out w ith in  four hours. Prolonged contact between 
plasma and red ce l ls  produces increased plasma v iscos ity  with s h i f t  of 
water in to  the in t ra c e l lu la r  compartment and resu lts  are therefore 
influenced by the delay between sampling and cen tr ifuga tion . A ll 
samples in th is  series were treated id e n t ic a l ly  and th is  delay was 
always between three and four hours and should have neg lig ib le  
influence on the resu lts . Once plasma has been separated from the 
c e l lu la r  blood components, i t  may be stored in a stoppered tube at 
room temperature fo r  up to a week without change in v isco s ity .  In the 
course of these studies samples were stored l ik e  th is  fo r  up to one 
week to allow processing to be carried out in batches.
E. Temperature correction
The re la tionsh ip  between plasma v isco s ity  and temperature is  
v i r t u a l l y  l inea r between 20° C and 40° C, and measurement may be made 
anywhere w ith in  th is  range and the re su lt  corrected fo r  temperature 
using a conversion fac to r (143). The International Committee fo r  
Standardisation in Haematology has recently  published guidelines fo r  
the measurement o f plasma v iscos ity  and the preferred method is  to 
carry out measurements at 37°C which obviates the need fo r  correction
(142). I n i t i a l l y  measurements fo r  studies in th is  thesis were made at 
25°C but la te r ,  in the l i g h t  of these recommendations, 37°C was the 
chosen temperature. The f i r s t  few resu lts  obtained at 25°C were 
corrected to 37° C by use of the conversion fac to r (1.288) (143).
5.3 WHOLE BLOOD VISCOSITY
A. P rinc ip les.
The measurement of whole blood v isco s ity ,  compared to the 
re la t iv e ly  simple techniques fo r  measuring plasma v isco s ity ,  is  a 
complex procedure fraught with potentia l sources of e rro r. Most 
d i f f i c u l t i e s  arise because blood is  non-Newtonian in behaviour, in 
tha t i t s  v iscos ity  varies with shear ra te. This discovery, made early
th is  century, meant tha t in te res t in the c l in ic a l  relevance of blood
v iscos ity  was la rge ly  suspended u n t i l  the 1960s when ro ta tiona l 
viscometers became available commercially. These instruments allow 
v iscos ity  measurements to be made at constant definable shear rates 
and give reproducible resu lts  which permit comparisons between 
d i f fe re n t  centres of study.
V iscosity  is  defined as the ra t io  of shear stress to shear rate
(chapter 3) and in Newtonian l iq u id s  th is  is  constant. To determine 
v isco s ity  in a non-Newtonian l iq u id  i t  is  necessary to maintain e ithe r 
the shear stress or the shear rate a t a constant level and measure the 
other. V iscos ity  is  then calculated using the ra t io  and expressed as 
v iscos ity  at tha t shear ra te. In addition to shear rate dependence, 
whole blood v isco s ity  is  also temperature dependent and measurements 
must be carried out at a f ixed  temperature, usually 37°C.
The p r in c ip le  of most ro ta t iona l viscometers is  tha t when a th in  
layer of blood is  sheared between two surfaces by ro ta t ing  one of 
them, the torque produced is  proportional to the resu lt ing  shear 
stress. V iscosity  is  then calculated thus:
V iscos ity  = Shear stress 
Shear rate
Several d i f fe re n t  viscometers are commercially available fo r  
c l in ic a l  use. The geometry of the surfaces between which the blood is  
sheared varies from instrument to instrument, as does the method fo r  
producing shear and measuring shear stress. In some instruments the 
shearing is  produced, and the resu ltan t shear stress measured, by the 
same component, while in others the shearing is  produced by one 
surface and the torque measured at the other. The instrument used fo r  
the studies presented in th is  thesis belongs in the la t te r  category 
and is  described below.
B. Viscometry.
The viscometer used in th is  study was the Contraves L.S. 30 
viscometer (Contraves Industr ia l Products L td .,  Times House, R u is lip , 
Middlesex.) (Figures 5.3 and 5.4). I t  is  well established in c l in ic a l  
research and gives accurate reproducible resu lts  at high and low shear 
rates (99). I t  is  a co-axial cylinder (Couette) viscometer, and blood 
is  sheared between the surfaces of the cup containing the sample and 
the bob suspended in i t .  The shear stress is  applied by the cup and 
the resu lt ing  torque measured by the bob. The diameters o f both bob 
and cup are large compared to the thickness o f the layer o f blood 
trapped between them, and the shear rate throughout the sample is  
consequently f a i r l y  constant.
Low-Shear30
FIGURE 5.3 
CONTRAVES LS 30 VISCOMETER.
FIGURE 5.4 
RHEOSCAN 20 PROGRAMMING UNIT.
As the cup ro ta tes, torque is  applied to the bob via the sample 
and th is  causes de flec tion  of the tension wire on which the bob is  
suspended. This de flec tion  is  opposed by torque exerted on the upper 
end of the wire by an electromagnet whose current is  contro lled by an
automatic feedback mechanism which operates v ia a m irror attached to
the upper end of the wire. Deflection of the wire and m irror is  
detected by a photoe lectr ic  system which is  responsible, v ia a 
d i f fe re n t ia l  a m p lif ie r ,  fo r  the variable current to the electromagnet. 
This current is  proportional to the torque exerted on the bob by the 
sample and is  displayed graph ica lly  against time using an XY/time 
recorder (Bryans Southern Instruments L td .,  Wilton Lane, Mitcham, 
Surrey, England.) The viscometer is  represented diagrammatically in 
f igu re  5.5.
The environment of the viscometer is  a constant source of 
possible measurement e rro r. Interference, with low shear measurements 
in p a r t ic u la r ,  may arise from a i r  currents around the bob, v ib ra t ion  
through the surface on which the viscometer stands and air/sample 
surface tension a r te fac ts . In order to minimise these e ffec ts  the bob 
and cup are sheltered by a perspex draught sh ie ld , the viscometer is  
mounted on a concrete bench and a guard r ing is  f i t t e d  over the top of 
the sample. The temperature at which measurements are made is
determined by a therm osta tica lly  contro lled water jacke t which
surrounds the cup.
C. Measurement.
The va r ia t ion  of blood v iscos ity  with shear rate makes i t  
ob liga to ry  to measure v isco s ity  at more than one rate to obtain an 
accurate overall assessment of any sample's cha rac te r is t ics . The 
International Committee fo r  Standardisation in Haematology has
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FIGURE 5.5
DIAGRAMMATIC REPRESENTATION OF CONTRAVES LS 30 VISCOMETER.
suggested tha t shear rates of Is"-*- and 100s” -*- are 
appropriate (144). At shear rates much below Is"-*- ( ie ,  very low 
shear rates) phase separation leads to inaccurate, a r t i f i c i a l l y  low 
readings, while at rates in excess o f 100s” -*- the shear dependence 
of blood v isco s ity  disappears and i t  assumes near Newtonian 
cha rac te r is t ics  as erythrocyte aggregates disperse and c e l ls  deform. 
For practica l purposes the v isco s ity  studies in th is  thesis were 
performed at 94.5s"-*- and 0.945s"-*- which are close to the 
recommended rates.
There is  a delay a f te r  addition of the sample to the cup, before 
the shear programme is  run, to allow bubbles to be removed from the 
sample and to permit the sample to reach the appropriate temperature. 
In an attempt to minimise the e ffec ts  of phase separation which may 
a ffe c t  low shear measurements the high shear programme is  run f i r s t  so 
tha t the sample is  remixed ju s t  before the low shear programme.
D. Haematocrit correction.
The con tr ibu tion of haematocrit to whole blood v isco s ity  has 
already been emphasised. In order to assess the con tr ibu tion  of other 
factors i t  is  necessary to correct v isco s ity  measurements to a 
standard haematocrit i f  p o te n t ia l ly  s ig n if ic a n t  changes are not to be 
obscured. Minor but perhaps c l in ic a l l y  meaningful a lte ra t io ns  in red 
ce ll r i g id i t y  or aggregation may eas ily  be concealed by re la t iv e ly  
small var ia tions in haematocrit, such is  i t s  influence on v is c o s ity .  
Furthermore i t  is  apparent tha t haematocrit is  not constant throughout 
the c ircu la t io n  and i t s  influence in vivo w i l l  therefore vary.
Correction fo r  haematocrit may be accomplished in three ways: 
each sample may be reconstitu ted to a standard haematocrit by the 
removal of red ce l ls  or plasma (99); a reference curve of “ normal"
samples of d i f fe r in g  haematocrits may be constructed and te s t  samples 
compared to i t  (144); or a regression equation such as tha t derived by 
Matrai using haematocrit, plasma v isco s ity  and apparent whole blood 
v isco s ity  may be u t i l is e d  (145). In practice the f i r s t  option has a 
number o f drawbacks, the most important of which are tha t i t  is  
time-consuming and p o te n t ia l ly  very inaccurate. In th is  thesis the 
regression equation below was used:
Corrected v iscos ity  = Exp(Loge(PV)+(45/Hct)xLoge(BV/P\/))
where: PV = Plasma v iscos ity  
Hct = Haematocrit
BV = Apparent blood v iscos ity  (145).
Haematocrit was measured by the microhaematocrit method using the 
Hawksley centrifuge. This method is  accurate, rapid, uses a small 
volume of blood and is  inexpensive. Samples were spun at 15,000g fo r  
f iv e  minutes and were measured in duplicate ; no allowance was made fo r  
plasma trapping between ce l ls  (144).
5.4 FIBRINOGEN
Several methods are available fo r  the measurement of plasma 
fibrinogen. The most popular, and the one which has been used fo r  a l l  
samples in th is  thes is , was i n i t i a l l y  described by von Clauss. The 
p r in c ip le  on which th is  te s t  depends is  tha t the fibrinogen 
concentration o f a plasma sample is  inversely proportional to the time 
taken fo r  c lo t  to form a fte r  the addition of thrombin to the sample.
The c lo t t in g  time of the te s t  sample is  compared to a previously 
constructed standard curve of f ibrinogen concentration against 
c lo t t in g  time and the fibr inogen concentration o f the sample derived 
(146).
Plasma samples were prepared by the addition of 4.5ml of venous 
blood, to 0.5 ml 3.2% trisodium c i t ra te  and centrifug ing th is  sample 
at 3,000g fo r  10 minutes; the supernatant plasma was then removed to a 
dry container.
Following d i lu t io n  of th is  p la te le t-poor plasma sample 1:10 with 
buffer the te s t sample was introduced to the semi-automated 
Coag-A-Mate (General Diagnostics, Miami, F lorida, USA) which obviates 
the need fo r  determining the precise moment of thrombus formation by 
eye.
Samples may be analysed in batches, i f  desired, by s tor ing  
separated plasma at -20°C; previous studies have demonstrated no 
s ig n if ic a n t  change in measurements repeated a f te r  storage fo r  one week 
in th is  fashion (147).
5.5 BLOOD SAMPLING
A standard routine when sampling blood fo r  v isco s ity  studies is  
desirable. At each of the stages of withdrawing and preparing a sample 
varia tions in technique can influence subsequent resu lts . I t  is  
p a r t ic u la r ly  important in contro lled studies tha t a l l  subjects are 
treated id e n t ic a l ly .
Plasma v isco s ity ,  haematocrit and whole blood v isco s ity  e xh ib i t  
small circadian changes and, i f  possible, a l l  samples should be taken 
at the same time of day (142,144). Changes in these variables may also
be induced by extreme physical exercise and a lte ra t io ns  in posture 
(142,144). Venous stasis p r io r  to withdrawal of blood samples produces 
plasma protein changes and a lte ra t io ns  in plasma v isco s ity .  Too rapid 
withdrawal of blood, or use o f a narrow guage needle w i l l  damage the 
c e l lu la r  elements and produce errors . No anticoagulant is  free from 
e ffe c t  on haemorheological measurements but potassium edetate has 
minimal e ffec ts  and is  recommended (144). Dry anticoagulant w i l l  
prevent d i lu t io n  e ffec ts . The length o f delay between sampling and 
analysis is  c r i t i c a l ,  and i f  prolonged delay is  unavoidable the method 
of storage of samples is  important. In ideal circumstances blood 
v iscos ity  should be estimated w ith in  four hours of sampling, and 
plasma fo r  v isco s ity  measurements should be separated from the 
c e l lu la r  elements w ith in  the same time period (144). Plasma, once 
separated, may be stored in stoppered tubes to prevent evaporation,for 
up to one week at room temperature, w ithout s ig n if ic a n t  change in 
v isco s ity  (104).
Mindful of these possible sources of e rro r, a l l  patients and 
control subjects studied in th is  thesis were treated id e n t ic a l ly .  
Samples were taken in the early afternoon, w ithout fas t in g , and 
analysed, or separated fo r  la te r  analysis in the case of plasma 
v isco s ity ,  w ith in  four hours. Blood was withdrawn using a p la s t ic  20ml 
syringe and a 21 guage needle from an antecubital vein. A l l  subjects 
were seated at the time of sampling and blood was removed without 
s tas is . I f  the application o f a tourniquet was necessary fo r  
venepuncture i t  was removed fo r  at least f iv e  seconds before 
withdrawing blood. Standard f u l l  blood count containers with dry EDTA 
were used to c o l le c t  whole blood and plasma v isco s ity  samples. The 
quantity o f EDTA in these containers is  s u f f ic ie n t  to provide ideal 
concentrations of anticoagulant (3.4 - 4.8mmol/l) a f te r  addition of
exactly 5ml of blood (144). The tubes were inverted ten times, rather 
than shaken, to ensure thorough mixing but prevent bubble formation 
and c e l lu la r  damage. Fibrinogen estimations were carried out on 
c it ra te d  samples as previously described (chapter 5.4). 
Microhaematocrit measurements were performed on a well mixed a liquo t 
from the sample used fo r  the determination of whole blood v isco s ity .
5.6 DOPPLER CAROTIDSCANNING
As observed in chapter 2.4, a large proportion of patients with 
symptoms o f carotid  d is t r ib u t io n  TIA have disease of the ip s i la te ra l  
extracranial carotid  a r te ry , and the presence and severity  of such 
disease is  d i re c t ly  re lated to the r is k  of subsequent stroke (46,85). 
Surgical correction of stenosis by carotid  endarterectomy in selected 
patients , by experienced surgeons, reduces the incidence o f stroke and 
recurrent TIA (148-150) although the sup e r io r ity  of surgical over 
medical management of these patients has not yet been demonstrated in 
a contro lled t r i a l .  Because surgical management is  so widely practised 
(over 100,000 carotid  endarterectomies are now performed each year in 
the USA (151)), the detection o f patients with disease amenable to 
surgery has assumed great importance in recent years. Arteriography is  
the t ra d i t io n a l method o f inves tiga tion , as well as being the 
yardstick  fo r  other methods, and few surgeons w i l l  undertake 
endarterectomy without f i r s t  reviewing an arteriogram. However, 
whether performed by in t ra -a r te r ia l  in jec t io n  or v ia the intravenous 
route with the aid of d ig i ta l  subtraction, arteriography is  an 
invasive procedure not w ithout r is k .  Although morbidity has lessened 
in recent years i t  is  s t i l l  measurable, and consequently th is
investiga tion  is  unsuitable fo r  use as a screening procedure, 
p a r t ic u la r ly  in view of the large percentage of patients who w i l l  not 
eventually require surgery.
Most vascular surgeons now use non-invasive assessment to 
evaluate the carotid  c irc u la t io n ,  and submit only selected ind iv idua ls  
to angiography. In the UK, more than 80% of the surgeons who regu la r ly  
perform caro tid  surgery use ultrasound as a prelim inary investiga tion
(152) and th is  is  the routine in the vascular laboratory in Gartnavel 
General Hospital, where the studies fo r  th is  thesis were carried out. 
Previous evaluation of the screening in th is  laboratory, using 
arteriography as the standard, has demonstrated an overall accuracy of 
96% in the detection of carotid  stenosis of 25% or more (92), and th is  
compares favourably with reports from other centres on the use of 
e ithe r s im ila r or d i f fe re n t  methods (93-95).
A detailed discussion of the physics and mathematics o f the 
Doppler e f fe c t  and i t s  measurement is  outwith the scope o f th is  
thes is , but an understanding o f the broad p r inc ip les  underlying the 
use o f Doppler ultrasonography in the assessment of the caro tid  
c ircu la t io n  is  desirable.
The Doppler p r in c ip le  states tha t the frequency of sound detected 
by a receiver w i l l  d i f f e r  from the frequency emitted by the source i f  
the distance between source and receiver changes during emission of 
the sound. The frequency detected by the receiver w i l l  be higher i f  
the source is  moving closer and lower i f  i t  is  moving away. I f  we now 
consider a receiver and a source s ituated side by side and sound being 
re flec ted  from a ta rge t, which therefore e f fe c t iv e ly  becomes the 
source, then movement o f the target re la t iv e  to the source/receiver 
w i l l  e f fe c t  s im ila r frequency changes in the re flec ted  sound. The 
d ifference between the emitted and the received frequencies is  the
Doppler s h i f t ,  and th is  may be detected by a demodulator, which 
compares the waveforms of the i n i t i a l  and re flec ted  sounds and 
generates the Doppler difference waveform in response. Appropriate 
analysis of the Doppler d ifference waveform y ie lds  information on the 
ve lo c ity  of the ta rge t. These e ffec ts  have been described in re la t io n  
to a system in which the target is  a sing le object moving in the axis 
of an ultrasound beam which is  continuous, but they are equally 
applicable, i f  more complex, when applied to m u lt ip le  objects, such as 
the c e l lu la r  elements of the blood, moving ob lique ly in the axis of 
the beam.
With continuous-wave Doppler ultrasound the detection of a 
Doppler s h i f t  in the beam gives no information on the distance between 
the object producing the s h i f t ,  and the source/receiver. This 
information is  c le a r ly  of some importance i f  p a r t icu la r  blood vessels 
are to be examined without interference from overlying or more deeply 
placed vascular structures. This handicap is  overcome by combining 
Doppler ultrasound with the pulse-echo p r in c ip le .  I f  the re f lec ted  
signal is  sampled a f te r  a defined time in te rva l then knowledge of the 
ve lo c ity  o f sound through tissue permits ca lcu la tion  o f the distance 
from the transducer face to the object being scanned. This process is  
fa c i l i ta te d  by producing pulses of ultrasound rather than a continuous 
wave, and these may be coded by varying th e i r  amplitude. Thus a 
pulse-Doppler can detect Doppler s h i f t  in a spe c if ic  volume o f t issue , 
the sample volume, which is  defined by the timing of the sampling and 
the beam width.
Moving from general to spe c if ic  considerations, i t  is  appropriate 
at th is  po int to describe the instruments curren tly  used in the 
vascular laboratory in Gartnavel General Hospital. According to the 
c la s s i f ic a t io n  described in chapter 2.4, Doppler screening in th is
laboratory is  a combined te s t ;  the f i r s t  part is  Doppler imaging and 
the second, spectrum analysis. Imaging is  performed using the Hokanson 
P2 U ltrasonic Arteriograph supplied by D.E.Hokanson, Issaquah, 
Washington, USA. This instrument essen tia lly  comprises an u ltrason ic  
probe attached to a position-sensing arm, a position computer and an 
oscilloscope screen. As the probe is  moved across the skin overly ing 
the vessl to be scanned, points at which Doppler s h i f ts  are detected 
are marked and stored on the oscilloscope screeen as br igh t spots. A 
two dimensional "map" of the vessel is  gradually b u i l t  up on the 
screen as the probe is  passed to and fro  over the vessel. Examples of 
normal and abnormal carotid  images are shown in f igures 5.6, 5.7 and 
5.8. Imaging of the vessel in th is  fashion is  a sensitive te s t  fo r  
c a r io t id  occlusion but is  much less useful in the detection of 
stenosis. In order to id e n t i fy  stenoses more information must be 
extracted from the Doppler s h i f t  signal by spectrum analysis.
Spectrum analysis of the Doppler s h i f t  signal may be used to 
produce a frequency/time p lo t  of the s igna l. This is  performed by a 
spectrum analyser which decodes the s h i f t  s igna l; the instrument used 
in the investigations on the patients in th is  thesis was the Doptek 
Spectrascan supplied by Doptek L td ., Terminus Road, Chichester, West 
Sussex, UK. The frequencies carried in the s h i f t  signal are d i re c t ly  
proportional to the ve lo c it ie s  of the pa rt ic le s  (c e l lu la r  elements of 
the blood) in the sample volume. A frequency/time p lo t  w i l l  therefore 
show the ve lo c ity  o f blood flow throughout the cardiac cycle. A normal 
trace from the in terna l carotid  is  shown in f igu re  5.9. Note the 
narrow band of frequencies obtained; th is  indicates tha t a l l  the 
pa rt ic le s  in the sample volume are moving at approximately the same 
ve lo c ity .  This is  a feature of laminar flow in which adjacent layers 
o f f lu id  move pa ra l le l to one another and at ve lo c it ie s  which d i f f e r
FIGURE 5 .6
DOPPLER IMAGING: APPEARANCE OF NORMAL CAROTID BIFURCATION.
FIGURE 5.7
DOPPLER CAROTID IMAGE: STENOSIS OF INTERNAL CAROTID JUST DISTAL
TO ITS ORIGIN.
FIGURE 5 .8
DOPPLER CAROTID IMAGE: INTERNAL CAROTID OCCLUSION. 
The stump of the in terna l caro tid  is  c le a r ly  v is ib le  
and the vertebral a r te ry  is  seen as a separate image 
on the extreme l e f t .
only s l ig h t ly .  Examination of f igures 5.10 and 5.11 which show the 
spectra from signals obtained at and ju s t  d is ta l to a carotid  
stenosis, demonstrates two clear differences from the normal signal in 
f igu re  5.9. F i r s t ly  the peak frequency in systole is  markedly 
increased and secondly the narrow band of frequencies previously 
present has been replaced by a much broader range - so-called spectrum 
broadening.
These two changes are a re su lt  of the changes which occur in flow 
downstream from a stenosis. Since volume flow remains unchanged, a 
reduction in luminal cross-sectional area produces an increase in mean 
ve lo c ity  and th is  is  re flec ted  in the increased peak frequency 
detected by spectral analysis. This change is  most obvious at or close 
to the stenosis. The second e f fe c t  o f diminished radius on flow 
cha rac te r is t ics  is  to produce a change from laminar to tu rbu len t flow . 
Instead of f l u id  layers moving p a ra l le l ,  with the greatest v e lo c it ie s  
in the centre o f the flow, a disorganised pattern o f flow ex is ts . A 
wide range of v e lo c it ie s  is  present among the c e l lu la r  elements in the 
bloodstream and th is  resu lts  in a wide range of frequencies in the 
Doppler s h i f t  s igna l.
Broadening of the frequency spectrum may be quantif ied  by 
physical measurement o f permanent copies of the frequency/time 
spectrum. These may be obtained by a va r ie ty  of methods including 
recording on heat sensitive  paper or photographing screen images. In 
practice however, i t  has been found tha t an experienced operator can 
id e n t i fy  s ig n if ic a n t  stenoses with equivalent accuracy by l is te n in g  to 
the Doppler s h i f t  signal on earphones.
A ll o f the TIA patients studied in th is  thesis had pulsed Doppler 
imaging and spectrum analysis of a l l  three carotid  vessels on both 
sides carried out. This examination normally takes under 30 minutes to
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FIGURE 5.9
FREQUENCY/TIME SPECTRUM: NORMAL INTERNAL CAROTID TRACE.
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FIGURE 5.10
FREQUENCY/TIME SPECTRUM: TRACE FROM INTERNAL CAROTID STENOSIS. 
Note ( i )  increased peak frequency and ( i i )  spectrum broadening
(compare f igu re  5 .9).
FIGURE 5.11
FREQUENCY/TIME SPECTRUM: TRACE FROM INTERNAL CAROTID 
DISTAL TO STENOSIS.
Note spectrum broadening (compare f igu re  5.9).
complete and is  well to le ra ted by the patients. Routine procedure is  
to id e n t i fy  each o f the vessels adjacent to the common carotid  
b ifu rca tion  and produce an image on the oscilloscope screen. An audio 
recording of the Doppler s h i f t  signal is  made from each of the vessels 
and in addition frequency/time spectra are displayed and photographed 
fo r  each vessel. In te rp re ta t ion  of each o f these recordings is  made by 
the inves tiga to r. Although th is  appproach has a subjective element, 
previous studies have shown tha t i t  is  no less accurate than objective 
measurements of permanent records, provided the observer is  adequately 
experienced. A ll o f the studies carried out on patients in th is  thesis 
were performad by the same operator, who has several years of 
experience using these techniques. Reference to Doppler examination or 
Doppler scanning elsewhere in th is  thesis re fers to the technique of 
combined Doppler imaging and Doppler spectrum analysis described in 
th is  section.
5.7 PATIENTS
A ll patients studied in th is  thesis were re ferred to the vascular 
laboratory in Gartnavel General Hospital, Glasgow fo r  Doppler 
ultrasound examination of the carotid  a r te r ie s . Sources o f re fe rra l 
are varied but are mainly the In s t i tu te  o f Neurological Sciences at 
the Southern General Hospital and medical un its  in Gartnavel and 
associated general hospita ls . There is  also a s ig n if ic a n t  number o f 
patients referred by ophthalmologists with a provisional diagnosis of 
amaurosis fugax. Patients in th is  study are drawn e n t i re ly  from the 
population of the West of Scotland.
The diagnosis of trans ien t ischaemic attack was made i n i t i a l l y  in 
a l l  cases by a neuro logist, physician, or vascular surgeon and 
confirmed by the author. A l l  cases of amaurosis fugax were seen 
i n i t i a l l y  by an ophthalmologist. At the time of interviews d e ta i ls  of 
the p a t ie n t 's  symptoms were noted along with information on symptoms 
and signs of other vascular disease. Relevant previous h is to ry  was 
also noted with p a r t icu la r  reference to myocardial in fa rc t io n  and 
hypertension. A deta iled note of the p a t ie n t 's  smoking habits was 
obtained.
The in te rva l between the trans ien t ischaemic event and re fe rra l 
to the vascular laboratory varied widely from a few days to several 
months. This va r ia t ion  was not thought to be important because 
v isco s ity  parameters in an ind iv idual are not subject to s ig n i f ic a n t  
change in the absence of marked physiological or pathological in s u lt .
5.8 STATISTICAL ANALYSIS
In a l l  o f the studies described in th is  thesis c l in ic a l  and other 
descrip tive data were c la ss if ie d  numerically and logged, together with 
a l l  numerical data obtained from measurements, on the mainframe 
computer at Glasgow Univers ity . The categories o f c la s s i f ic a t io n  of 
non-numerical data are described, where re levant, in the various 
experimental chapters. The mainframe computer is  an ICL 2988 
manufactured by In ternational Computers L td .,  and is  run using the 
V irtua l Machine Environment (VME) Operating System. Data were logged 
and edited using the Edinburgh Compatible Context Editor (ECCE) 
implemented under the VME system.
S ta t is t ic a l  analysis of a l l  data was carried out on the GVME 
computer using the MINITAB s ta t is t ic a l  package (Minitab In c . ,  3081 
Enterprise Drive, State College, Pa. 16801, USA.). MINITAB is  a 
general purpose data analysis system designed fo r  researchers who have 
l i t t l e  previous experience with computers and is  consequently 
re la t iv e ly  simple to use. Despite i t s  ease of use, i t  is  f le x ib le  and 
f a i r l y  powerful, and read ily  capable of handling data sets larger than 
the one generated by the work in th is  thesis. I t  consists of a 
worksheet made up o f rows and columns in which the data are stored. 
Manipulation, ed it ing  and analysis of the data are performed with a 
range of about 180 commands, whose functions are outlined in the 
Minitab Reference Manual (Minitab Inc .) and the Minitab Handbook
(153).
To f a c i l i t a t e  selection of appropriate s ta t is t ic a l  tests  and 
check data logging, the d is t r ib u t io n  of a l l  data sets and subsets was 
checked using a va r ie ty  o f f a c i l i t i e s  in the Minitab programme. Visual 
displays of data in the form of dotplots and histograms confirmed tha t 
a l l  data sets conformed to a normal d is t r ib u t io n .  Comparisons between 
groups were made using a pooled t - t e s t  and values expressed as means ± 
the standard e rro r. The nu ll hypothesis was re jected when p was less 
than 0.05.
Chapter 6.
FOLLOW-UP OF DOPPLER-NORMAL TIA PATIENTS
6.1 INTRODUCTION
A large percentage of patients who present with TIA are 
subsequently found to have atheroma of the in terna l caro tid , usually 
situated close to , or invo lv ing, the common carotid  b ifu rca tion  
(34,50,82-5). Of the remainder, a proportion w i l l  have cardiac disease 
which may provide a source of emboli or give r ise  to arrythmias which 
may in unusual circumstances produce focal cerebral d e f ic i ts  (Chapter 
2). Haematological disease and other conditions w i l l  account fo r  
symptoms in a fu r th e r few patients. However, exhaustive investiga tion  
of any group of TIA patients w i l l  id e n t i fy  a number whose symptoms are 
unexplained. The size of th is  group varies among d i f fe re n t  series but 
may be as large as 25% (34).
There are a number o f possible explanations fo r  th is  diagnostic 
d i f f i c u l t y .  F i r s t ly  the diagnosis of the TIA may be incorrect. As 
previously observed (Chapter 2) a number o f other conditions may 
closely mimic TIA and even experienced c l in ic ia n s  may be misled. In 
such cases the true diagnosis may become apparent in due course, 
although not revealed by appropriate investiga tion  at the time of 
presentation.
Another p o s s ib i l i t y  is  tha t embolic sources are overlooked and 
th is  may occur fo r  three reasons. They may be small, abnormally 
s ituated or the investiga tion  used to detect them may be 
in s u f f ic ie n t ly  sens it ive . Ulcerated non-stenotic atheromatous plaques 
in the carotid  may produce emboli (47) and yet remain undetected by 
arteriography. S im ila r ly ,  atheromatous lesions in the more proximal 
vasculature, the o r ig in  of the common carotid  a rte ry  and the a o rt ic  
arch fo r  example may escape detection, as indeed may more d is ta l 
in trac ran ia l lesions. The fa i lu re  to detect unusually s ited  lesions is  
of l i t t l e  practica l c l in ic a l  relevance because surgical correction is  
not normally feas ib le , but i t  may account fo r  the 25% of patients 
whose TIAs are unexplained.
The s e n s i t iv i t y  of investigations used to screen fo r  caro tid  
disease in p a r t icu la r  has been extensively studied in recent years 
because of the increasing va r ie ty  of non-invasive tests  and the 
increase in th e ir  use. S e n s it iv i ty  is  a function both of the inherent 
accuracy of the te s t  i t s e l f  and the s k i l l  and experience o f the 
investiga ting  technician. Widely varying accuracies fo r  non-invasive 
assessment o f carotid  a rte ry  disease have been reported (Chapter 2.4) 
and th is  p a r t ly  explains the varying proportion o f patients with TIA 
who are u lt im a te ly  shown to have an embolic source. The operator 
dependent aspect o f some investigations applies also to the use of 
ultrasound in the detection of cardiac va lvu la r disease, another 
potentia l embolic source.
One fu r the r p o s s ib i l i t y  worthy of consideration to account fo r  
unexplained TIAs is  tha t th e ir  mechanism may be d i f fe re n t  from a l l  
other TIAs. I t  has been proposed fo r  example, tha t abnormal p la te le t
function may cause TIAs in patients who lack other detectable 
pathophysiological mechanisms (154) and la te r  in th is  thesis the ro le 
of abnormal blood v isco s ity  in these patients w i l l  be discussed.
Whatever the reason fo r  the symptoms in these patients i t  is  of 
some in te res t to know th e ir  prognosis. I f  they have the same r is k  of 
subsequent stroke as untreated TIAs then close fo llow  up and repeated 
or more extensive investiga tion  of th e ir  symptoms may be warranted. On 
the other hand, i f  th e ir  symptoms constitu te  a single event w ith no 
important sequelae then no fu r the r care is  required. The outcome in 
th is  group of patients may vary from centre to centre depending on the 
screening techniques used and the s k i l l  with which these are applied 
as noted above. There may also be national and regional va r ia t ions  in 
the incidence and patterns of a r te r ia l  disease and i t  is  therefore 
necessary to establish the c l in ic a l  outcome of local patients with 
TIAs. For th is  reason i t  was thought necessary to fo llow  up a group of 
these patients who had non-invasive carotid  evaluation carried out in 
the vascular laboratory in Gartnavel General Hospital.
6.2 PATIENTS & METHODS
The vascular laboratory in Gartnavel General Hospital, Glasgow 
receives re fe rra ls  fo r  assessment of caro tid  disease from a wide 
va r ie ty  o f sources: neurologists, neurosurgeons, vascular surgeons, 
ophthalmologists and general physicians, both from w ith in  the hospital 
and from other in s t i tu t io n s .  Because Doppler examination of the 
carotids is  free from complications and because access to the service 
is  la rge ly  unrestr ic ted the reasons fo r  re fe rra l are many and varied. 
In order to concentrate on patients with a f irm  diagnosis o f ca ro t id
t e r r i t o r y  TIA i t  was decided to review two groups of patients . The 
f i r s t  group comprised those who had been referred from the In s t i tu te  
of Neurological Science (INS) at the Southern General Hospital fo r  
assessment of hemispheric symptoms. In practice a l l  of these patients 
are referred by, or on the ins truc tions  o f, a senior neuro logist or 
neurosurgeon. The second group o f patients were selected from those 
id e n t i f ie d  in a previous study of amaurosis fugax (155).
Group One
In the period 1981-1985 a l l  patients referred from the INS with 
hemispheric symptoms and who had normal Doppler examinations were 
considered fo r  review. I n i t i a l  information on these patients was 
obtained by examination o f th e ir  records and follow-up was carried out 
by postal questionnaire, telephone in terv iew, or in some cases by 
contact with the p a t ie n t 's  general medical p ra c t i t io n e r .  P a rt icu la r 
a tten tion  was paid to establishing the i n i t i a l  diagnosis and the 
occurrence of relevant subsequent events. In the follow-up review 
patients were asked s p e c i f ic a l ly  about recurrence of i n i t i a l  symptoms, 
new neurological symptoms, and any periods o f in -p a t ie n t hospital 
care.
Group Two
A separate review o f patients with amaurosis fugax was carried 
out in a s im ila r manner. These patients were i n i t i a l l y  id e n t i f ie d  in a 
previous study (155) and fo llow  up data was obtained using the same 
techniques o f questionnaire administration and telephone in terv iew.
The i n i t i a l  study had been designed to discover the prevalence of 
haemodynamically s ig n if ic a n t  carotid  disease in a population of 
patients with amaurosis fugax. Two hundred patients were i n i t i a l l y  
considered; of these one hundred and f iv e  were excluded from analysis 
fo r  one or more of the fo llow ing reasons: symptoms suggestive of
vertebrobasilar ischaemia, concurrent eye disease, migraine, permanent 
visual d e f ic i t  at presentation, possible non-carotid embolic source or 
vague symptoms. By using these c r i te r ia  i t  was intended tha t only 
patients with d e f in i te  amaurosis fugax and without a possible cardiac 
embolic source would be considered. Patients with a pos it ive  Doppler 
examination were excluded and the remainder considered fo r  follow-up 
in the present study.
6.3 RESULTS
Table 6.1. shows data on age, sex d is t r ib u t io n  and length o f 
follow-up fo r  both groups. I t  is  noteworthy tha t the mean age in both 
groups (51 years and 52 years respective ly) is  low when i t  is  
considered tha t the peak incidence of stroke occurs in the seventh and 
eighth decades of l i f e .  The preponderance o f males in both groups is  
also noticeable; th is  corresponds to the biased sex d is t r ib u t io n  which 
is  apparent in young stroke patients. A ll patients in group two were 
followed fo r  a t least two years and although some patients in group 
one had a re la t iv e ly  short follow-up in te rv a l ,  the mean time to review 
in th is  group was 31.7 months, and 75% of these patients were followed 
fo r  at least two years.
Group One
One hundred and seventy nine patients who had been re ferred with 
un ila te ra l symptoms, and who had no carotid  disease detected by pulsed 
Doppler examination, were id e n t i f ie d .  In s u f f ic ie n t  data were ava ilab le  
on 17 patients (9.5%) and they were excluded from the study. Of the 
remaining 162, a fu r the r 88 patients were excluded as fo llows:
-19 with symptoms suggestive of vertebrobasilar ischaemia.
Group 1 
n = 74
Mean age (range) 51 (29-70)
Sex (M : F) 51 : 23
Mean fo llow  up (range) 31.7 (6-57)
(months)
TABLE 6.1 
PATIENT DATA : FOLLOW UP STUDIES
Group 2 
n = 28
52 (22-78)
17 : 11
39.3 (24-65)
(48.6%) 
(36.5%) 
(8 . 1%) 
( 6 . 8%)
Total 74
TABLE 6.2
Symptom free 36
Recurrent TIA (including AF) 27
Stroke 6
Death 5
OUTCOME OF TIA PATIENTS WITH NORMAL DOPPLER
Symptom free 9 (32.1%)
Recurrent AF (or TIA) 12 (42.9%)
Stroke 3 (10.7%)
Death 4 (14.3%)
Total 28
TABLE 6.3
OUTCOME OF AMAUROSIS FUGAX PATIENTS WITH NORMAL DOPPLER
-18 with amaurosis fugax alone.
-43 with permanent or prolonged d e f ic i ts  at presentation (stroke
or PRIND).
-8 patients in whom prolonged follow-up revealed non-vascular 
causes fo r  th e ir  symptoms.
The resu lts  of fo llow-up of the residual 74 patients are
summarised in table 6.2. Less than h a lf  (48.6%) were symptom-free at 
the time of review while almost an equivalent proportion (44.6%) had 
experienced recurrent trans ien t ischaemic symptoms or a completed 
stroke. Of the f iv e  deaths in th is  group three were due to 
cardiovascular causes, one was due to carcinoma of the bronchus and 
the cause of the f i f t h  is  unknown.
Group Two
Twenty e ight o f the previously id e n t i f ie d  Doppler-normal patients 
were available fo r  fo llow-up. The resu lts  in th is  group are deta iled 
in table 6.3. and a high incidence of recurrent symptoms is  again 
evident. Fewer than one-th ird of these patients were symptom-free a t 
the time of review while more than h a lf  (53.6%) had suffered e ithe r 
recurrent eye symptoms, hemisphere TIAs, or a completed stroke. 
Although the m o rta l i ty  rate was high (14.3%), only one of these deaths 
was due to a cardiovascular cause.
6.4 DISCUSSION
There have been several studies which have examined the fa te  of 
patients with TIAs of unknown aetio logy. In 1971 Marshall reported 64 
patients who had had carotid  d is t r ib u t io n  TIAs (excluding amaurosis 
fugax) and who had had normal angiograms (156). There were 11 deaths
during fo llow-up, f iv e  due to cardiovascular causes and two 
a tt r ib u ta b le  to cerebrovascular disease. During the fo llow  up period 
(5.4 years) 19 (36%) of the survivors had fu r the r manifestations of 
cerebrovascular disease in the form of TIAs or completed stroke. In 
addition, almost 20% developed symptomatic vascular disease in other 
s ite s . I t  was concluded from th is  study tha t patients with TIA in whom 
no ae tio log ica l cause could be discovered were at considerably 
increased r is k  from the subsequent development of c l in i c a l l y  evident 
vascular disease. The cause of the TIAs remained obscure but a cardiac 
source of emboli was suggested by a number o f features. F i r s t ly  there 
was a high incidence of ECG abnormalities among patients who developed 
complications. Secondly, myocardial in fa rc t io n  occurred in 15% of 
patients during fo llow  up, and f in a l l y ,  there was no corre la t ion  
between the side o f the TIA and any subsequent stroke, which might 
have been expected i f  sub -c lin ica l carotid  disease was responsible.
In 1976 Toole (157) reported a series o f 226 patients with TIA 
(both carotid  and vertebrobasilar) investigated by angiography. No 
embolic source was id e n t i f ie d  in 16 patients who were then followed 
fo r  a mean o f 5.7 years. The incidence of subsequent vascular disease 
was high. Four patients developed strokes, two continued to have TIAs 
and one suffered a myocardial in fa rc t io n .  A to ta l o f f iv e  patients 
died. Toole noticed, as Marshall had done, tha t patients with 
associated disorders such as hypertension and myocardial disease at 
the time o f presentation were at most r is k  o f dying soon a f te r .
A th i rd  follow-up study o f TIAs with normal arteriograms has been 
reported in two stages by Evans and colleagues (158,159). Their most 
recent f igures show tha t in 56 patients followed fo r  a mean o f 25 
months only three have had fu r the r TIAs and one has had a myocardial
in fa rc t io n .  There have been no strokes. This suggests a more benign 
prognosis than e ithe r Marshall or Toole, but the fo l low  up period is  
s t i l l  short by comparison.
Of the studies mentioned so fa r  each has used arteriography to 
investigate a l l  patients with TIAs, in contrast to the current 
practice in Glasgow which is  to reserve arteriography fo r  those 
patients whose non-invasive evaluation suggests haemodynamically 
s ig n if ic a n t  disease (>25% stenosis). However, one study which has 
followed patients investigated by non-invasive tests  only, has been 
reported by Hershey (160). In th is  series, non-invasive assessment was 
carried out using a combination o f oculoplethysmography (OPG) and 
carotid  phonoangiography (CPA) which together have an accuracy 
approaching 90% when compared with angiography (160). Patients with a 
stenosis >50% and those with frequent "crescendo" TIAs were re ferred 
fo r  arteriography and possible surgery. The remaining patients formed 
the group fo r  review. Three hundred and f i f t y  three patients were 
followed fo r  a mean of about four years. In th is  group 7.7% developed 
strokes, 14.3% suffered recurrent TIAs and 17.5% had a myocardial 
in fa rc t io n .  I t  was observed tha t 14 of the 20 strokes in th is  series 
occurred a f te r  recurrent TIAs and tha t roughly one th i rd  o f patients 
experiencing recurrent TIAs went on to have a completed stroke.
With the exception o f the series reported by Evans, which has a 
shorter follow-up than the others, these studies ind icate tha t TIAs 
fo r  which no cause can be found do not have a good prognosis. The 
find ings from the two surveys carried out fo r  th is  thesis support th is  
contention. The 8% stroke rate in group one and the 10% rate in group 
two represent crude annual rates o f 3% and 5% respective ly, not 
sub s tan tia l ly  d i f fe re n t  from the 5% annual incidence of stroke
fo llow ing untreated TIA (21,70)(Chapter 1). Morbidity and m o rta l i ty  
from vascular diseases other than cerebrovascular disease were also 
prominent features of a l l  of the other studies, again with the 
exception of Evans's. Four of the nine deaths which occurred in our 
studies were due to cardiovascular causes.
The pathophysiological mechanism involved in the production o f 
TIAs in these patients is  not c lear, but the high incidence of 
subsequent vascular disease suggests tha t i t  is  re la ted, at least in 
some cases, to a r te r ia l  disease. The simplest explanation is  tha t the 
investigations used to detect atheroma are not s u f f ic ie n t ly  sens it ive . 
This may c le a r ly  be the case when non-invasive assessment is  u t i l is e d .  
Non-stenotic or minimally stenotic  carotid  disease w i l l  not be 
detected by the pulsed Doppler imaging and spectral analysis used in 
Gartnavel. Although atheroma which produces stenoses of <25% does not 
produce s u f f ic ie n t  flow disturbance to permit i t s  detection by these 
methods, i t  may ulcerate, become thrombogenic and act as a source of 
emboli. The OPG/CPA routine used by Hershey disregarded stenoses of 
less than 50% and th is  may account fo r  the re la t iv e ly  high stroke rate 
in his group (160).
Although conventional arteriography is  the standard by which 
non-invasive tests are judged, i t  is  by no means in f a l l i b le  and i t  is  
possible tha t minimal a r te r ia l  disease may escape detection, 
p a r t ic u la r ly  i f  in s u f f ic ie n t  views are taken or i f  the proximal and 
d is ta l vasculature are not examined. Progression of minimal a r te r ia l  
disease, overlooked at i n i t i a l  examinations, may thus be responsible 
fo r  recurrent symptoms or the development o f stroke. Since th is  
disease is  l i k e ly  to be in the early  stages of development when the 
patient f i r s t  presents, i t  is  possible tha t the in te rva l to the
development o f stroke may be longer than usual and th is  in turn may 
account fo r  the lower incidence of complications in the single study 
with a short fo llow-up (159).
6.5 SUMMARY
The prognosis of patients who present with carotid  d is t r ib u t io n  
TIAs, including amaurosis fugax, and who do not appear to have 
atheromatous disease of the carotid  b ifu rca t io n , may not be benign. 
The studies presented here suggest tha t there is  a high incidence of 
recurrent symptoms and an increased r is k  of stroke and other 
cardiovascular disease in these patients when compared to the normal 
population. Most o f the evidence in the available l i te ra tu re  supports 
th is  view. This find ing  is  at variance with what had been assumed as 
the relevance o f a "normal" Doppler carotid  scan, and has meant tha t 
follow-up of such patients has had to be changed. Further study of 
th is  group of ind iv idua ls , p a r t ic u la r ly  with regard to the aetio logy 
of th e ir  symptoms, seems warranted.
Chapter 7.
RHEOLOGICAL COMPARISON OF TIA PATIENTS WITH AND WITHOUT 
SIGNIFICANT CAROTID DISEASE
7.1 INTRODUCTION
In chapter 4.2. i t  was observed tha t although P o ise u i l le 's  law 
imprecisely described flow in the conductance vessels o f the 
c irc u la t io n ,  i t  was useful in id e n t i fy in g  the major factors 
influencing flow: the d r iv ing  pressure, the vessel radius and the 
v iscos ity  of the blood. TIAs are due to local fa i lu re  o f perfusion and 
i t  is  apparent tha t th is  may occur fo r  three reasons: inadequate 
d r iv ing  pressure, diminished vessel radius or increased blood 
v iscos ity .  Each of these three possible changes has been established 
as an ae tio log ica l fac to r in the causation of TIA. Reduced d r iv in g  
pressure (systemic hypotension) may produce perfusion fa i lu re  although 
focal signs w i l l  only re su lt  with the additional presence o f a 
stenosis which w i l l  se le c t ive ly  reduce flow (Chapter 2 .2 .)  Increased 
blood v iscos ity  has loosely been implicated in the pathogenesis of TIA 
by the re la t iv e ly  high incidence of focal ischaemia in patients  with 
polycythaemia. As discussed previously (Chapter 2 .2 .) the way in which 
increased haematocrit leads to TIA is  complex. Decreased cerebral 
blood flow (CBF) is  produced by autoregulation in response to 
increased a r te r ia l  oxygen content and possibly increased v is c o s i ty .  In 
certa in circumstances - hypotension, coincident cerebral atheroma -
th is  reduced CBF may lead to stasis and thrombogenesis. Focal 
ischaemia is  opposed by local autoregulatory mechanisms but these have 
physiological l im i ts  which may be exceeded in the presence of disease. 
Under these circumstances perfusion is  passive, ie , no longer 
determined by changing vessel radius, and increased v isco s ity  may be 
relevant.
There is  evidence to suggest tha t a t the margins of areas of 
cerebral in fa rc t io n ,  maximal vasodila ta tion occurs and perfusion is  
dependent on perfusion pressure and blood v isco s ity  (130). Harrison et 
al discovered tha t in patients with occluded in terna l caro tid  a r te r ie s  
and completed stroke, the size of the cerebral in fa rc t  measured by 
computed tomography was re lated to the level o f the haematocrit (129). 
They speculated tha t the increased v isco s ity  and lowered cerebral 
blood flow associated with elevated packed ce ll volumes adversely 
affected the development o f co l la te ra l c irc u la t io n .  In th is  s i tu a t io n  
a decrease in blood v iscos ity  might be expected to improve c irc u la t io n  
in these c r i t i c a l  marginal regions and l im i t  the extent o f in fa rc t io n .  
This is  p a r t ly  the basis fo r  haemodi1ution therapy in stroke (Chapter 
4.7).
I t  seems tha t blood v iscos ity  may be a relevant fac to r in local 
and global cerebral perfusion in some circumstances. The p o s s ib i l i t y  
tha t abnormal blood v iscos ity  may contribute to the symptomatology of 
patients with TIAs, which are otherwise unexplained, was considered.
In his i n i t i a l  report on the influence o f blood rheology changes in 
patients with in te rm it te n t c laudication, Dormandy observed tha t there 
was a subgroup of patients in whom the primary or main abnormality was 
increased v iscos ity  (114). This chapter describes a study designed to 
explore the possible ro le of increased blood v iscos ity  in the genesis 
of otherwise unexplained TIAs. Patients without non-carotid causes fo r
th e i r  symptoms were studied ( ie ,  any pa tien t with a cardiac or 
haematological cause fo r  th e ir  symptoms was excluded). They were 
divided in to  two groups on the basis of the presence or absence of 
caro tid  disease and blood v iscos ity  p ro f i le s  were measured in each 
group. The resu lts  were compared to look fo r  a v iscos ity  e f fe c t  in the 
patients without carotid  disease.
7.2 METHODS
Patients with a h is to ry  of TIA ( inc luding amaurosis fugax) were 
selected from those attending the vascular investiga tion  laboratory in 
Gartnavel General Hospital. On the basis of h is to ry  and examination, 
routine f u l l  blood count, serum biochemistry, and twelve lead ECG, 
those who had possible cardiac or other non-carotid causes fo r  th e ir  
symptoms were excluded. The fo llow ing data were recorded fo r  each 
pa tien t studied: sex, age, pattern of TIA, h is to ry  or physical 
f ind ings of a r te r ia l  disease, h is to ry  of hypertension or 
anti-hypertensive medication, s i t t in g  blood pressure and smoking 
habits. In addition the resu lts  from routine haematological and 
biochemical tests  were recorded. A ll patients had Doppler caro tid  
imaging and spectrum analysis on both sides carried out by one 
operator. A Doppler scan re su lt  was considered pos it ive  i f  ca ro tid  
occlusion or stenosis of a t least 25% was detected ip s i la te ra l  to the 
symptomatic hemisphere (Chapter 5.6). (In no pa tien t in th is  series 
was isolated contra la tera l disease discovered.) Blood fo r  v isco s ity  
measurements was ro u tine ly  withdrawn at the ou t-pa tien t c l in ic  v i s i t  
fo llow ing the Doppler studies. The timing and method o f sample 
analysis was as described in Chapter 5.5. Whole blood v is c o s ity  was
measured at high (94.5s " l)  and low (0.945s- ^) shear rates 
and expressed both as native values and corrected to a haematocrit of 
45%. These shear rates were selected as convenient machine sett ings 
which were as close as possible to the rates recommended by the 
International Committee fo r  Standardisation in Haematology (144). 
Haematocrit fo r  the correction was estimated by the microhaematocrit 
method (Chapter 5 .3). Plasma v iscos ity  and plasma fibrinogen leve ls 
were also determined by methods previously described (Chapter f iv e )
S ta t is t ic a l  analysis was carried out using MINITAB (Minitab Inc .) 
on the Glasgow Univers ity  mainframe computer (VME).
7.3 RESULTS
A to ta l of f i f t y  patients were studied and the relevant 
charac te r is t ics  of both groups are summarised in table 7.1. Twenty 
patients (40%) had carotid  a rte ry  disease detected by Doppler 
inves tiga tion , and since th is  was a consecutive series i t  is  assumed 
tha t th is  is  representative of the population referred fo r  evaluation 
in Gartnavel. I t  compares with incidences o f between 31% and 78% as 
the proportion of a l l  TIA patients shown to have in terna l caro tid  
disease (34,50,82-5)(see Chapter 2.4).
Blood v iscos ity  may be influenced by age (137,161), sex 
(161,162), smoking (137,163) and hypertension (136) and the 
d is t r ib u t io n  of these variables between the groups is  therefore o f 
some importance. Table 7.1 shows the mean age of the Doppler-normal 
group (54.3 years) to be markedly less than the Doppler-abnormal group 
(65.3 years), but very s im ila r  to the mean ages o f the patients in the 
two follow-up groups described in the la s t  chapter (51 and 52 years).
Doppler
Abnormal
Doppler
Normal
Number of patients
Male : Female
Age (mean) yrs.
Smoking habit %
(Never:Current:Former)
Hypertensives
20 
12 : 8 
65.3 
5:65:30 
9
30
19 : 11 
54.3
23:54:23
9
TABLE 7.1
TIA PATIENT DATA
The sex d is t r ib u t io n  between groups is  s im ila r  with a preponderance o f 
men in both groups. While th is  might have been expected in the younger 
Doppler-normal group, the mean age of the other group is  s u f f ic ie n t ly  
high fo r  the benefit of female sex, in respect of reduced r is k  of 
a r te r ia l  disease, to be no longer apparent. This anomaly is  presumably 
the re su lt  of the re la t iv e ly  small numbers under study.
The e f fe c t  o f smoking on v iscos ity  has been well documented. This 
e f fe c t  is  p a r t ly  revers ib le , and fo r  th is  reason non-smokers were 
recorded e ithe r as former smokers or never having smoked (143). The 
d is t r ib u t io n  of patients among the three smoking categories shows a 
s l ig h t  preponderance of smokers in the Doppler-abnormal group 
(X2=3.008, NS).
Patients were decreed to be hypertensive i f  they were receiving 
anti-hypertensive medication or i f  th e ir  d ia s to l ic  blood pressure 
exceeded 90mmHg (164).There is  a greater proportion of hypertensives 
in the Doppler-abnormal group (X2=1.172, NS).
Native whole blood v iscos ity  measurements at high and low shear 
rates are shown in table 7.2 along with values corrected to a 
haematocrit of 45%, and haematocrits. No s t a t is t i c a l l y  s ig n i f ic a n t  
differences in any of these measurements were observed between groups, 
although examination of 95% confidence in te rva ls  indicated tha t small 
differences could not be excluded by th is  study.
Table 7.3 shows plasma v iscos ity  values with re la t iv e  high and 
low shear v isco s it ie s  and plasma fibrinogen values. Relative high 
shear v isco s ity ,  which is  the ra t io  of high shear v isco s ity ,  corrected 
to a haematocrit of 45%, to plasma v isco s ity ,  may be used as a measure 
of red ce ll deformabi1i t y  (RCD)(144). Relative low shear v is c o s ity ,  
the ra t io  o f corrected low shear v iscos ity  to plasma v isco s ity ,  may 
s im i la r ly  be used as a measure of red ce ll aggregation (RCA).
Doppler
Abnormal
Doppler
Normal
WVB - 
mPa.s
High shear : native 5.01 ± 0.17 4.93 ± 0.14
: corrected 5.30 ± 0.15 5.23 ± 0 .0 9
Low shear : native 18.00 ± 0.86 17.68 ± 0.92
; corrected 19.79 ± 0.77 19.54 ± 0.60
Haematocrit 43.00 ± 0.82 43.07 ± 0.79
WBV = Whole blood v iscos ity
TABLE 7.2
TIA PATIENTS: WHOLE BLOOD VISCOSITY AND HAEMATOCRIT
Doppler
Abnormal
Doppler
Normal
Plasma v iscos ity 1.41 ± 0.02 1.38 ± 0.02
mPa.s
RCD 3.78 ± 0.11 3.77 ± 0.06
RCA 14.09 ± 0.52 14.05 ± 0.35
Fibrinogen 4.20 ± 0.22* 3.60 ± 0.19*
g /i
* p = 0.041
RCD = Red ce ll deformation 
RCA = Red ce ll aggregation
TABLE 7.3
TIA PATIENTS: PLASMA VISCOSITY, RELATIVE VISCOSITIES AND FIBRINOGEN
Fibrinogen leve ls in the Doppler-abnormal group are higher than in the 
Doppler-normal group and th is  d ifference is  s t a t is t ic a l l y  s ig n i f ic a n t  
(p = 0.041). This d ifference is  re flec ted  in the higher plasma 
v iscos ity  in the Doppler pos it ive  group although the plasma v isco s ity  
difference does not reach s ta t is t ic a l  s ign if icance. Relative 
v isco s it ie s  in both groups are s im ila r .
7.4 DISCUSSION
Cerebral perfusion is  normally maintained by autoregulation, 
which has been defined as the " in t r in s ic  tendency o f an organ to 
maintain constant blood flow despite changes in a r te r ia l  perfusion 
pressure" (165). Several organs including kidney, l i v e r ,  and skeletal 
muscle as well as brain, e xh ib it  th is  property and d i f fe re n t  
mechanisms have been postulated to account fo r  i t .  In the cerebral 
c irc u la t io n ,  autoregulation is  probably accomplished by a combination 
of mechanisms which respond to changes in perfusion pressure, or local 
metabolic a lte ra t io ns . Vascular smooth muscle may respond d i re c t ly  to 
these changes or they may be mediated by changes in autonomic tone 
(130). Whatever the mechanisms involved, normal CBF can be maintained 
over a wide range o f a r te r ia l  pressures in a normal ind iv idua l (166). 
The a b i l i t y  o f autoregulation to preserve CBF may be compromised in 
disease however, and under these circumstances the range o f a r te r ia l  
pressures over which blood flow can be maintained is  narrowed. Beyond 
the l im i ts  of autoregulation blood flow becomes passive and is  
d i re c t ly  re lated to perfusion pressure; under these circumstances 
blood v iscos ity  may be an important determinant o f flow (130).
In the pathogenesis of TIA elevated blood v iscos ity  could 
contribute in two ways. F i r s t ly  in patients in whom local 
autoregulation is  impaired by pre-ex is t ing  disease, i f  blood v isco s ity  
is  s u f f ic ie n t ly  elevated the resu ltan t increased y ie ld  stress may 
exceed the perfusion pressure and s tas is  w i l l  re su lt .  In th is  
s itua t ion  minor changes in systemic blood pressure may be s u f f ic ie n t  
to produce in te rm it te n t s tas is  and ischaemia. Support fo r  th is  
hypothesis is  provided by Hutchison's study which demonstrated an 
increased y ie ld  stress in TIA patients (167). The second mechanism by 
which increased blood v iscos ity  could predispose ind iv idua ls  to TIA is  
by in h ib i t in g  the development of co l la te ra l c ircu la t io n  when vascular 
occlusion does occur. Colla tera l c ircu la t ions  are by nature c ircu itous  
and often v ia narrow channels; since, according to P o ise u il le 's  law, 
an increase in tube length and a decrease in radius both adversely 
a f fe c t  flow, the e f fe c t  o f any added v isco s ity  changes in these 
circumstances w i l l  be g rea tly  magnified.
The resu lts  of the study presented here show l i t t l e  d iffe rence 
between whole blood v isco s ity  in patients with and without detectable 
carotid  disease. I t  seems un like ly  therefore tha t symptoms in patients 
without detectable embolic sources are due to abnormally elevated 
v isco s ity .  Indeed the small differences which have been demonstrated 
are a l l  in the opposite d ire c t ion ; patients with carotid  disease 
tended to have s l ig h t ly  higher blood v isco s it ie s  although the 
differences are not s t a t is t ic a l l y  s ig n i f ic a n t .  These d ifferences may 
be explained by the observed differences in f ibrinogen leve ls , which 
are elevated in both groups. This elevation may well be re la ted to 
vascular disease or i t  may simply be a non-specific reaction to
i l ln e s s ,  since fibr inogen is  an acute phase reactant. The cause of 
symptoms in patients without a demonstrated embolic source remains 
obscure but a number of p o s s ib i l i t ie s  can be suggested.
The most obvious suggestion with regard to the present study is
tha t a minor degree of carotid  disease may be present. The overall 
accuracy of Doppler ultrasound in the detection of carotid  disease as 
used here is  96% fo r  stenosis >25% (92). However non-stenotic or 
minimally s tenotic  disease does not produce the turbu lent flow which 
is  necessary fo r  a pos it ive  te s t  and remains undetected. While 
atheroma of th is  degree is  less l i k e ly  to form thrombus and carries a 
much lesser r is k  of subsequent stroke than disease which is
s ig n if ic a n t ly  s tenotic  (46), there is  l i t t l e  doubt tha t i t  may be a
source of emboli p a r t ic u la r ly  i f  i t  is  ulcerated (47,48,168). Some 
patients may therefore have lesser degrees o f carotid  disease to 
account fo r  th e ir  symptoms but th is  cannot explain them a l l .  In 
previous studies of th is  group of patients angiography was used to 
assess the carotids and th is  would be expected to detect most minor 
i r re g u la r i t ie s ;  even so there was s t i l l  a proportion of patients whose 
symptoms remained unexplained (156,157,159). S im ila r ly ,  in tra c ra n ia l 
atheroma could be expected to account fo r  the symptoms of a number of 
patients in th is  study but th is  too has been investigated in other 
studies and i t  does not account fo r  a l l  ind iv idua ls  (156,157). One 
area where angiography might be expected to miss s ig n if ic a n t  atheroma 
is  in the proximal vasculature; a o r t ic  arch lesions are d i f f i c u l t  to 
demonstrate and may be presumed to be responsible fo r  some embolic 
events. I t  is  reasonable to suppose tha t minor, undetected a r te r ia l  
lesions, in a va r ie ty  of vessels, are the s i te  of thrombosis and 
subsequent embolism in a proportion o f patients (169), but the fa c t
tha t even when a careful search with re l ia b le  methods is  made fo r  such 
lesions, 25% of patients have none found (34) suggests tha t other 
mechanisms are involved.
As discussed previously (Chapter 2 .2 .) the heart is  not 
in frequently  implicated as a possible source of embolic material and 
although most patients with relevant lesions w i l l  be id e n t i f ie d  by 
examination of the cardiovascular system and a standard 12 lead ECG, 
some conditions require more elaborate investigations to uncover 
appropriate pathology. M itra l valve prolapse fo r  example, has recently  
been recognised as a more frequent cause of cerebral embolism than had 
i n i t i a l l y  been thought (58) and i t s  id e n t i f ic a t io n  depends on cardiac 
ultrasound. Although the overall contribu tion of th is  diagnosis to the 
pathophysiology of TIA is  small, i t  is  proportionate ly much more 
frequently encountered in symptomatic younger ind iv idua ls . There is  a 
case fo r  investiga ting  a l l  patients under the age of 45 who have 
unexplained TIAs by cardiac sonography to look s p e c i f ic a l ly  fo r  th is  
condition. Unrecognised va lvu la r disease probably contributes in some 
measure to the group with unexplained symptoms. The mean age of th is  
group in the present study was only 54.3 years and contained a 
s ig n if ic a n t  proportion of patients less than 45 years o f age.
Abnormal p la te le t  numbers or function have been suggested as 
causes of TIA. Primary thrombocytosis as a cause of cerebral symptoms, 
including TIA and amaurosis fugax, has been described by Bernad (170). 
In 26 o f the 28 patients whom he reviewed, p la te le t  counts were in 
excess of 1 million/mm^; a reduction in p la te le t  count fo llow ing 
therapy prevented recurrent TIA. Patients in th is  category should be
read ily  id e n t i f ia b le .  Other p la ta le t  abnormalities may not be so
eas ily  recognised. P la te le t adhesiveness has been shown to be
increased in young patients with thromboembolic stroke (119) but the
relevance of th is  f ind ing  to the occurrence o f the stroke is  unclear. 
In a study comparing TIA patients with controls Olsson (171) was 
unable to demonstrate any overall d ifferences in p la te le t  function or 
in the numbers of c irc u la t in g  p la te le t  aggregates (CPA). However 
ind iv idual patients had high numbers of CPA and enhanced p la te le t  
aggregation. Al-Mefty and his colleagues reported 22 patients with TIA 
in whom no cause fo r  th e ir  symptoms could be found a fte r  appropriate 
investiga tion  by angiography, isotope brain scan, cardiac ultrasound 
and ECG (154). A ll patients had abnormalities of p la te le t  adhesiveness 
and/or aggregation demonstrated during th e ir  investiga tions. Treatment 
with asp ir in  and/or dipyridamole or sulphinpyrazone produced 
improvements in the abnormal p la te le t  studies during follow-up and 
prevented recurrence of TIA; in two cases discontinuation of treatment 
was associated with recurrent symptoms and a de te r io ra tion  in p la te le t  
function . I t  is  perhaps noteworthy tha t o f these 22 patients 15 were 
less than 50 years of age.
A ll o f th is  evidence suggests tha t abnormal p la te le t  function 
leading to the production of p la te le t  emboli may underlie the 
diagnosis o f TIA in some patients. This may be p a r t ic u la r ly  relevant 
in young patients . However the p o s s ib i l i ty  tha t abnormal levels of 
c irc u la t in g  p la te le t  aggregates re su lt  from, rather than cause, 
cerebral thromboembolism in many patients must also be considered.
In summary i t  appears tha t some TIAs of unknown aetio logy are due 
to embolic sources, e ithe r a r te r ia l  or cardiac, undetected by 
screening procedures, or p la te le t  abnormalities; an incorrect 
diagnosis of TIA which eventually becomes apparent w i l l  account fo r  
others (eg, e ight patients in the follow-up study presented in chapter
6). I t  is  possible tha t as yet undiscovered mechanisms w i l l  explain 
some TIAs but the number o f patients involved in any such group is  
1ike ly  to be smal1.
Although the study in th is  chapter fa i le d  to reveal any ro le  fo r  
elevated blood v iscos ity  in the genesis o f id iopa th ic  TIAs i t  did 
suggest tha t fibrinogen leve ls are elevated in a l l  TIA patients . In 
order to explore th is  fu r the r and to assess the e f fe c t  tha t elevated 
fibrinogen may have on whole blood v isco s ity  in these pa tients , a 
study comparing TIA patients with normal controls and with patients 
with established peripheral vascular disease, in whom v isco s ity  
abnormalities are well documented, was set up. This is  reported in the 
fo llow ing chapter.
7.5 SUMMARY
Screening patients with TIAs using Doppler ultrasound at 
Gartnavel General Hospital categorised carotids as e ithe r occluded, 
stenosed or normal. For patients with occluded or stenosed vessels a 
ra tiona l management plan had been evolved, but the management of 
Doppler-normal patients had not been f u l l y  ra t iona lised . Aetio logies 
fo r  these pa tien ts ' symptoms had been considered and i t  was thought 
possible tha t v isco s ity  abnormalities might be the mechanism o f th e ir  
symptoms. The possible ro le of abnormal blood v iscos ity  in the genesis 
of TIAs of unknown aetio logy was therefore investigated. No 
differences in whole blood v isco s ity ,  or haematocrit, between patients 
with carotid  stenosis and those without, were demonstrated. However, 
plasma fibrinogen was elevated in both groups and was s ig n i f ic a n t ly  
higher in the group with demonstrable caro tid  disease. Thus, while
raised blood v isco s ity  does not appear to explain the symptoms o f 
patients whose TIAs are otherwise id iopa th ic , haemorheological 
abnormalities may be present in a l l  TIA patients and may re f le c t  
changes due to a r te r ia l  disease.
Chapter 8
HAEMORHEOLOGY OF TIA: COMPARISON WITH PERIPHERAL VASCULAR 
DISEASE AND NORMAL CONTROLS
8.1 INTRODUCTION
In chapter 4.1 evidence was presented which supports the 
hypothesis tha t blood v iscos ity  is  linked to cerebrovascular disease. 
In p a rt icu la r  i t  was observed tha t blood v iscos ity  is  elevated in 
patients who have had a thromboembolic stroke and i t  remains elevated 
during convalescence from stroke. I t  is  possible tha t these changes in 
blood rheology arise at least p a r t ly  as a consequence o f the ischaemic 
event but i t  is  equally possible tha t they are antecedent to the event 
and play some part in i t s  genesis. Such a s itu a t io n  ex is ts  in patients 
with ischaemic heart disease, in tha t rheological changes are apparent 
in patients with angina (110,111) but are more obvious fo llow ing  a 
myocardial in fa rc t io n  (108). The im plications of such f ind ings  are 
c lear. I f  rheological abnormalities contribute to the r is k  o f 
subsequent ischaemic events then i t  may be possible to diminish tha t 
r is k  with therapy designed to correct abnormal v isco s ity .  I f  pa tients  
with TIA are haemorheologically abnormal i t  would suggest th a t:  a) 
such abnormalities may contribute to the stroke r is k  associated with 
TIA and b) rheological manipulation may be bene fic ia l.
In order to assess the haemorheology of patients with TIA a group 
of these patients was studied, along with a matched group of control 
patients who had no c l in ic a l  vascular disease, and a th i rd  group with 
in te rm it te n t c laudication. This la s t  group was included because 
v iscos ity  changes associated with th is  condition have been well 
documented and are re lated to the presence of s ig n if ic a n t  atheroma, 
which is  also the underlying pathology in the m a jority  o f patients 
with TIA.
8.2 PATIENTS & METHODS
Group One. Patients with TIA ( inc luding amaurosis fugax) were 
selected from those attending the vascular laboratory fo r  carotid  
scanning as described in chapter 7.2.
Group Two. Control subjects came from two main sources. One group 
comprised surgical inpa tien ts , or outpatients, admitted fo r  minor 
procedures such as herniorrhaphy or varicose vein surgery. No pa tien t 
with c l in ic a l l y  apparent vascular disease, undiagnosed symptoms, 
malignant disease, in fec tion  or recent surgery was included in th is  
group. The second group of control subjects were members of the 
hospital s ta f f .  Again care was taken to exclude those with symptomatic 
vascular disease or other relevant i l lnesses. A ll control subjects 
provided de ta i ls  o f th e ir  smoking habits and any h is to ry  o f 
hypertension, including therapy. Blood pressure was measured with a 
standard pneumatic cu ff  with the subject in a s i t t in g  pos it ion .
Group Three. Patients with in te rm it te n t claudication were 
selected from among those attending the peripheral vascular disease 
outpatient c l in ic ,  or were inpatien ts admitted fo r  peripheral vascular
surgery. Again no pa tien t with other s ig n if ic a n t  disease or recent 
surgery was included. Patients with ischaemic res t pain, ulcers or 
gangrene were excluded. Age and sex, which have important influences 
on blood v isco s ity ,  were matched between groups.
The fo llow ing measurements were carried out on each ind iv idua l 
studied: whole blood v isco s ity  at high (94.5s"1) and low 
(0.945s"1) shear rates, plasma v isco s ity ,  haematocrit, plasma 
fibr inogen. In addition , a f u l l  blood count was carried out and serum 
biochemistry was estimated. Derived values were calculated as fo llows: 
blood v isco s ity  corrected to a haematocrit of 45% at both shear ra tes; 
re la t iv e  blood v isco s ity  at high and low shear rates (RCA, RCD). A ll 
measurements and calcu la tions were performed exactly as described in 
chapter 5.2 - 5.5. S ta t is t ic a l  analysis was carried out using methods 
and procedures described in chapter 5.8.
8.3 RESULTS
F i f t y  patients with a diagnosis o f TIA were studied and compared 
with 20 claudicants and 64 control subjects. Comparative data on sex 
d is t r ib u t io n ,  age, and smoking habits are shown in table 8.1. The sex 
d is t r ib u t io n  is  s im ila r in a l l  groups. The mean age of the control 
subjects (54.3 years) is  a l i t t l e  less than e ithe r of the pa tien t 
groups (58.7 and 60.4 years). Smoking habits were categorised as 
previously outlined in chapter 7.3: non-smokers, current smokers and 
former smokers. Apart from a s l ig h t ly  larger proportion o f ind iv idua ls  
who had never smoked in the control group, smoking habits were 
comparable.
TIA Control PVD
No. 50 64 20
M : F 31 : 19 39 : 25 12 : 8
Age (mean) yrs. 58.7 54.3 60.4
Smoking % 16:60:24 23:63:14 15:70:15
(Never:Curent:Former)
Hypertensives 18 11 4
TABLE 8.1
CLINICAL DATA: PATIENTS AND CONTROL SUBJECTS
Whole blood v isco s ity  (WBV) resu lts  are shown in table 8.2; both 
native v iscos ity  and v isco s ity  corrected to a haematocrit of 45% are 
shown. There are no s ig n if ic a n t  differences between TIA patients and 
controls in any of the values shown. The patients with peripheral 
vascular disease (PVD) on the other hand were found to have 
s ig n if ic a n t ly  higher native v is c o s it ie s ,  a t both shear rates, than 
e ithe r of the other groups. These differences diminish, but do not 
disappear, when v isco s ity  is  corrected fo r  haematocrit; haematocrit is  
higher in the PVD group although the d ifference does not reach 
s ta t is t ic a l  s ign if icance . At low shear ra te , even when v isco s ity  is  
corrected fo r  haematocrit, PVD patients have a greater v isco s ity  than 
the TIA group suggesting tha t e ithe r red ce ll properties 
(deform ab ility  or aggregabi1i t y )  or plasma v isco s ity  d i f fe rs  
s ig n if ic a n t ly  between these groups, in addition to haematocrit 
d ifferences.
Table 8.3 shows plasma v iscos ity ,  re la t iv e  v isco s it ie s  and plasma 
fibrinogen leve ls fo r  a l l  three groups. Plasma v isco s ity  is  highest in 
the PVD patients but there is  no s ig n if ic a n t  difference between them 
and the TIA pa tients ; the values fo r  both of these groups are 
s ig n i f ic a n t ly  higher than those fo r  the control group. These 
differences are mirrored by the differences in plasma fibrinogen 
levels which must be at least p a r t ly  responsible fo r  the d i f fe r in g  
plasma v is c o s it ie s .  Relative high shear v isco s ity  and re la t iv e  low 
shear v isco s ity ,  measures of red ce ll deformation and aggregation 
respective ly, show differences between the TIA and control groups 
ind ica ting  tha t the red ce lls  from the former group deform more and 
aggregate less than those from the la t te r  group.
TIA Control PVD
WBV - high shear : 
mPa.s
- native 4.96* ± 0.11 4.97* ± 0.10 5.36-* ± 0.12
- corrected 5.26 ± 0.07 5.28 ± 0.06 5.39 ± 0.09
WBV - low shear : 
mPa.s
- native 17.81° ± 0.64 18.43* ± 0.69 21.08°* i : 0.81
- corrected 19.36* ± 0.47 20.30 ± 0.33 21.21* ± 0.54
Haematocrit 43.04 ± 0.58 43.11 ± 0.64 44.76 ± 0.64
WBV = Whole blood v iscos ity  * p < 0.05
p < 0.05
° p < 0.01
TABLE 8.2
PATIENTS AND CONTROLS: WHOLE BLOOD VISCOSITY AND HAEMATOCRIT
TIA Control PVD
Plasma v iscos ity  
mPa.s
RCD
RCA
Fibrinogen
g/1
1.397* ± 0.016 
3.781° ± 0.056
1.330*- ± 0.011 1.452- ±
3.945°** ± 0.052 3.713** ±
14.06°° ± 0.29 15.15°° ± 0.24 14.60 ± 0
3.83- ± 0.15 2.89-* ± 0.31 4.01* ± 0
RCD = Red ce ll deformation 
RCA = Red ce ll aggregation
* p < 0.001
• p < 0.001
o p < 0.05
** p < 0.05
oo p < 0.01
TABLE 8.3
0.026
0.093
.49
.26
PATIENTS AND CONTROLS:
PLASMA VISCOSITY,RELATIVE VISCOSITIES AND FIBRINOGEN
T .I.A . Control
Haemoglobin (g /d l) 14.35 ± 0.22 14.17 ±
Red ce ll  count ( x l O 1 ^ ) 4.56 ± 0.062 4.466 ±
MCV ( f l ) 91.90 ± 0.84 93.29 ±
MCH (pg) 31.48 ± 0.33 31.81 ±
MCHC (g /d l) 34.24 ± 0.13 34.08 ±
MCV = Mean corpuscular volume
MCH = Mean corpuscular haemoglobin
MCHC = Mean copuscular haemoglobin concentration
TABLE 8.4
0.22
0.070
0.80
0.31
0.98
TIA AND CONTROL PATIENTS: CELLULAR MORPHOLOGY
In the absence of d ire c t  measurements o f red ce ll deformabi1i t y ,  
inferences about i t  may be drawn from data on c e l lu la r  morphology 
obtained from a Coulter counter; in terna l red ce ll v isco s ity ,  a 
component in ce ll deformabi1i t y ,  is  re lated to mean corpuscular 
haemoglobin concentration (143,144). Data on c e l lu la r  morphology fo r  
the TIA and control groups are shown in table 8.4; no differences are 
apparent between groups.
8.4 DISCUSSION
Viscosity  changes associated with peripheral vascular disease are 
well documented. Increased blood v iscos ity  in claudicants was noted as 
long ago as 1973 and was re lated at tha t time to an adverse c l in ic a l  
outcome (114,115). Elevated haematocrit, raised serum fibrinogen and 
increased red ce ll r i g id i t y  are a l l  believed to contribute to abnormal 
v iscos ity  in peripheral vascular disease (172,173). The d iffe rence 
between the claudicant and control groups presented here (Tables 8.2 & 
8.3) are in keeping with previously published observations (114).
Whole blood v iscos ity  at both shear rates is  s ig n i f ic a n t ly  higher in 
claudicants than in contro ls. Correction of v isco s ity  to a haematocrit 
o f 45% reduces the differences, confirming tha t the higher haematocrit 
of the claudicants is  responsible fo r  some of the d is p a r i ty .  Plasma 
v iscos ity  is  also s ig n if ic a n t ly  higher in the claudicants and th is  
contributes to the residual differences in whole blood v is c o s ity  a f te r  
correction fo r  haematocrit. Fibrinogen is  a major determinant of 
plasma v iscos ity  and the higher leve ls found in the claudicants are at 
least p a r t ly  responsible fo r  th e ir  observed elevation in plasma 
v iscos ity .
There is  essen tia l ly  no d ifference in the whole blood v isco s ity  
between the TIA group of patients and the contro ls. This is  perhaps 
surpris ing i f  we consider tha t a r te r ia l  disease is  the underlying 
abnormality in the m a jority  of these patients . While the extent or 
degree of th e ir  a r te r ia l  disease may not be as marked as i t  is  in 
claudicants, they might have been expected to show changes in blood 
v iscos ity  which tended towards those exhibited by the claudicants.
That the haematocrit of the TIA patients is  identica l to the control 
group is  also surpris ing in view o f the published observations o f 
Harrison et al (174). In a retrospective study of 154 patients with 
TIA they discovered tha t haematocrit was s l ig h t ly ,  but s ig n i f ic a n t ly ,  
raised compared with controls assessed s im i la r ly .  This d ifference 
persisted when allowance was made fo r  the d i f fe r in g  incidences o f 
hypertension and smoking, both of which may a f fe c t  haematocrit 
(136,175), in the two groups. There are several possible reasons fo r  
th is  discrepancy. Harrison's series of TIA patients contained 19 males 
(17.4% of males) with haematocrits >49%, while the present study had 
only two such patients (6.4% of males). In view o f the widely 
recognised r is k  o f raised haematocrit, i t  is  possible tha t patients 
with abnormally elevated haematocrits were not referred fo r  Doppler 
examination, at least u n t i l  the PCV had been lowered to more 
physiological leve ls ; th is  would introduce bias to the se lection of 
patients in th is  series. On the other hand Harrison's study was 
carried out re trospective ly  with a l l  the l im ita t io n s  which tha t 
imposes on data co llec t ion  and in te rp re ta t io n . Other con tro lled 
studies o f haematocrit in TIA are lacking.
While haematocrit and whole blood v isco s ity  in TIA pa tients  show 
no differences from contro ls , table 8.3 indicates tha t plasma 
v iscos ity  and fibrinogen, important determinants o f whole blood
v isco s ity ,  do show s t a t is t i c a l l y  s ig n if ic a n t  differences. Since 
fibrinogen contributes d isproportionate ly to measured plasma 
v isco s ity ,  i t  is  l i k e ly  tha t the r ise  in plasma v iscos ity  observed in 
TIA patients is  due p a r t ly  or wholly to the abnormal fibrinogen 
leve ls . The fa c t  tha t increased plasma v isco s ity  is  not re f lec ted  in 
increased whole blood v iscos ity  means tha t other determinants of 
v isco s ity ,  red ce ll aggregation and deformabi1i t y  fo r  example, must 
compensate fo r  the raised plasma v isco s ity  and fibrinogen leve ls .
The re la t iv e  low and high shear v isco s it ie s  shown also in table
8.3 ind icate as much. These figures suggest tha t erythrocytes in the 
TIA patients deform more and aggregate less than ce lls  from control 
patients. The increased de form abi!ity  may be due to e x tr in s ic  (plasma) 
factors or in t r in s ic  (c e l lu la r )  fac to rs . Mean corpuscular haemoglobin 
concentration is  a major determinant o f in terna l c e l lu la r  v is co s ity  
(103) and, in the absence of accurate, d ire c t  measurements of red ce ll  
deformabi1i t y ,  may be u t i l is e d  as a measure of c e l lu la r  f l e x i b i l i t y .  
The f igures presented in table 8.4 f a i l  to show s ig n if ic a n t  
morphological differences between the red ce l ls  o f TIA and control 
patients and i t  is  possible to in fe r  tha t increased deformabi1i t y  is  
probably due to plasma, rather than c e l lu la r ,  fac tors . Thus the 
increased plasma v isco s ity  due to raised fibrinogen leve ls produces 
more deformation o f the suspended red ce lls  and the net e f fe c t  on 
whole blood v isco s ity  is  n i l .
The apparent reduction in red ce ll aggregation in TIA patients 
compared to controls indicated by the re la t iv e  low shear v is c o s i t ie s  
(RCA) in table 8.3 is  in te res ting . Fibrinogen contributes to blood 
v iscos ity  in two ways: f i r s t l y  v ia i t s  con tr ibu tion  to plasma 
v iscos ity  and secondly by v ir tu e  of i t s  a b i l i t y  to form cross l in ks  
between red ce l ls  and encourage aggregation. The elevated plasma
fibrinogen levels of the TIA patients might be expected to lead to 
enhanced rather than diminished aggregation. This paradoxical re su lt  
may be an a r te fa c t of low shear v isco s ity  measurement. Although the 
time taken to complete both v iscos ity  measurements on a sample is  only 
about s ix  minutes, and the blood is  mixed during the high shear 
programme, the delay between high and low shear measurements may be 
s u f f ic ie n t  to allow sedimentation and separation of the sample and 
re su lt  in a fa ls e ly  low v iscos ity  reading in the presence o f high 
fibrinogen concentrations.
I t  appears tha t a l l  the differences between the control and TIA 
groups may be accounted fo r  by raised fibrinogen levels in the la t te r  
group. This may be re lated to the greater numbers o f smokers and 
hypertensives in th is  group, since these are both factors shown to be 
associated with elevated fibrinogen leve ls . The re la tionsh ip  between 
fibrinogen leve ls , a r te r ia l  disease and these two shared r is k  factors  
is  complex and is  considered in chapter 9.
8.5 SUMMARY
High blood v iscos ity  is  known to be associated with stroke and 
other vascular disorders, and manipulation of v isco s ity  may be 
benefic ia l in these patients . The resu lts  of the studies presented in 
chapter 7 suggested tha t TIA patients may also have abnormal v isco s ity  
and therefore an analysis of v iscos ity  and i t s  main determinants in 
these patients was undertaken. The resu lts  were compared to v is c o s ity  
values from matched populations of patients with c laudication and 
normal contro ls.
Whole blood v isco s ity  is  elevated in claudicants compared to the 
other two groups and th is  is  due to a combination o f raised 
haematocrit, increased plasma v isco s ity ,  and elevated plasma 
fibrinogen. No differences in whole blood v isco s ity  have been 
demonstrated between TIA patients and contro ls, but plasma v iscos ity  
and fibrinogen are s ig n i f ic a n t ly  higher in TIA patients. These 
differences are not re flec ted  in differences in whole blood v isco s ity  
due to a compensatory increase in red ce ll deformation in TIA 
patients , which appears to be due to e x tr in s ic  (plasma) fac tors  rather 
than c e l lu la r  fac to rs . The cause of the elevated fibrinogen leve ls in 
TIA patients is  unclear, but i t  may be re lated to the increased 
prevalence of smoking and hypertension in th is  group.
Chapter 9
FIBRINOGEN: ITS RELATIONSHIP TO ATHEROMA AND CARDIOVASCULAR 
RISK FACTORS
9.1 INTRODUCTION
Fibrinogen is  an acute phase reactant and is  elevated in response 
to in fe c t io n , malignant disease, surgical operations and "s tress". I t  
may also be elevated in response to more chronic, less obvious s t im u li 
and i t  is  in the context of these influences tha t the changes 
discussed in the la s t  chapter must be considered. Epidemiological and 
c l in ic a l  studies have re lated fibrinogen levels to age, smoking and 
blood pressure in healthy ind iv idua ls .
The increasing levels which occur with age may be re la ted to the 
increased prevalence o f subclin ica l disease in older ind iv idua ls  or to 
the ageing process i t s e l f  (137,142,146).
The elevations which occur in smokers are re lated to c iga re tte  
rather than pipe or cigar smoking (137,163) and may be p a r t ly  
revers ib le ; ind iv idua ls  who desist from smoking have lower leve ls than 
current smokers but not as low as those who have never smoked (143). 
The reason fo r  th is  association has not been established.
Systo lic  and d ia s to l ic  blood pressure have been shown to be 
s ig n if ic a n t ly  correlated with plasma fibrinogen and plasma v isco s ity  
in a study in healthy middle aged men (176). Perhaps more re levant, in 
the context of cerebrovascular disease, is  tha t many studies have
delineated a re la tionsh ip  between hypertension and blood rheology 
(103). This is  due to increased haematocrit and plasma protein 
concentration. The corre la t ion  of hypertension with haematocrit is  
weak because although plasma volume is  contracted, tending to increase 
haematocrit, renal disease, consequent on the raised blood pressure, 
may produce anaemia which opposes th is  change (177). A much greater 
corre la t ion  between whole blood v iscos ity  and blood pressure .is 
observed i f  measurements are corrected to a haematocrit o f 45% (178) 
or i f  comparisons are made with a normotensive population with matched 
haematocrits (136). The increase in v iscos ity  which is  observed then 
is  la rge ly  due to raised fibrinogen leve ls . There is  no corre la t ion  
between the v iscos ity  of defibrinated blood and a r te r ia l  pressure 
(136). Contracted plasma volume may explain many of the v isco s ity  
a lte ra t ions  in hypertension, but the increase in f ibrinogen is  
d isp roportiona lly  large and may represent a chronic phase reaction 
(179).
The increased incidence of hypertension in cerebrovascular 
disease in general and among TIA patients in p a rt icu la r  is  well 
documented (3,174) as is  the association o f smoking with a r te r ia l  
disease. The p o s s ib i l i t y  tha t the changes in plasma fibrinogen noted 
in the studies reported in the chapters 7 and 8 have arisen as a 
re su lt  o f these previously recognised associations must be considered. 
To explore th is  p o s s ib i l i t y  the data obtained in these studies was 
subjected to sub-group analysis to look fo r  evidence tha t the observed 
elevation in plasma fibrinogen in TIA patients was independent o f 
associations with hypertension and smoking.
9 .2  METHODS
Smoking habits were c la ss if ie d  in three categories as previously 
described: non-smokers, current smokers and former smokers. This la s t  
group was defined as those who had stopped fo r  at least three months. 
No attempt was made to subdivide smokers according to the quantity  of 
tobacco consumed. The TIA and control groups from the study described 
in the previous chapter were divided in to  sub-groups on the basis o f 
th is  smoking c la s s i f ic a t io n ,  and the mean fibrinogen levels calculated 
fo r  each group. In addition , the TIA patients were fu r the r subdived, 
according to the find ings on Doppler examination of th e ir  carotids, 
in to  Doppler-normal and Doppler-abnormal.
The e f fe c t  of blood pressure was assessed in two ways. F i r s t ly  
the control and TIA groups were subdivided on the basis o f the 
presence or absence of hypertension. This was defined, as before, as 
the find ing  of a d ia s to l ic  pressure greater than 90mmHg or the current 
prescrip tion of anti-hypertensive medication. Mean fibrinogen levels 
fo r  each of these sub-groups were calculated and the resu lts  compared. 
The second method of assessing the influence of blood pressure was to 
corre late i t  with whole blood v iscos ity  and i t s  determinants, in a l l  
patients not receiving anti-hypertensive drugs. Systo lic  and d ia s to l ic  
pressures were correlated in d iv id u a l ly  with haematocrit, high and low 
shear v iscos ity  corrected and uncorrected, plasma v isco s ity  and plasma 
fibr inogen. The l inea r co e f f ic ie n t  of corre la t ion  ( r )  was determined 
fo r  each analysis (MINITAB) and i t s  s ign if icance in fe rred by reference 
to standard tables.
9 .3  RESULTS
Smoking
Mean plasma fibrinogen leve ls fo r  each of the smoking sub-groups 
in the control and TIA groups are shown in table 9.1. I t  can read ily  
be seen tha t in each of the smoking sub-groups the values fo r  TIA 
patients are higher than those found in control patients. The e f fe c t  
o f smoking is  obvious w ith in  each of the two diagnostic groups; values 
among smokers and ex-smokers being higher than those in non-smokers, 
a lb e i t  only marginally in the control group.
Table 9.2 d e ta i ls  the fibrinogen values found in each of the two 
Doppler sub-groups o f the TIA patients, divided on the basis o f th e ir  
smoking habits. The highest levels are found in the three sub-groups 
of the Doppler-abnormal group, ie , in patients with detectable ca ro tid  
disease. Again, in both diagnostic groups, values fo r  smokers and 
ex-smokers are higher than fo r  non-smokers. In each of these tables i t  
appears tha t smoking and the presence of a r te r ia l  disease have a 
modest additive  e f fe c t  on fibrinogen leve ls ; the highest leve ls  are 
found in patients who have a pos it ive  smoking h is to ry  and greatest 
evidence of a r te r ia l  disease, and the lowest levels in non-smokers who 
are asymptomatic.
Hypertension
A comparison of the control group and a l l  TIA patients with 
regard to hypertension, shows (table 9.3) tha t the highest plasma 
fibrinogen levels occur among the TIA patients irrespective  o f the 
presence of hypertension. Among the control pa tients , however, the 
recognised re la tionsh ip  between fibrinogen leve ls and hypertension is  
apparent. I t  is  worth noting tha t the fibrinogen leve ls in
Control TIA
Non-smokers 2.80 ± 0.28
Current smokers 2.92 ± 0.17
Ex smokers 3.00 ± 0.47
Values are g/1 ± SEM.
TABLE 9.1
PLASMA FIBRINOGEN LEVELS IN CONTROL SUBJECTS AND TIA PATIENTS 
CLASSIFIED BY SMOKING HABIT
3.17 ± 0.25 
3.88 ± 0.17 
4.16 ± 0.44
Doppler
normal
Doppler
abnormal
3.86 *
3.95 ± 0.19 
4.88 ± 0.56
Values are g/1 ± SEM.
* single measurement
TABLE 9.2
Non-smokers 3.05 ± 0.26
Current smokers 3.82 ± 0.29
Ex-smokers 3.56 ± 0.58
PLASMA FIBRINOGEN LEVELS IN TIA PATIENTS 
CLASSIFIED BY DOPPLER RESULT AND SMOKING HABIT
Control TIA
Normotensive 2.68 ± 0.13
Hypertensive 3.62 ± 0.24
Values are g/1 ± SEM.
TABLE 9.3
PLASMA FIBRINOGEN LEVELS IN CONTROL SUBJECTS AND TIA PATIENTS 
CLASSIFIED BY BLOOD PRESSURE
3.93 ± 0.18 
3.68 ± 0.22
Doppler
normal
Doppler
abnormal
Normotensive 3.64 ± 0.22 4.55 ± 0.33
Hypertensive 3.50 ± 0.37 3.85 ± 0.25
Values are g/1 ± SEM.
TABLE 9.4
PLASMA FIBRINOGEN LEVELS IN TIA PATIENTS 
CLASSIFIED BY DOPPLER RESULT AND BLOOD PRESSURE
asymptomatic hypertensives (contro ls) are s im ila r to those found in 
Doppler-normal TIA patients . This perhaps suggests tha t sub -c lin ica l 
a r te r ia l  disease ex is ts  in both of these groups.
In chapter 6 i t  was observed tha t a s l ig h t ly  higher proportion of 
the Doppler-abnormal patients were hypertensive (d ia s to l ic  blood 
pressure >90mmHg) or were receiving anti hypertensive medication 
compared with the Doppler-normal group. The mean fibrinogen leve ls in 
each of these subgroups are shown in table 9.4. In both the 
Doppler-normal and abnormal groups the hypertensive patients have 
lower levels than the normotensive ind iv idua ls , which is  the reverse 
of what might have been expected. In both normotensive and 
hypertensive patients however, fibrinogen levels are higher in those 
who have carotid  disease detected by Doppler scanning.
Table 9.5 shows the l inea r corre la t ion  c e f f ic ie n ts  and th e ir  
level of s ign if icance fo r  blood v iscos ity  measured against sy s to l ic  
and d ia s to l ic  blood pressure. No s ig n if ic a n t  re la tionsh ips have been 
demonstrated, except between plasma v iscos ity  and s ys to l ic  pressure.
9.4 DISCUSSION
The studies in th is  thesis were set up f i r s t l y  to observe 
rheological differences between Doppler-abnormal and Doppler-normal 
TIA patients, and secondly to compare TIA patients with con tro ls . In 
the f i r s t  study, as the patients were consecutive, no attempt was made 
to match the groups in terms of age, smoking habits, or the incidence 
of hypertension. In the second study, control subjects were selected 
in such a way tha t age and smoking habits were roughly matched between 
the two groups. This matching however, was not perfect and w ith regard
S ysto lic  p value D ia s to lic  p value
Whole blood v iscos ity :
-high shear native -0.026 NS 0.130 NS
-high shear corrected 0.061 NS 0.079 NS
-low shear native -0.051 NS 0.160 NS
-low shear corrected -0.010 NS 0.124 NS
Haematocrit -0.078 NS 0.072 NS
Plasma v iscos ity 0.215 <0.05 0.025 NS
Plasma fibrinogen 0.188 <0.1 0.025 NS
TABLE 9.5
CORRELATION COEFFICIENTS(r): BLOOD PRESSURE AND VISCOSITY
to hypertension was not performed. In an e f fo r t  to allow fo r  the 
differences in d is t r ib u t io n  of these important variables the analysis 
described in th is  chapter was carried out.
This kind of sub-group analysis is  imperfect, f i r s t l y  because the 
groups have not been selected prospectively and matching is  
incomplete, and secondly because the numbers in some sub-groups are 
small. Fortunately elaborate s ta t is t ic a l  manipulation has not been 
necessary. Subdivision of the various groups read ily  demonstrates tha t 
the biased d is t r ib u t io n  o f smoking habits and incidence of 
hypertension does not account fo r  the observed differences in 
f ibrinogen leve ls . Indeed, among the TIA patients , those c la s s i f ie d  as 
being hypertensive had lower plasma fibrinogen leve ls than 
normotensive ind iv idua ls .
The absence of any s t a t is t ic a l l y  s ig n if ic a n t  corre la t ion  between 
sys to l ic  and d ia s to l ic  blood pressure measurements and any of the 
whole blood v iscos ity  measurements in th is  study is  at variance with 
previously published studies, which have shown a re la tionsh ip  between 
blood pressure and blood v isco s ity  (177,178). This is  perhaps 
explained by the fa c t  tha t the numbers studied in th is  thesis are 
smaller than in studies which have been s p e c i f ic a l ly  designed to look 
a t th is  re la t ionsh ip . Furthermore re la tionsh ips which e x is t in an 
asymptomatic population sample may not be e n t i re ly  relevant in the 
presence o f  symptomatic a r te r ia l  disease. Plasma v iscos ity  d id 
corre late with sys to l ic  pressure in th is  analysis however, and th is  
may be p a r t ly  due to plasma fibrinogen levels whose co rre la t ion  with 
s ys to l ic  pressure measurements ju s t  fa i le d  to reach a s ign ifcan t 
leve l. These f ind ings are in keeping with previous studies which 
suggest tha t a pos it ive  corre la t ion  ex is ts  between a r te r ia l  pressure 
and fibrinogen levels (136).
Although the re la tionsh ip  with hypertension was not quite as 
expected the re la tionsh ip  between smoking and plasma fibrinogen 
changes is  more consistent with previously reported f ind ings 
(137,180). Smokers and former smokers both have higher leve ls than 
patients who have not smoked, although the revers ib le nature o f the 
influence o f smoking has not been c le a r ly  demonstrated. The leve ls 
found in former smokers are s ta t is t i c a l l y  ind is tingu ishable from those 
in current smokers. This disagrees with data previously published by 
Lowe and Kannel but i t  may be explained by the comparatively smaller 
numbers studied here (137,180).
Having established tha t increased fibrinogen levels are 
associated with TIA and detectable carotid  stenosis independently of 
the r is k  factors of smoking and hypertension, the im plications o f th is  
re la tionsh ip  remain to be explained. The l in k  between a r te r ia l  disease 
and raised plasma fibrinogen may be due to common ae tio log ica l fac tors  
and therefore coincidenta l, or each may be a consequence o f the other. 
From a therapeutic standpoint the most in te res ting  p o s s ib i l i t y  is  tha t 
raised fibrinogen produces a r te r ia l  disease. I f  th is  were the case 
then reduction of fibrinogen levels would be expected to produce a 
decrease in the subsequent r is k  from a r te r ia l  disease.
Abnormal plasma fibrinogen leve ls may th e o re t ic a l ly  contribu te  
to c l in ic a l l y  evident a r te r ia l  disease in several ways. F i r s t ly  
increased plasma and blood v iscos ity  may be implicated in the 
mechanical in i t ia t io n  of atheroma. Secondly, f ibrinogen is  
incorporated in to  atheromatous plaques and th is  process may be 
enhanced in the presence of raised plasma leve ls . F in a lly ,  raised 
fibrinogen levels may be a manifestation of a wider haemostatic 
disorder which predisposes to a r te r ia l  thrombosis and embolism.
There is  dispute about the precise ro le  of flow mechanics in the 
production of atheroma. There is  no doubt however, tha t i t  does play 
some part as atheroma is  c le a r ly  a loca lised disease, which occurs in 
regions of high pressure and altered flow patterns, eg, the abdominal 
aorta and major b ifu rca tions . I t  seems l ik e ly  tha t the d is t r ib u t io n  of 
eddies, reverse flow, high and low shear stress regions, and other 
manifestations of tu rbu lent flow, which occur at b ifu rca tions , is  
affected not only by vascular geometry but also by the mechanical 
cha rac te r is t ics  of blood. Factors which a l te r  v iscos ity  could thus 
have an e f fe c t  on the mechanical forces which appear to be re levant in 
the in i t ia t io n  of atheroma (103).
Atheromatous plaques accumulate fib r inogen. Knowledge o f th is  has 
been used in some cases to detect a r te r ia l  disease by observing the 
incorporation of rad io - labe lled  fibrinogen in to  carotid  plaques 
(181,182). Whether th is  is  purely a secondary event or is  important in 
the development of a r te r ia l  plaques is  uncertain and the relevance of 
a raised fibrinogen level to th is  event is  equally unclear.
The f in a l  method by which high fibrinogen levels may exert an 
influence on the subsequent development of a r te r ia l  disease is  v ia  
enhanced coagulation. Many of the c l in i c a l l y  evident e ffec ts  of 
atheroma are re lated to superimposed thrombus formation, e ith e r a t the 
s i te  of the a r te r ia l  lesion or more d is ta l ly  fo llow ing embolism. 
Fibrinogen enhances both red ce ll and p la te le t  aggregation and an 
increased level w i l l  c lea r ly  contribute to thromboembolism (179).
Several epidemiological studies have related elevated fibrinogen 
levels to adverse events in cerebrovascular and coronary a r te ry  
disease (135,180,183) and at least one study has correlated fibrinogen 
levels with extent of coronary atheroma (184). Kannel indicated tha t 
th is  e f fe c t  was independent of any association with smoking habit and
suggested tha t the e f fe c t  of smoking in a r te r ia l  disease might be 
produced by i t s  a b i l i t y  to raise the plasma fibrinogen (180). I f  
f ibrinogen is  indeed central to the development of atheroma then 
c lea r ly  therapy aimed at lowering i t s  level in ind iv idua ls  at r is k  
could have substantia l benefit .
9.5 SUMMARY
Sub-group analysis of TIA patients and control subjects was 
undertaken to determine whether the changes observed in plasma 
fibrinogen reported in chapters 7 and 8 could be explained by 
differences in smoking habits and incidence of hypertension among the 
groups. I n i t i a l  analysis of the sub-groups c le a r ly  indicates tha t 
neither of these factors accounts fo r  the observed changes. In 
conclusion i t  appears tha t elevated fibrinogen levels are associated 
with c l in ic a l l y  evident a r te r ia l  disease, the presence of hypertension 
and a pos it ive  smoking h is to ry ; the most s ig n if ic a n t  of these three 
influences appears to be the find ing  o f c l in i c a l l y  evident a r te r ia l  
disease. I f  elevated plasma fibrinogen is  implicated in the production 
of a r te r ia l  disease then pharmacological attempts to lower i t  in 
selected ind iv idua ls  may be rewarding.
Chapter 10
CONCLUSIONS 
10.1 INTRODUCTION
The management of trans ien t ischaemic attacks associated with 
carotid  a rte ry  disease is  a controversial top ic . This chapter w i l l  
attempt to draw together the find ings of th is  thesis and discuss them 
in the context of these controversies. The f i r s t  section w i l l  consider 
the investiga tion  of patients with TIAs and the second part w i l l  look 
at the treatment o f d i f fe re n t  groups of patients categorised by 
presence or absence o f carotid  a rte ry  disease. Section three w i l l  
consider the possible ro le of rheological therapy in patients with 
cerebrovascular disease. The f in a l  section w i l l  discuss ideas fo r  
fu ture research which have been generated by the f ind ings of the 
studies reported in th is  thesis.
10.2 INVESTIGATIONS
The diagnosis o f trans ien t ischaemic attacks depends la rge ly  on 
accurate and complete h is to ry  taking. Once th is  has been done, a f u l l  
physical examination should be carried out, and in an e f fo r t  to 
discover the l i k e ly  cause of an attack, p a rt icu la r  a tten tion  should be 
paid to examination of the cardiovascular system. Examination of the 
pulse and of the precordium should be carried out ca re fu l ly  in an 
e f fo r t  to detect abnormalities which may indicate underlying va lvu la r 
disease. Examination o f the peripheral pulses on both sides may 
indicate evidence of widespread vascular disease. Measurement of the 
blood pressure in both arms is  important not only to detect 
hypertension, but to search fo r  any abnormality which might ind icate 
disease of the proximal great vessels. Cardiovascular examination 
should also include careful examination of the op tic  fundi which may, 
in unusual circumstances, provide evidence of embolic disease.
Standard haematological and biochemical blood tests  may y ie ld  
important information in patients with TIAs. A f u l l  blood count may 
reveal polycythaemia or a high-normal haemoglobin which may be 
re levant. Abnormally large p la te le t  counts may also be of diagnostic 
importance. Bearing in mind the well demonstrated association of 
coronary artery  disease and trans ien t ischaemic attacks, the 
estimation of fas t ing  blood l ip id s  is  of value. A random blood sugar 
should also be measured.
Other investigations which should be carried out on a l l  patients 
include a 12 lead ECG to search fo r  other evidence of myocardial 
ischaemia, va lvu la r disease, or arrhythmia. I f  th is  inves tiga tion , or 
any aspect of examination of the cardiovascular system, reveals 
evidence o f cardiovascular disease, an echocardiogram and 24 hour
ambulatory ECG monitoring should also be performed (185,186). The 
increased incidence of unsuspected va lvu la r disease in young patients 
suggests tha t an echocardiogram should be carried out in a l l  patients 
under the age of 45 years regardless of the presence of signs, or 
pos it ive  investigations ind ica ting  myocardial disease. A ll patients 
should have cerebral computed tomograpy to exclude in trac ran ia l 
disease which may mimic TIA.
Non-invasive evaluation of the carotid  c ircu la t io n  is  indicated 
in a l l  pa tients. A number o f accurate methods are now in use and the 
best of these appear to be combined tes ts : occuloplethysmography and 
carotid  phonoangiography; or Doppler imaging and spectrum analysis; or 
Duplex scanning. Each of these routines is  s u f f ic ie n t ly  accurate to 
detect haemodynamically s ig n if ic a n t  carotid  stenosis in more tha t 90% 
of cases. I t  is  probably not important which of these investigations 
is  u t i l is e d ,  provided the investigators have s u f f ic ie n t  experience in 
the application and in te rp re ta t io n  o f the tes ts . I t  seems l i k e ly  tha t 
Duplex scanning, a combination o f real time ultrasonography and 
spectrum analysis w i l l  provide the best screening method fo r  caro tid  
disease in the fu tu re . The a b i l i t y  of th is  te s t  to d iscrim inate 
between f ib rous, c a lc i f ie d ,  and haemorrhagic plaques may allow 
patients to be categorised d i f fe re n t ly  with regard to r is k  of 
recurrent stroke (45,98).
In patients who have pos it ive  carotid  screening tes ts , and in 
whom surgery is  contemplated, carotid  angiography should be carried 
out. This is  s t i l l  most often done by a conventional in t r a -a r te r ia l  
in jec t io n  but some centres now use d ig i ta l  subtraction angiography. 
This does not carry the r isks  associated with in t r a -a r te r ia l  in je c t io n  
but i t s  resolution is  less than tha t of conventional angiography.
In t ra -a r te r ia l  angiography should be carried out by experienced 
rad io log is ts  i f  an acceptably low complication rate is  to be achieved 
(70).
10.3 TREATMENT
In most series a m a jority  of patients with carotid  t e r r i t o r y  TIAs 
have disease of the in terna l carotid  a rte ry  (34,50,82-85). I f  th e ir  
carotid  stenosis is  haemodynamically s ig n if ic a n t  and ip s i la te ra l  to 
th e ir  syptoms then these patients are candidates fo r  carotid  
endarterectomy, assuming tha t the lesion is  su rg ica l ly  accessible.
The association between carotid  stenosis and subsequent stroke is  
complex. I t  is  apparent tha t a symptomatic, high grade stenosis 
predisposes to a high r is k  of stroke, while an asymptomatic stenosis 
o f s im ila r  degree or a low grade symptomatic lesion carries a much 
lesser r is k .  This may be explained by the fa c t  tha t a large plaque 
which causes a high grade stenosis is  more l ik e ly  to be unstable and 
associated with thrombus formation. Conversely, a smaller plaque or a 
large asymptomatic plaque is  l i k e ly  to be more stable and less l i k e ly  
to be associated with thrombus formation and subsequent emboli. I t  is  
l ik e ly  tha t,  as our understanding of plaque morphology and re la ted 
stroke r is k  increases, surgical treatment w i l l  be offered not simply 
fo r  symptomatic high grade stenosis but fo r  stenosis re la ted to 
spec if ic  types of plaque. Usual practice in the UK at present however, 
is  to confine surgical treatment to patients with symptomatic stenosis 
of at least 25% (152).
The re la t iv e  merits o f surgical and medical therapy are being 
studied at present in a large mult inational randomised t r i a l  of 
carotid  endarterectomy and asp ir in  therapy. While the resu lts  w i l l  not 
be known fo r  some time yet i t  is  possible to speculate on the l i k e ly  
conclusions which w i l l  be drawn from the t r i a l .  The difference between 
the benefits of surgery and medical therapy is  l i k e ly  to be small and 
the conclusion may be tha t i f  surgery can be carried out with a 
morbidity and m o rta l i ty  below a certa in level then i t  should be
preferred to medical therapy. On the other hand surgery with a higher
morbidity and m o rta l i ty  is  l i k e ly  to be less benefic ia l than medical
therapy. This w i l l  mean tha t carotid  surgery should probably only be
carried out in recognised centres where many operations are done and 
appropriate expertise is  ava ilab le. Although the benefits o f asp ir in  
therapy in TIA and stroke have not been conclusively demonstrated the 
available evidence suggests tha t a reduction in stroke rate of up to 
16% is  l i k e ly  (187-189).
With regard to patients who have minimal carotid  disease there is  
l i t t l e  argument in the UK tha t at present they should be managed 
conservatively with medical therapy. These patients should probably be 
kept under review using non-invasive carotid  tes t ing  to monitor 
progress of th e ir  carotid  plaque. Any increase in plaque size or 
recurrence of symptoms might be an ind ica tion  to reconsider surgical 
in te rven tion . At present there is  in s u f f ic ie n t  information on the 
natural h is to ry  o f carotid  plaque and i t s  modification by drug therapy 
to speculate on the ideal management of these patients.
In patients in whom a contra la tera l stenosis is  found, ie , an 
asymptomatic stenosis, surgery is  not indicated. Although a great 
number of operations fo r  asymptomatic caro tid  stenosis are carried out 
annually in the United States (151), th is  approach has not found
favour with vascular surgeons in th is  country (152). Asymptomatic 
carotid  b ru its  are associated with increased r is k  of stroke in men 
over 45 years of age, but the side o f the stroke correlates poorly 
with the side of the b ru i t .  In addition there is  a corre la t ion  with 
increased r is k  of myocardial in fa rc t io n  in the same group, ind ica ting  
tha t such b ru its  are more important as ind icators of generalised 
a r te r ia l  disease than as harbingers of ip s i la te ra l  stroke (190). A 
recent study however, has suggested tha t an asymptomatic stenosis 
greater than 50% is  associated with an increased incidence of 
ischaemic cerebral events (191). Until the natural h is to ry  of 
asymptomatic stenosis is  c le a r ly  defined and the stroke r is k  
evaluated, i t  w i l l  not be possible to evaluate the l ik e ly  benefits of 
surgery in these circumstances. However as already observed, i t  is  
possible tha t with improved understanding and recognition o f plaque 
morphology, sub-groups of patients more l ik e ly  to benefit from surgery 
w i l l  be id e n t i f ie d .
The f in a l  group of patients to be considered in are those in whom 
no cause fo r  the TIA can be found. The follow-up studies presented in 
th is  thesis (Chapter 6) ind icate tha t such patients do not necessarily 
have a benign prognosis. The find ing  of an elevated fibrinogen level 
in these patients suggests tha t undetected a r te r ia l  disease may be the 
basis of th e ir  symptoms. These patients should probably be treated 
along lines s im ila r  to those in whom non-haemodynamically s ig n if ic a n t  
a r te r ia l  disease is  detected. Management should be i n i t i a l l y  by 
medical therapy, with routine review using non-invasive caro tid  
imaging. The subsequent appearance of haemodynamically s ig n i f ic a n t  
lesions should be regarded as a reason to reconsider surgical
in tervention and recurrent trans ien t symptoms should perhaps be an 
ind ica tion  fo r  more aggressive investiga tion  in the form of 
arteriography.
10.4 RHEOLOGICAL THERAPY
Rheological therapy may be directed at one or more of the pr inc ipa l 
factors which influence blood v iscos ity ,  ie , haematocrit, plasma 
v isco s ity ,  red ce ll deformabi1i t y  and red ce ll aggregation. The 
possible therapies which could be directed at each of these 
determinants and th e ir  l i k e ly  benefits in patients with 
cerebrovascular disease w i l l  now be considered in turn.
Haematocrit
As was observed e a r l ie r  in th is  thesis several studies have 
indicated tha t elevated haematocrit may be a r is k  fac to r fo r  stroke 
(125) and TIA (174). However, more recent studies have indicated tha t 
the re la tionsh ip  between haematocrit and cerebrovascular events may be 
more complex than was i n i t i a l l y  appreciated. In a secondary study on 
the patients included in the co-operative study of 
in trac ra n ia l-e x trac ran ia l bypass, Wade was unable to demonstrate any 
increased r is k  of cerebrovascular events in patients with high-normal 
haematocrits compared to those with normal leve ls (192). He was 
equally unable to demonstrate, among those who had strokes, tha t those 
with high haematocrits were more severely disabled. This is  c le a r ly  at 
odds with Harrison's previous study which demonstrated tha t in
patients with carotid  occlusion, the volume of cerebral in fa rc t  
measured by CT scan was re lated to the height of the haematocrit 
(129).
This apparent d ifference between these studies may be due to the 
fa c t  tha t a l l  the patients in Wade's study were treated with asp ir in . 
This raises the p o s s ib i l i t y  tha t the e f fe c t  of haematocrit is  not 
re lated to blood v isco s ity  but rather to i t s  e f fe c t  on p la te le t  
function. As discussed in chapter 3 the mechanics o f bulk blood flow 
d ic ta te  tha t erthrocytes occupy axial positions and p la te le ts  are 
displaced to the periphery o f the flow, the high shear areas close to
the vessel w a ll.  As the haematocrit increases, th is  tendency of
p la te le ts  to be displaced la te ra l ly  also increases and they are 
consequently more prone to damage in these high shear areas. High 
shear damage to p la te le ts  can induce p la te le t  aggregation and in i t i a t e  
thrombus formation. I t  is  possible tha t the e f fe c t  of haematocrit is  
thrombogenic rather than v isco s ity  re la ted. This would account fo r  the
abo li t ion  of the e f fe c t  of haematocrit in Wade's study in re la t io n  to
the prescrip t ion  of asp ir in .
The in troductory part o f th is  thesis drew a ttention  to the 
i n i t i a l  encouraging resu lts  from a number of studies of haemodi1ution 
in acute stroke (138-140). Very recently the resu lts  of two extensive, 
m u lt i-cen tre , randomised, studies of haemodilution in Sweden and I t a ly  
have been reported.
In the Scandinavian study, co-ordinated by Asplund, almost 400 
patients were randomised to treatment and control groups (193,194).
The protocol fo r  the treatment group is  shown in table 10.1. When the 
control and treatment groups were compared at three months there was 
no difference in m o rta l i ty  and th is  re flec ted  the resu lts  found in the 
f i r s t  p i lo t  study (140). However, a f te r  the same in te rv a l ,  the
Day 1
Day 2
Days 3-5
Hct 38-42% Venesect 250ml + infuse 500ml dextran
Hct > 42% Venesect 500ml + infuse 500ml dextran
Hct 38-42% Venesect 250ml + infuse 500ml dextran
Hct > 42% Venesect 500ml + infuse 500ml dextran
Dextran 500ml
TABLE 10.1
ISOVOLAEMIC HAEMODILUTION PROTOCOL: SWEDISH MULTICENTRE STUDY
neurological scoring among the survivors was also no d i f fe re n t  between 
the groups, and th is  was at variance with the previously reported 
resu lts  (140). I t  appears tha t th is  regimen of haemodilution bestows 
no benefits . In fa c t ,  when the two groups were compared with regard to 
the to ta l number of cardiovascular events, including myocardial 
in fa rc t io n ,  congestive heart fa i lu re  and pulmonary thromboembolism, 
there was an excess of events in the treatment group.
The I ta l ia n  m u lt i-centre  study was an even larger t r i a l  of 
haemodilution in acute stroke co-ordinated by Candelisi (195, Royal 
Society of Medicine, Forum on Haemorheology, London, September, 1987, 
personal communication). In th is  study there were over 600 patients in 
each group and the protocol fo r  the treatment group is  shown in table 
10.2. When the two groups were compared at s ix  months the m o rta l i ty  
rates were s im ila r .
These resu lts  are obviously disappointing fo llow ing the 
encouraging resu lts  obtained from the i n i t i a l  studies. Possible 
reasons fo r  fa i lu re  of haemodi1ution to make a d ifference in these 
patients are f i r s t l y  tha t the in tervention is  too la te  and delay 
between onset of stroke and the time o f admission to hospital 
e f fe c t iv e ly  prevents any therapy from being applied soon enough. The 
second p o s s ib i l i ty  is  tha t the reduction in v iscos ity  obtained from 
these two protocols is  too small. While venesection reduces 
haematocrit and therefore v isco s ity ,  infusion of dextran increases 
plasma v iscos ity  and the net change in v iscos ity  may not be large. We 
cannot be certain of th is  since v iscos ity  was not measured in these 
studies e ithe r before or a f te r  haemodilution. Another p o s s ib i l i t y  is  
tha t the reduction of haematocrit reduces oxygen de livery  to such an 
extent tha t th is  o ffse ts  any benefit obtained from reduction in 
v iscos ity .
On admission Hct > 35%
6-12 hours post admission Hct > 35%
12-24 hours post admission Hct > 35%
Venesect 350ml
+ infuse 350ml dextran
Venesect 350ml 
+ infuse 350ml dextran
Venesect 350ml 
+ infuse 350ml dextran
TABLE 10.2
ISOVOLAEMIC HAEMODILUTION PROTOCOL: ITALIAN MULTICENTRE STUDY
In view of the disappointing resu lts  obtained from these t r i a l s  
i t  has been suggested tha t fu r the r studies should examine the 
p o s s ib i l i ty  tha t only certa in types of stroke w i l l  benefit from 
haemodi1ution and selection of cases fo r  haemodilution may be 
necessary (196). In addition hypervolaemic rather than isovolaemic 
haemodilution may be necessary (196). However, i t  seems tha t more work 
requires to be done in laboratory models or small c l in ic a l  studies 
before fu r the r large scale c l in ic a l  t r i a l s  are undertaken.
While i t  appears now tha t haemodi1ution fo llow ing acute stroke 
does not work, at least in unselected series, the p o s s ib i l i t y  tha t 
haemodi1ution may o f fe r  some protection in patients at r is k  of stroke 
must be considered. However, while Harrison demonstrated tha t patients 
with TIAs had an increased haematocrit compared to controls (174) the 
f igures presented in th is  thesis do not agree. In addition Wade's 
study of haematocrit in patients with symptomatic cerebrovascular 
disease indicates tha t patients with higher haematocrits do not appear 
to fare worse than others i f  asp ir in  is  prescribed (192). I t  seems 
l ik e ly ,  therefore, tha t haematocrit reduction in patients with 
symptomtic cerebrovascular disease is  not indicated, except in cases 
of primary p ro l i fe ra t iv e  polycythaemia which is  known to carry a 20 
fo ld  increased r is k  of stroke (124).
Fibrinogen
Although increased haematocrit has not been demonstrated in TIA 
patients i t  has been shown in th is  thesis tha t these patients do have 
elevated fibrinogen leve ls and furthermore tha t the magnitude o f the 
elevation appears to be re lated to the degree of detectable a r te r ia l  
disease. These observations f i t  well with work done by other authors
which indicates tha t fibrinogen is  a r is k  fac to r fo r  stroke and 
coronary a rte ry  disease (135,180,183). Fibrinogen is  re lated to 
smoking habit but recent data from the Framingham study have indicated 
tha t the r is k  associated with fibrinogen is  present even when smoking 
habits are taken in to  account (180). I t  is  possible tha t the 
deleterious e ffec ts  of c iga re tte  smoking are mediated in part by i t s  
e f fe c t  on plasma fibrinogen leve ls .
The re la tionsh ip  between raised plasma fibrinogen and a r te r ia l  
disease is  complex and not f u l l y  understood. An association has been 
convincingly demonstrated in epidemiological studies and although th is  
does not imply any causative re la t ionsh ip , i t  is  possible to speculate 
tha t such a re la tionsh ip  ex is ts . The development of a r te r ia l  disease 
may be encouraged by elevated fibrinogen in a number of ways. I t  may 
enhance endothelial damage by increasing shear stresses at susceptible 
points in the c irc u la t io n ,  i t  may be incorporated in increased 
quantit ies  in to  atheromatous plaques or i t  can lead to increased red 
ce ll and p la te le t  aggregation, and in i t i a t e  thrombus formation.
I f  we are to consider the l ik e ly  benefits o f therapy to reduce 
fibrinogen levels however, we must bear in mind the p o s s ib i l i t y  tha t 
fibrinogen is  simply a marker fo r  a r te r ia l  disease and is  not i t s e l f  
d i re c t ly  implicated in stroke r is k .  In recognition of th is ,  S tuart 
coined the expression "haematological stress syndrome" to describe 
haemostatic abnormalities which accompany a r te r ia l  disease and which 
may arise as a re su lt  of i t  (197). Another d i f f i c u l t y  when considering 
therapy to lower f ibrinogen levels is  the l im ited  number o f drugs 
available to do th is ,  and the hazards associated with those in current 
use (198). In a model of acute global cerebral ischaemia in ra ts , 
Grotta examined the e ffec ts  of acutely lowering fibrinogen leve ls  by 
exchange transfusion. Although he was able to lower blood v is c o s ity
s ig n i f ic a n t ly ,  no d ifference in outcome between treated and control 
animals was observed (199). Ancrod is  a defibrinogenating agent which 
has been used to lower whole blood v isco s ity  in the treatment of acute 
stroke. A small randomised study demonstrated minimal benefit in the 
ancrod treated group over the control group (200). Ancrod therapy is  
l im ited  by the need fo r  parenteral administration and the development 
o f resistance due to antibody formation which occurs in some pa tients . 
C lo fib ra te  lowers fibrinogen as well as l ip id s  but in a large t r i a l  of 
th is  therapy in ischaemic heart disease there was an unexplained 
excess o f non-cardiac deaths in the treatment group (201). F in a l ly ,  
p e n to x ify l l in e  may reduce fibrinogen leve ls but i t  may also act v ia  
other rheological mechanisms and i t s  mode o f action has not been f u l l y  
determined. In practice there is  as yet in s u f f ic ie n t  evidence to 
suggest tha t lowering fibrinogen levels using any of these methods in 
patients at r is k  of stroke is  desirable.
Red Cell Deformabi 1 it.y and Aggregation
Several studies have suggested tha t red ce ll r i g id i t y  may be 
increased in stroke although Pollock demonstrated tha t red ce ll  
r i g id i t y  is  not an independent r is k  fac to r (121). Recent work however, 
has indicated tha t what was thought to be increased red ce ll  r i g i d i t y  
is  ac tua lly  an increase in leucocyte r i g id i t y ,  and the relevance of 
th is  is  uncertain (202). The f igures obtained from the studies 
reported in th is  thesis ind icate tha t in TIA patients red ce ll 
deformation is ,  i f  anything, increased and therefore therapy to 
improve th is  even fu r the r would appear unnecessary. One small 
randomised study reported tha t p e n to x ify l l in e ,  a drug which reduces 
red ce ll r i g id i t y ,  was superior to asp ir in  and dipyridamole in
preventing recurrent symptoms in patients with TIA (203). However 
p e n to x ify l l in e ,  in addition to i t s  action on red ce ll deformabi1i t y ,  
reduces fibrinogen leve ls , reduces blood v isco s ity  and in h ib i ts  
p la te le t  aggregation; any benefic ia l e ffec ts  could therefore be due to 
a number of factors  (204).
Red ce ll  aggregation is  influenced la rge ly  by haematocrit and by 
plasma fibrinogen leve ls . No evidence exists to suggest tha t abnormal 
aggregation may independently contribute to stroke r is k  nor tha t i t  
may be manipulated other than v ia a lte ra t ions  in haematocrit or 
fibrinogen leve ls.
Rheological Therapy - Summary
In conclusion i t  appears tha t apart from increased fibrinogen 
levels leading to an increased plasma v isco s ity ,  TIA patients have no 
rheological abnormalities which might be amenable to treatment. Until 
the re la tionsh ip  between elevated fibrinogen and cerebrovascular 
disease is  better defined there is  no ind ica tion  to lower plasma 
fibrinogen other than by in d ire c t  means such as stopping smoking and 
con tro l l in g  hypertension. I t  appears tha t rheological therapy has been 
la rge ly  unsuccessful so fa r  in reducing stroke r is k  and l im i t in g  
m o rta l i ty  and d is a b i l i t y  fo llow ing the onset o f acute stroke.
10.5 FURTHER STUDIES
The follow-up study reported in chapter 6 indicated tha t patients 
with a normal Doppler examination fo llow ing a c lassica l caro tid  
t e r r i t o r y  TIA were at increased r is k  o f developing a stroke
subsequently. I t  seems tha t close study of th is  group in a prospective 
fashion may y ie ld  clues to the l ik e ly  aetio logy of th e ir  attacks, 
p a r t ic u la r ly  i f  repeated non-invasive imaging of the carotids is  
undertaken. A small study in these patients is  under way a t present, 
comparing the f ind ings of Doppler imaging and spectral analysis with 
duplex scanning; early  resu lts  ind icate tha t both routines produce 
identica l resu lts . Longitudinal study of these patients, using one or 
both of these imaging techniques, may detect the development of 
s ig n if ic a n t  atheroma which may account fo r  th e ir  symptoms. Until the 
cause of th e ir  symptoms is  adequately explained i t  would seem prudent 
to prescribe a n t i -p la te le t  medication fo r  a l l  of these ind iv idua ls . 
These studies could use fu lly  be integrated with s im ila r cohort studies 
of patients with non-s ign if ican t carotid  stenosis and those with 
asymptomatic stenosis. Only long term follow-up of groups of patients 
in th is  fashion w i l l  allow an understanding of the natural h is to ry  o f 
TIA and stroke and th e ir  association with extracranial a r te r ia l  
disease. I t  is  lack of such epidemiological knowledge which prevents 
agreement on the most appropriate management o f, fo r  example, 
asymptomatic carotid  stenosis.
The fu ture o f rheological studies in cerebrovascular disease 
seems less certa in now than i t  did some months ago. A series o f 
negative studies, the multicentre t r i a l s  of haemodi1ution being the 
most s t r ik in g  examples, has produced doubt about the ro le of 
rheological factors in the pathophysiology o f cerebrovascular disease. 
Nevertheless many questions remain to be answered. The pr inc ipa l 
rheological f ind ing  of th is  thesis was the s ig n if ic a n t  e levation of 
fibrinogen levels in TIA patients and the association of th is  w ith 
detectable carotid  disease. Longitudinal study of TIA patients with 
monitoring of th e ir  haemorheological parameters, p a r t ic u la r ly
f ib r inogen, w i l l  ind icate i f  any p a rt icu la r  abnormality predisposes to 
stroke. A randomised t r i a l  of therapeutic defibrinogenation in 
patients with elevated fibrinogen levels would help to ind icate i f  
fibrinogen is  simply a marker fo r  a r te r ia l  disease or is  implicated in 
i t s  pathogenesis. Unfortunately no sa tis fa c to ry  drugs are yet 
available fo r  th is  purpose and such studies must be postponed.
Ten years ago an e d ito r ia l  in the Lancet, addressing the advances 
made in haemorheological studies, stated tha t "we s t i l l  await proof 
tha t changes in v iscos ity  precede c l in ic a l  manifestations (o f disease) 
and are the prime fac to r"  (205). Despite the many discoveries of the 
past decade we may s t i l l  say the same today.
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